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Dear K:
On behalf of AMAC, I am pleased to provide to you the enclosed report, "Strategic
Considerations for Support of Humans in Space and Moon/Mars Exploration
Missions." In the process of developing this report, AMAC deliberated with many
individuals, including NASA program and project managers, scientists, and
engineers, various advisory committees, and our Russian space partners. It
represents a consensus among a diversity of perspectives regarding the life
sciences research priorities.
This is a unique report in that it provides both a top-down and "grass roots"
consensus of the internal and external life sciences communities. It is built upon a
comprehensive database that serves to organize the major enabling research
thrusts, integrates ground-based programs with flight resources, and provides a
basis for identifying the national and international organizations and resources that
must be brought to bear if we are to achieve our goal of space exploration.
The most salient finding based on a detailed analysis of all the scientific information
available is, "there is no issue, a priori, that precludes human exploration to the
Moon or Mars, if appropriately focused research is conducted and enabling
technologies developed." Three major problems that must be the major focus of the
biomedical life sciences program to support exploration are identified in
Recommendation 1.
The AMAC will work with all elements of NASA to integrate the findings and
recommendations of the report with the planning for future space missions, including
the Space Station Freedom, the lunar outpost, and the mission to Mars. The report
will be updated and refined as NASA plans and programs are further developed.
The efforts of the Life Sciences Division staff to create and consolidate the
supporting scientific database for this report are to be commended. This database is
unique in this nature and more detailed than anything produced by other science
disciplines. It is a demonstration of the life sciences' intent to proceed with
implementation of these strategic considerations for human space flight missions.
Mr. Caleb B. Hurtt
June 1, 1992
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This report comes at a time when detailed analysis of program priorities for
exploration missions can play a critical role in defining the requirements and setting
the pace for future space activities. It has been a tremendous opportunity to work
together with so many individuals and develop a consensus of life sciences
research priorities. I am pleased to turn the report over to you and the NAC.
Sincerely,
Harry C. Holloway, M.D.
Deputy Dean
Enclosure
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Reply to Attn of: •
Dr. Harry C. Holloway
Uniformed Services University of
Health Sciences
4301 Jones Bridge Road
Bethesda, MD 20814-4799
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Dear Harry:
You and the AMAC are to be commended for your efforts to produce such an
important, useful, and timely document, "Strategic Considerations for Support of
Humans in Space and Moon/Mars Exploration Missions." You have put forth a
strong, sound and reasonable strategy for setting life sciences research priorities
and making decisions that will enable human exploration missions.
The report demonstrates a thorough understanding of the resources that are
required if we are to meet the challenge of human space exploration. A broad, far-
reaching, and integrated plan has been developed to guide the Nation's scientists,
engineers, mission planners and policy makers in their decisions and commitments
to the expansion of our knowledge in space life sciences.
On behalf of the NAC, I want to express congratulations to you, the AMAC, and the
Life Sciences staff for their significant efforts in planning our nation's human
exploration missions. I am confident that the findings and recommendations
contained in this report will provide a solid foundation for our future space missions.
Sincerely,
C_ale_B. Hurtt
Chairman, NAC

hlASA
National Aeronautics and
Space Administration
Washington, D.C.
20546
Reply to Attn of: Mr. Daniel S. Goldin
Administrator
Code A
NASA Headquarters
Washington, DC 20546
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Dear Dan:
I am pleased to forward with this letter the report of the NASA Advisory Council's
Aerospace Medicine Advisory Committee. The report, "Strategic Considerations
for Support of Humans in Space and Moon/Mars Missions," is the product of an
intensive study by the AMAC, with participation from many NASA program
managers, project scientists and engineers, advisory committees, and
international science community. It represents an integrated consensus for
establishing life sciences research priorities and making decisions that will
enable human exploration missions.
This report is a template that will guide NASA scientists, mission planners and
policy makers in their decisions and commitments to the expansion of our
knowledge in space life sciences. It is based on an extensive database that
serves to organize the major enabling research thrusts, integrates ground-based
programs with flight resources, and provides a basis for identifying the national
and international organizations and resources that must be brought to bear if we
are to achieve our goal of space exploration.
The AMAC analysis concluded that within the confines of our current knowledge,
there was no issue a priori that precludes human exploration of the Moon or Mars
if appropriately focused research is conducted and enabling technologies are
developed. AMAC did conclude that the three primary areas for research and
technology development are: characterizing and alleviating risks from radiation,
long-duration exposure to microgravity, and reliable life support systems. The
AMAC analysis produced 15 findings and recommendations that either were
considered "overarching" in that they affected fundamental policies concerning
research and technology needs, or were categorized into one of three major
thrusts: Environmental Health and Life Support Systems; Countermeasure
Systems; or Medical Care Systems. The report also provides the resource
requirements and milestones for life sciences deliverables.
To accomplish the strategic considerations set forth in this report, NAC strongly
recommends a single focus of responsibility and accountability, within the NASA
top management, for carrying out all agency life sciences/life support activities.
The most effective structural solution for such focus is best decided by the agency
Mr. Daniel S. Goldin
June 1, 1992
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following review of previous committee recommendations and inputs from the
Life Sciences community.
In conclusion, the report provides a strong foundation for planning our future
space missions, it represents a consensus for setting life sciences research
prioirities, and it offers an integrated plan for making decisions to enable
exploration missions. It is a high water mark for planning the respective
programs for the future. Harry Holloway and his committee members, as well as
the Life Sciences Division staff and other participants have made a significant
contribution to the future of the nation's space program. It is a job well done.
Sincerely,
Caleb Hurtt, NAC Chairman
Enclosures
PREFACE
The Augustine Committee developed an exciting, challenging blueprint for the
future of the United States space program. They postulated that NASA has five
space related operational missions: Space Science; Mission to Planet Earth;
Space Utilization (goods and services made available for use on Earth);
Transportation (economically reliable delivery of payloads to orbit); and Mission
from Planet Earth, which culminates with President Bush's Space Exploration
Initiative.
NASA also has a sixth mission, implicit in the Space Act, to develop the
technology base required to assure continued American preeminence in space
for the overall benefit of the nation. The debate over mission priorities, timing,
and the size of the NASA budget continues within both the Administration and
Congress. While it is still not clear which goals will be embraced now and in the
future, whatever the choices, the nation should have the capability to execute
the options chosen within predictable cost and schedule estimates.
Key to that capability will be the research and advanced technology data base
that is available in the technologies critical to the chosen missions. However,
over the past 20 years, NASA's investment in advanced space research and
technology has been inadequate. Today's technology base is inadequate to
support advanced space missions. It should be obvious that a modest
increased investment in basic technologies today can reap major savings in
future costs and schedules. But the program remains underfunded, at
approximately two percent of the NASA budget, by a factor of nearly three. 1
By far, the biggest challenge postulated for NASA is Mission from Planet Earth,
the focus of human activity in space, culminating with permanent presence on
the Moon and landings on Mars. The President proposes, Congress opposes.
But the question is not really whether we, either as a nation or a planet, will
make the journey. The question is when.
We should use whatever time is available before a decision to proceed is made,
to reduce fundamental uncertainties and assure that enabling technologies are
ready for development. For the Moon/Mars exploration missions three areas
predominate -- propulsion, power, and support for humans in space.
This AMAC report, now fully endorsed by the NASA Advisory Council, is a
milestone in the history of human space flight. Concluding that there is no issue
that precludes human exploration of Mars, it defines a focused research and
technology program to address the risks of radiation, long-duration exposure to
microgravity, and reliable life support systems.
Footnote 1. The Report of the Advisory Committee on the Future of the U.S. Space
Program (1990) and the National Research Council Report (1987), "Space Technology
to Meet Future Needs."
This report "Strategic Considerations for Support of Humans in Space and
Moon/Mars Exploration Missions," is intended to serve as a template to guide
scientists, engineers, mission planners, and policy makers in their decisions
and commitments to the expansion of our knowledge in space life sciences. It
develops a strong strategy for setting life sciences research priorities and
making decisions that will enable human exploration missions. It is a blueprint
for our future exploration in space and the challenges that NASA, other
agencies, and our international partners will face as we begin this new eraof
exploration.
The report is organized into six sectiohs. Section I provides the Executive
Summary and contains the 15 findings and recommendations. The
recommendations are presented as follows: Overarching Recommendations
(Recommendations 1 - 11); Environmental Health and Life Support
recommendations (Recommendation 12); Countermeasures Systems
recommendations (Recommendations 13 & 14); andMedical Care Systems
recommendation (Recommendation 15). In addition, the Overarching
Recommendations are further categorized according to grouhd, flight, or both
types of activities. _ identifies resource requirements and milestones
for deliverables necessary to accomplish the research required to support
human exploration mission solutions described in Sections IV. V. & Vl that
address the research thrusts (i.e., Environmental Health and Life Support
Systems, Countermeasures Systems, and Medical Care Systems). For each
thrust, the constrained and robust program is described. The constrained
program included those elements defined as essential and critical- "criticality
1 & 2"), and the robust program included elements of all four criticalities m
"criticalities 1,2, 3, & 4." Section III addresses the Mission From Planet Earth
goal, specifically, "to maximize scientific return from exploration that will benefit
the people on Earth."
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I, EXECUTIVE SUMMARY
During the next several decades our nation will embark on human exploration in
space. In the microgravity environment we will learn how human physiology responds
to the absence of gravity and what procedures and systems are required to maintain
health and performance. As the human experience is extended for longer periods in
low Earth orbit, we will also be exploring space robotically. Robotic precursor
missions, to learn more about the lunar and martian environments will be conducted
so that we can send crews to these planetary surfaces to further explore and conduct
scientific investigations that include examining the very processes of life itself.
Human exploration in space requires the ability to maintain crew health and
performance in spacecraft, during extravehicular activities, on planetary surfaces, and
upon return to Earth. This goal can only be achieved through focused research and
technological developments. This report provides the basis for setting research
priorities and making decisions to enable human exploration missions (Table I-1).
TABLE I-1
MISSION SCENARIO 1
MOON
-- Visit (IOC)*
- Timeframe: 2003-2006
accelerated date 2000
- Surface: 14days
- Crew Size:6
-- Outpost**
- Timeframe: 2007-2010
- Surface: 40-180 days
- Crew Size: 6
-- Settlement**
- Timeframe: 2007-2011
- Duration: 360-600 days
- CrewSize: 6-18
MARS
-- Vis_ (Ioc)*
- Timeframe: 2014-2018
- Duration: 600-1000 days
- Surface: 30-100 days
- Crew Size: 6
-- Outpost
- Timeframe: 2016-2020
- Duration: 1500 days
- Surface:600 days
- Crew Size: 6
-- Settlement
- Evolving capability
* Initial Operational Capability
** Mars Simulation would include 120 to 460-day Moon orbit
The report expands the recommendations of several previous advisory committees
(Table I-2). It is based on the results of comprehensive studies conducted by 12 Life
Sciences Discipline Working Groups (DWGs). The appendices (Section VII) contain
the methodology and membership for this report: In conjunction with NASA scientists,
the DWGs defined the unresolved issues considered critical to advancement of
knowledge in their discipline.
Footnote 1. This report is based on current life sciences knowledge bases, Vision 21, The
NASA Strategic Plan (1992) and Offices of Aeronautics and Space Technology, and
Exploration planning (Appendix G). Table 1 is not based on any single specific mission
architecture.
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Table I-2 Recommended Life Sciences Milestones
LIFE SCIENCES AMAC REPT SEI DATA NRC REPT AUGUSTINE SYNTHESIS NASA HEI 90- ROBBINS LIFE SCI
CAPABILITIES TO SUPPORT (SEE BOOK (OABT} (SEE REPT (SEE REPT (SEE DAY REPT REFIT (SEE STRATEGIC
EXPLORATION MISSIONS APPENDIX G) (SEE APPENDIX G) APPENDIX G) APPENDIX G) (SEE APPENDIX G) PLAN (SEE
APPENDIX G) APPENDIX G) APPENDIX G)
1. ENHANCED X X X -- X X X X
RESEARCH AND
ANALYSIS PROGRAM
DATA COLLECTION
USING FREE FLYERS
3, COUNTERMEASURES X -- X -- -- -- X X
FOR EXTENDED
HUMAN-TENDED SSF
CAPABILITY
.,... _,_,_.,., ..................................... ............ ,.............
4. HUMAN FACTORS X X X -- -- X X X
GROUND SIMULATORS
5. HUMAN-RATED CELSS X X X X X -- X X
GROUND TESTBED
_;:_;_s_i__s_ ..... x x x x x x x x
TESTBED
7. MOON DATA X X .... X X X
REQUIREMENTS
................................................ i ! !
8. LIFE SCIENCES X X -- X X X X X
STANDARDS AND
REQUIREMENTS FOR
MOON MISSIONS
9, MOON SCIENCE X X -- X X X X X
OPERATIONS
10. MARS DATA X X -- X X X X X
REQUIREMENTS
......____._____.........................................................: .. : ............... .................: ...................: .................
11. LIFE SCIENCES X X -- X X X X X
STANDARDS AND
REQUIREMENTS FOR
MARS MISSIONS
12. MARS SCIENCE X X -- X X X X X
OPERATIONS
An Executive Steering Committee, composed of members from the Aerospace
Medicine Advisory Committee (AMAC) and Chairpersons of the DWGs, and other
distinguished advisors initially prioritized those issues into three major research
thrusts (Figure I-1) that enable missions to Moon and Mars. Finally, the full AMAC
reviewed and prioritized the critical issues for this report (Table I-3). The report
describes constrained and robust programs. The constrained program was defined as
essential and contained criticality 1 and 2 elements; and the robust program included
1, 2, 3, and 4 criticalities. The constrained program contains those elements
necessary for all human missions, but it may not be sufficient for Mars mission
execution.
From its review, AMAC concludes that, within the current confines of our knowledge,
no issue, a priori, precludes human exploration of the Moon or Mars if appropriately
focused research is conducted and enabling technologies are developed. However,
experimentation and/or long-term experience in space may disclose unexpected
difficulties that will require reassessment of this conclusion.
The AMAC analysis identified 15 major issues (i.e., findings) and provides
recommendations for corrective action. These findings and recommendations either
were considered "overarching," in that they affected fundamental policies concerning
research and technology needs, or were categorized into one of the three major
research thrusts: (1) Environmental Health and Life Support Systems (EHLSS), (2)
Countermeasures Systems (CS), or (3) Medical Care Systems (MCS).
C
2
?,
Figure I-1
ENVIRONMENTAL HEALTH
AND
LIFE SUPPORT SYSTEMS
(EHLSS)
Protect froml_the space
environment
for example:
.Vacuum
.Radiation
•Absence of atmosphere,
food, water
Life Sciences Research Thrusts
COUNTERMEASURE
SYSTEMS
(cs)
Compensate for effects caused
by the space environment
for example:
.Hypogravity
•Confined space
•Limited crew size
MEDICAL CARE
SYSTEMS
(MCS)
Provide clinicalintervention
and or treatment
for example:
•Decompression sickness
,Transfusions
•Bone fracture
Table I-3 Definitions of Criticality
CRITICALITY
CATEGORY
EHLSS
CS
MCS
PROGRAM 1 I 2 I 3 4
.,,..,..,,.,,,,,,.,,,.,,..
,...,,..,,.,,,,,,,,,,,,.,,CONSTRAINED
......,.....,.]:_:i:_:_:i:i:i:i:i:i:i:i:i:i:i:=================================
iiiiiiiiiiiii!i_iii;_i!_:::
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
_:!:i:i:i:_:i:_:i:.:::i:i:i_:i:i:i:i:i:_:i:i:i:i:i:i:i:i:i:i:i:i:_:i:_:i:i:_:i:i::`:_:;:i:i:_:i:i:::i:i:_:i:i:i:i:_:i:i_:_i:i:::i:::i:_:::_::_
ROBUST
CONSTRAINED
ROBUST
CONSTRAINED
ROBUST
Criticality Criteria
Crltlcallty 1 : Consensus that answer Is requlred for Mars mlsslon (known effect and known problem
for mlsslon).*
Crltlcallty 2: Answers mlght be required, but science basls to evaluate rlsk Is not adequate.
Crltlcality 3: Requlred for practical optlmlzatlon of resources (or countermeasure effectiveness)
and mlnlmlzatlon of rlsk.
Crltlcallty 4: Important sclence that Is relevant to exploratlon mlsslon.
*Crewmembers must be able to effectlvely perform mlsslon tasks Intranslt vehlcles and on planetary surfaces;
and must recover, In a reasonable tlme, upon return to earth.
Category Deflnltlons
l_nvlronmental Health and Llfe Suooort Systems (EHLSS_ are deslgned to protect the crew from Inhospitable
space and planetary envlronments.
Countermeasure systems (CS_ are designed to continuously compensate for detrimental physical, physiological
and behavioral manifestations of the space environment (e.g., mlcrogravlty, confined volume). They must
provide acceptable mission performance and postfllght recovery when: (1) EHLSS designed to provide habitable
environmental conditions for the crew are not totally feasible because of mission design, or Inadequacy of
scientific or technological basis, or where cost and schedule are prohibitive; or (2) partial EHLSS failures
occur, until appropriate remedial action Is taken.
Medical Care Systems (MCS_are designed to handle Illness and Injuries based on probability of occurrence, to
restore crew health for continued mission performance, or stabilize an III or injured crewmember for rescue.
MCS are also designed to handle Illness or Injuries resulting from temporary failure, degradation, or maintenance
of EHLSS or CS systems, until full function isrestored.
ENABLED
SCIENCE
BASIC
SCIENCE
I I I
EXPLORATION
CRITICALITY NOT
APPLICABLE
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OVERARCHING RECOMMENDATIONS
To accomplish this recommended work, a single focus of responsibility and
accountability, within the NASA top management, for carrying out all agency life
sciences/life support activities is required. The 15 findings and recommendations are
as follows:
Finding 1: Health risks from exposure to ionizing radiation, long-duration exposure
to microgravity, and reliable, self-sufficient life support systems are the three major
unresolved issues for human exploration.
Recommendation 1: Research and advanced technology development must
focus intensely on characterizing and alleviating risks from radiation, long-
duration exposure to microgravity, and de.velopmentof life support technology.
This effort must include continuing availability of a ground facility for proton and
heavy charged particle (HZE) radiation research, variable gravity centrifuges on
space-based platforms, and ground and space-based testbeds for life support
systems.
Finding 2: In spite of numerous recommendations by previous committees, life
sciences/life support efforts have not been funded or supported as a sustained and
integrated program of research and technology development that will adequately
support Moon/Mars missions.
Recommendation 2: Starting with the FY 1994 budget, provide sustained
support for a phased and integrated program that includes Spacelabs,
international flight platforms, and utilization of Space Station Freedom (SSF)
early in man-tended capability (MTC). Accelerate availability of permanently
man-tended capability (PMC) to develop, test and validate concepts for Moon
and Mars missions, including as a minimum limited bioregenerative life support.
Employ Moon bases when available to enhance the scientific database and
develop, test and validate concepts, hardware and operational protocols for
Mars surface operations.
Finding 3: Robotic precursor missions are required to prevent contamination of Mars
or potential back-contamination to Earth, as well as to collect essential information
necessary for radiation protection and development of life support systems.
Recommendation 3: Implement robotic precursor missions with life sciences
participation to characterize radiation and resources available for life support,
and for designing planetary protection protocols (i.e., contamination of Mars and
back-contamination to Earth).
GROUND-BASED ACTIVITIES
Finding 4: Archiving and frequent updating of a comprehensive life sciences/life
support database do not exist.
4
Recommendation 4: Based on the benchmark database generated during
this study, develop a life sciences life support database by FY 1993, and update
it on a regular basis. Incorporate ground and_ flight-based mission results,
relevant •science and technology data from other NASA organizations, and
evolving exploration scenarios and plans. Include appropriate information from
other federal agencies, international partners, industry and universities.
Mandate an annual AMAC review to assess progress toward answering critical
.... questions defined in this plan.
Finding 5: Human exploration missions require fully coordinated and integrated
participation among international, interagency, university and industrial institutions.
_ Recommendation 5: Achieve participation and full coordination of required
.... .,international, interagency, university and industrial organizations by FY 1994.
Finding 6: Life sciences research in space has produced significant benefits to
quality of life on Earth; additional contributions to human welfare on Earth can be
expected from enhanced knowledge of the effects of gravity on biological systems, as
well as from new medical and life support technologies developed during research to
enable Moon and Mars missions.
Recommendation 6: Establish a regular AMAC evaluation of potential near-
and long-term beneficial applications on Earth from life sciences research and
•technology development conducted for human exploration missions; promote
further development and transfer of these applications to academia and
industry.
Finding 7: National and international analog and testbed facilities (e.g., special
facilities at NASA centers, DOD, DOE, NIH, National Science Foundation, and NOAA)
for.advanced space missions are unused or underutilized.
Recommendation 7: In concert with other agencies (e.g., DOE, NIH, NSF,
NOAA, DOD), NASA must increase investment at NASA centers, universities
and in industry to maintain and optimally utilize testbed facilities, particularly to
promote research and advanced technology development.
Finding 8: Policies, equipment and procedures for preventing the back
contamination of Earth and the biological contamination of Mars by humans are not yet
developed. _
Recommendation 8: Establish an interagency/international committee to
focus development of planetary protection policy and appropriately fund the
development of necessary equipment and procedures.
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GROUND AND FLIGHT ACTIVITIES
Finding 9: Environmental Health and Life Support Systems, Countermeasure
Systems, Medical Care Systems, and ultimately, mission design and hardware
requirements, are driven by standards (e.g., air, water, and food purity) based on life
sciences research and available technology. There is no comprehensive validated set
of standards for Moon and Mars missions.
Recommendation 9: Establish an interagency coordinating task force to
develop a comprehensive set of standards required for human exploration
missions; jointly conduct a detailed evaluation of the adequacy of each item;
and expand the existing programs to collect relevant data and reach policy
decisions.
FLIGHT ACTIVITIES
Finding 10: The absence of SSF funding for basic biological and biomedical
research (like BMAC) in space, will result in underutilization of this facility for both
science and space exploration.
Recommendation 10: Enhance utilization of Shuttle middeck, Spacelab,
and Russian assets for life sciences/life support, including BMAC, and provide
early life sciences access for SSF. Immediately allocate resources for basic
and applied life sciences research to facilitate utilization of SSF throughout the
first 10 years of operations.
Finding 11: The current plan for a program in space life sciences and in the science
needed for human exploration is well-balanced and must be supported. Partial
funding of the program is likely to deprive NASA of a significant portion of the life
sciences community.
Recommendation 11: Maintain a balanced, synergistic core life sciences
program which provides additional resources necessary to enable Moon and
Mars missions, define and support exobiology research on those missions,
transmit knowledge to life sciences students and make such knowledge and
technology available to private commercial enterprises.
ENVIRONMENTAL HEALTH AND LIFE SUPPORT SYSTEMS
RECOMMENDA TIONS
Finding 12: A high degree of self-sufficiency and reliability in the life support
systems is required for exploration missions. Regenerative physico-chemical life
support systems and hybrid bioregenerative life support systems are not adequately
supported.
Recommendation 12: Accelerate efforts to enable trade-off studies of the life
support system capabilities for any given exploration mission scenario.
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Develop bioregenerative life support systems and associated testbeds on the
ground and for SSF on a schedule and with a level of effort sufficient to support
early Moon and Mars missions until physico-chemical capabilities are verified.
Develop Controlled Ecological Life Support Systems (CELSS) for Moon and
Mars bases.
COUNTERMEASURE SYSTEMS RECOMMENDATIONS
Finding 13: Full characterization of the human adaptation process to long-duration
space flight is incomplete. Differentiation between healthy adaptation and
pathophysiological adaptation is required in order to devise appropriate
countermeasures.
Recommendation 13: Develop a prospective standardized health and
performance monitoring capability and research program to be implemented on
all national and international missions, thus creating a consistent database to
assess the efficacy of countermeasures. This database would also include
information on environmental conditions and habitability factors (e.g., human-
machine interfaces) associated with this research.
Finding 14: Ultimately crew selection, organization and training will be a critical
countermeasure for dealing with psychological and physiological problems associated
with space travel.
Recommendation 14: Using the databases created by the life sciences
research program in analog and space flight environments, develop and test
protocols for crew selection, organization and training.
MEDICAL CARE SYSTEMS RECOMMENDA"IIONS
Finding 15: Experience with medical care in space is limited to first generation
systems appropriate for short-duration missions (i.e., essentially enhanced first-aid
kits). Data and techniques to define equipment requirements and protocols
appropriate for transit vehicles and planetary habitats are not available. Experience
with decompression sickness in space is equally limited.
Recommendation 15: Develop clear protocols for medical triage and
treatment of surgical and medical problems during transit and on planetary
surfaces. Conduct multidimensional trade-off studies between risk for specific
medical events, medical care system equipment and capabilities and crew
medical skills, versus telemedicine and rescue capabilities. Develop and test
health maintenance systems in ground-based simulators and at remote sites
and deploy them to SSF for space flight validation. Evaluate effectiveness of
the hyperbaric chamber on SSF.
In addition to the specific issues and recommendations, the AMAC analysis
emphasized the benefits of providing access to space for life sciences basic research.
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Space flight provides the only environment in which the force of gravity can be partially
or completely removed to permit assessment of the undoubtedly profound influence of
gravity on the structure and functional evolution of all living organisms.
AMAC realizes that a time table for space exploration has notbeen established and
recognizes that development may occur in the future that will alter the emphasis,
importance and timing of these findings and recommendations. Further, the ultimate
time of transit to Mars is uncertain because of the undetermined nature of the
propulsion scheme to be employed.
Despite these uncertainties, AMAC believes the findings and recommendations reflect
the best assessment, that can be made at this time, of the most important issues in the
life sciences facing human exploration, and would apply independent of mission
scenario. Indeed, most of the issues identified and the paths proposed examine basic
questions concerning the possibility of an extraterrestrial venture and are at the heart
of any determination as to the potential of such missions.
AMAC did not presume to undertake the task of NASA program planning. However, it
felt a responsibility to determine whether the recommendations could be implemented
in a timely manner consistent with NASA's published plans. Figures I-2,3, and 4
identify life sciences milestones consistent with the plans available in NASA (e.g.,
Vision 21 m The NASA Strategic Plan, January 1992, and Office of Aeronautics Space
Technology Plan provided on September 23, 1991). Figure I-5 illustrates major
opportunities for continuous support for external science group input to development
of hardware and the definition of the science included in the Moon and Mars missions.
External science community will be involved in defining the major life sciences
research areas, lunar precursor missions, the research on the lunar base, Mars
precursor missions, and the research in the Mars transit vehicle and for the Mars base.
Detailed schedules and specific milestones and deliverables for human exploration
missions are provided in Section II of the report. The science and technology
necessary to provide the deliverables is discussed in Sections IV through VI. Section
III addresses the Mission From Planet Earth goal: "to maximize scientific return from
exploration that will benefit the people on Earth." This section discusses three
categories of research:
• Science identified as supporting MFPE that is justifiable based on its
inherent scientific or technical merit.
• Science that is enabled by Moon and/or Mars exploration missions. 2
Enabled science is a unique component of basic science.
• Basic science not directly applicable to Moon or Mars missions. 3
Footnote 2. 12% of the critical questions in Life Sciences Discpline Plans will be specifically
enabled by Moon and/or Mars missions. See Volume II, Table 7
Footnote 3. 22% of the critical questions in Life Sciences Discipline Plans are basic science
not immediately applicable to Moon and/or Mars missions. See Volume II, Table 3
8
Changing budgets and technical complexities are realities that will affect mission
scenarios and milestones, and thus, the execution of this strategy. AMAC assumed
that scheduling adjustments, flexible engineering and development planning (e.g.,
retaining parallel paths of development for contingencies until data is available), and
acceleration of appropriate programs could compensate to some degree for any
shortfalls and schedule compression. If timely development of the deliverables
described in Section II is not possible, the consequence will be increased risk.
Frequent updates and refinements of mission scenarios, planned crew activities, and
schedule and design decisions as NAS_ plans for Mars and Moon missions mature,
will allow focused life sciences research, thereby decreasing costs and ensuring
timeliness.
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II. RESOURCE REQUIREMENTS AND MILESTONES FOR
DELIVERABLES
A. Introduction
Based on the mission scenarios available and the resources, the milestones and
deliverables have been phased in where ground-based research, spacelabs and SSF
provide a foundation for future human exploration missions, and the Moon transfer
vehicle, orbiter and base (habitat) are considered testbeds for the Mars missions. The
phased approach is recommended because:
It is a prudent way to invest in life sciences research and technology
development. Life sciences research characteristically advances
through an iterative process of experimentation, data synthesis and
hypothesis generation leading to the next phase of experimentation.
The phased approach m starting with ground-based research and then
refinement of ground models through sequential stages of flight testing
and validation m makes sense because knowledge gained from
research and operations in early stages can be used to focus and refine
the research program in ground-based laboratories, and to define
research and operational hardware and procedures for mature mission
operational stages.
It maximizes return on investment. It facilitates focused experiments and
missions which fill gaps in scientific and technological knowledge as
complexity gradually increases, allowing NASA and national decision
makers the ability to develop realistic plans for delivering Mars
exploration capability.
It provides for near-term returns. Answers to most basic science
questions which must be obtained to minimize risks during transit and
planetary operations will have applications (medicine, biotechnology,
agriculture, environmental management, and other human activities that
require knowledge of our biological resources) that "improve the quality
of life on Earth" and our industrial competitiveness. They are also
necessary to fulfill our quest to understand life itself.
Changing budgets and technical complexities are realities that will affect mission
scenarios and milestones, and thus, the execution of this strategy. AMAC assumed
that scheduling adjustments, flexible engineering and development planning (e.g.,
retaining parallel paths of development for contingencies until data is available), and
acceleration of appropriate programs could compensate to some degree for any
budget shortfalls and schedule compression. If timely development of deliverables
described in this section is not possible, the consequence will be increased risk.
Frequent updates and refinements of mission scenarios, planned crew activities, and
schedule and design decisions as NASA plans for Mars and Moon missions mature,
will allow more focused life sciences research, thereby decreasing costs and ensuring
timeliness. Schedules and deliverables are summarized for the following
subcategories:
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• Robotic Precursor Missions
• EHLSS B Early Missions Without Bioregenerative Life Support
• Radiation Health
• EHLSS B Later Missions With Bioregenerative Life Support
• Countermeasure Systems For Hypogravity
• Countermeasure Systems For Other Environmental Factors
• Medical Care Systems
• Basic Research and Research Enabled By Moon and Mars Missions
• Utilization of Ground-based Research, Spacelabs, SSF, Moon Base,
and Free Flyers.
B. Robotic Precursor Missions
The robotic missions can provide data useful for development of regenerative life
support and radiation risk assessment for both Moon and Mars missions. In addition,
Mars missions will provide planetary protection information.
Mars mission plans include two Mars Site Reconnaissance Orbiters (MSRO), both
launched in one year, and two Mars Surface Rovers (MSVR), launched two years
apart to identify and certify locations for landing and establishing a base. The MSRO
will map approximately 50 % of the Mars surface over a 20 month period. The two
MSVRs involve two year explorations of candidate landing sites to collect data to: (1)
verify safe landing and surface base locations; (2) determine the presence of
potentially toxic materials; (3) survey the sites for construction plans; and (4) conduct
initial scientific investigations (e.g., characterize resource availability).
These precursor missions must determine suitability for human habitation and provide
in situ resource information necessary for development of EHLSS requirements in
time to meet delivery schedules for Moon and Mars mission designs. In addition, life
sciences must deliver the science requirements necessary for MSRO and MSVR
designs. The Planetary Protection Program must enable robotic precursor missions '
and protect the scientific value of Mars for exobiology studies. Volume II, Table 8 lists
the critical questions which would utilize precursor missions. See Tables I1-1 and 11-2
for deliverables and Figure 11-2for a notional schedule.
C. EHLSS m Early Missions Without Bioregenerative Life Support
Figure 11-3 provides a notional schedule for life sciences deliverables and facility
requirements in relationship to current flight resources and exploration missions.
Deliverables From Life Sciences. Ground-based research and technology and
results from Spacelab missions are being used to generate the deliverables for SSF.
Experience and research on SSF will form the basis for deliverables for Moon
missions which will, in turn, be used for Mars missions (Table 11-3).
/
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Table I1-1
Robotic Precursor Missions -- Deliverables From Life Sciences
Data and science requirements for robotic missions:
• Determine the planetary and transit radiation environment, including fluence, flux, energy,
and linear energy transfer spectra of the radiation
• Provide data on radiation shielding characteristics of regolith
• Provide data necessary to utilize regolith as a raw material for bioregenerative life support
• Identify potentially toxic materials
• Provide data on sources of water and oxygen
Identify potential sources of back contamination by biological materials
• Equip orbiters and rovers to study effects of radiation, microgravity, and magnetic fields on
suitable organisms
• Equip orbiters and rovers to incorporate appropriate exobiology studies
Develop sterilization technologies for vehicles landing on Mars
Develop technologies and protocols for sterilizing, sealing, and monitoring samples
returning to Earth
Conduct risk analysis for development of policy regarding planetary contamination
• = Required for Mars
• • = Required for Moon and Mars
F
b
Table 11-2
Robotic Precursor Missions -- Dellverables To
• Data from robotic missions required for EHLSS, CS, and MCS
Data for Planetary Protection Program
• Experimental results from Exobiology
• = Required for Mars
• • = Required for Moon and Mars
Life Sciences
Deliverables To Life Sciences. Until physico-chemical and food storage
capabilities are proven, it is prudent for ground-based bioregenerative life support
research and development to proceed on a schedule that could support the early
manned Mars mission. At that time, effort on bioregenerative systems could be
rescoped for later missions and resources could be focused on other high priority early
mission requirements. In general, regular updates on planned mission scenarios,
crew activities and design decisions will allow focus on optimum use of life sciences
resources (Table 11-4).
Facility Requirements. Human-rated ground based testbeds will be required to
develop and validate the equipment and procedures (including EVA and EHA) under
simulated mission conditions to optimize: (1) performance and mental health; (2) crew
selection; and (3) environmental health and habitability criteria and monitoring; (4)
food, atmosphere, and water suitability; and (5) impact of humans on EHLSS (Table II-
5).
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Table 11-3
Environmental Health and Life Support Systems
Dellverables From Life Sciences
• • Define acceptable human health and safety limits for quality and quantity of water, food,
and atmosphere
• • Identify requirements and technology for food storage, processing, and preparation
• • Verify life support system capability for EVA and EHA, and provide enhanced technologies
• • Identify requirements and technology for real time monitoring systems for air, water, and
surfaces quality
• • Determine requirements for lighting, work-rest schedules, privacy, odor, etc.; and identify
means to design habitable facilities
• • Provide basis for optimum design of human-machine interfaces
• = Required for Mars
• • = Required for Moon and Mars
Table 11-4
Environmental Health and Life Support Systems
Dellverables To Life Sciences
• • Verify sufficiency of expendable supplies and physico-chemical regenerative technologies
for early missions
• • Regular update and refinement of mission scenarios, planned crew activities, and design
decisions
• = Required for Mars
• • = Required for Moon and Mars
Research Initiatives or Major Enhancements. Ground-based programs will
have to be focused, expanded, and accelerated. Enhanced, focused flight programs
are essential to take advantage of SSF operational experience and research
opportunities, and to validate equipment and procedures for extended duration in the
microgravity environment. Opportunities on Mir should be aggressively pursued.
Table 11-5
Description of Facility Requirements
Human Factors Simulators
Ground-based analogs including transit vehicle simulators and planetary habitats
simulators will be used as testbeds for medical protocols and countermeasures
development.
Human-Rated Ground-Based CELSS Testbed
Will be used to develop and validate research and technologies required for an
operational bioregenerative life support system and to address environmental, health, and
safety issues.
Life Sciences SSF Testbed
Will be used for validation of life support, medical care and countermeasures under
operational conditions for transit vehicles.
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D. Radiation Health
Figure 11-4 provides a notional schedule for life sciences deliverables and facility
requirements in relationship to current flight resources and exploration missions.
Deliverables From Life Sciences. Life sciences must provide the human dose
limits for space missions (proton and GCR) and the science and technology base
necessary to design transit vehicles and planetary bases with shielding and safe
havens that satisfy those limits (Table 11-6).
Table 11-6
Radiation Health m Deliverables From Life Sciences
• • Characterize deep space radiation environments
• • Determine the human radiation dose limits for space missions (protons and GCR)
• • Provide solar event warning capability
• • Provide protection from radiation (protons and GCR)
• = Required for Mars
• • = Required for Moon and Mars
!i_,i
f,
ir
Deliverables To Life Sciences. Life sciences research and advanced technology
programs require data which characterize the deep space radiation environment; and
the radiation shielding characteristic of spacecraft materials and regolith (Table 11-7).
Facility Requirements. Availability of sufficient beam time at an HZE ground
source facility is absolutely essential. A free flyer capable of supporting appropriate
biological specimens outside the Earth's magnetosphere would allow early
characterization of the radiation environment and its biological effects. Early
experimental data would allow focused research, reduce risk, and resolve the
uncertainties regarding HZE particles (Table 11-6).
Table 11-7
Radiation Health -- Deliverables To Life Sciences
• • Data on deep space radiation environment from precursor missions and any other
deep space missions
• • Data on the radiation shielding characteristics of spacecraft materials and regolith
• = Required for Mars
• • = Required for Moon and Mars
Initiatives or Major Enhancements. Ground-based and flight research and
technology programs must be accelerated and expanded to provide timely inputs to
planning and design of Moon and Mars missions.
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E. Life Support- Later Missions With Bioregenerative Life Support
Figure 11-5 provides a notional schedule for life sciences deliverables and facility
requirements in relationship to current flight resources with focus on the Mars
exploration missions.
Deliverables From Life Sciences. Life sciences will provide the design criteria,
models, and trade-off studies for crew sustenance for different spacecraft and habitat
designs (Table 11-8).
Table 11-8
Life Support m Deliverables From Life Sciences
• • Provide criteria for design and operation of bioregenerative components of a life support
system that, as a minimum, provides partial recycling of oxygen, water, carbon dioxide, and
waste
• • Provide trade-off analysis comparing expendable, PC, integrated PC-bioregenerative, and
predominantly bioregenerative life support systems
• • Provide criteria for design and operation of a predominantly bioregenerative life support
system
• • Identify storage, processing, and preparation technologies for food produced in
bioregenerative life support systems
• • Provide mathematical models for simulation, design, and operation
• Provide technologies to use regolith as a resource in bioregenerative life support systems
• Establish nutritional and behavioral requirements for fresh food on long duration missions
• = Required for Mars
• • = Required for Moon and Mars
Deliverables To Life Sciences. Data on regolith and radiation environments
necessary for design of regenerative life support systems (Table 11-9).
Table 11-9
Life Support -- Deliverables To Life Sciences
• • Data on oxygen and water availability
• • Data on composition and characteristics of regolith
• • Data on radiation environment throughout mission scenario
• = Required for Mars
• • = Required for Moon and Mars
Facilities Requirements. Applicable research will be conducted in the ground-
based human-rated controlled Environmental Life Support System Testbed. SSF Life
Sciences Testbed (including an evolutionary prototype operational CELSS) (Table II-
5).
Initiatives or Major Enhancements. The ground-based CELSS (e.g., CELSS
Breadboard Test Facility, CELSS RTOP) and plant biology research programs will
require significant enhancements. Ongoing (Spacelab) and planned research (SSF
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CELSS Test Facility and plant research in the Gravitational Biology Facility) should be
accelerated and enhanced.
F. Countermeasures for Hypogravity Effects
Figure 11-6 provides a notional schedule for life sciences deliverables and facility
requirements in relationship to current flight resources and exploration missions.
Deliverables From Life Sciences. It is very likely that human adaptation and thus
countermeasure requirements will be different for SSF, Moon, and Mars missions
(Table I1-10).
Table I1-10
Countermeasures for Hypogravlty Effects
Dellverables From Life Sciences
• • Provide the criteria for design and operation of CS (e.g., exercise, dietary,
pharmacological, mechanical, physiological, training) for human adaptations (e.g.,
musculoskeletal, cardiovascular, physiological, neurological, and cellular) to microgravity
• • Provide the criteria for design and operation of CS for human adaptations to the Moon
(0.16g) environment
• • Provide the criteria for design and operation of CS for human adaptations to the Mars
(0.38g) environment
• • Provide criteria for design and operations of CS for readaptation to Earth
• = Required for Mars
• • = Required for Moon and Mars
Deliverables To Life Sciences. The expected timelines are necessary because
human adaptation and appropriate countermeasures will vary with sequence, gravity
level, duration of exposure, and human activity. Limited resources must be focused on
a restricted set of highly probable scenarios (Table I1-11).
Table I1-11
Countermeasures for Hypogravlty Effects
Deliverables To Life Sciences
Mission scenarios, including a timeline with duration of exposure to the various levels of
hypogravity and a description of the expected activity (including EVA and EHA) during
increments
• = Required for Mars
• . = Required for Moon and Mars
Facilities Requirements. Countermeasure systems will utilize the SSF Life
Sciences Testbed. However, equipment specifically for developing, testing, and
verifying countermeasures will be required. Neurolab, a Spacelab mission already
included in the Life Sciences Division Strategic Plan, will provide scientific knowledge
and information necessary for design of countermeasures applicable to SSF, Moon,
and Mars missions. Advanced instruments (e.g., nuclear magnetic resonance (NMR)
imaging, virtual reality) specifically designed for compatibility with SSF, will facilitate
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both basic research and the development of countermeasures. Larger SSF crew size
(e.g., eight) and longer rotation periods (e.g., >180 days) are needed when the SSF
Life Sciences Testbed is operational. If microgravity countermeasures are ineffective
for longer durations, a low Earth orbit artificial g testbed will be required (Table 11-5).
Initiatives or Major Enhancements. Ground-based and flight programs will have
to be enhanced to conduct fundamental microgravity research and to take advantage
of operational experience on SSF. An initiative to determine the consequences of
long-duration exposure to 0.16g and 0.38g (especially after a period in microgravity) is
essential for planning and execution of Moon and Mars missions. An initiative to
evaluate the usefulness of human centrifuges on planetary and transit vehicles might
provide enormous benefits to human safety and performance, and could potentially
decrease the complexity of countermeasure systems.
G. Countermeasures to Other Environmental Factors
Figure 11-7 provides a notional schedule for life sciences deliverables and facility
requirements in relationship to current flight resources and exploration missions.
Deliverables From Life Sciences. Russian and U.S. space flight experiences
suggest that improved countermeasures are more critical for longer duration missions.
Life sciences must deliver increasingly sophisticated and complex systems as the
missions proceed from long-duration SSF to the Moon base and to Mars bases (Table
11-12).
Table 11-12
Countermeasures to Other Environmental
Deliverables From Life Sciences
Factors
• ° Provide the criteria for design and operation of countermeasures for human
responses to space vehicle and planetary base environments not specifically
related to hypogravity (e.g. atmosphere, toxins, food quality, confined volume, light,
restricted human interaction, privacy, recreational activities, esthetic diversity, and
stress)
• • Provide criteria and protocols for crew selection, training, and scheduling to
mitigate affects of space flight environmental factors
° • Provide trade-off studies for countermeasure alternatives
° = Required for Mars
° ° = Required for Moon and Mars
Deliverables To Life Sciences. Except for a central core, scheduling and focus
of life sciences research is dependent upon mission scenarios and crew activities
including EVA and EHA (Table 11-13).
Facilities Requirements. Applicable research will be conducted in the Human
Factors Simulators, Human-Rated CELSS Testbed, and SSF Life Sciences Testbed
discussed in Section II - C, E and F. However, task-specific instrumentation and
hardware will be required (Table 11-5).
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Table 11-13
Countermeasures to Other Environmental
Deliverables To Life Sciences
Factors
• • Mission scenarios including timelines for activities including EVA and EHA
• = Required for Mars
• • = Required for Moon and Mars
Initiatives or Major Enhancements. Ground-based programs will have to be
enhanced. Countermeasure capabilities will evolve as the duration of Spacelab and
SSF missions increases. Enhancements will be required for long-duration Moon
orbiter, Moon base, and Mars missions.
H. Medical Care Systems
Figure 11-8 provides a notional schedule for life sciences deliverables and facility
requirements in relationship to current flight resources and exploration missions.
Deliverables From Life Sciences. Development of Medical Care System
deliverables will be phased, evolving from increasingly longer duration experience on
SSF (Table 11-14).
Table 11-14
Medical Care Systems m Dellverables From Life Sciences
• Provide the criteria necessary to design and equip health maintenance facilities (including
EVA and EHA risks) for Moon and Mars transit vehicles and bases
• • Develop preventive medicine, and monitoring, therapy and treatment protocols for
exploration missions
• . Provide telemedicine capability for medical contingencies
• • Provide medical criteria for crew selection
• • Develop the medical training protocols for exploration mission crews
• • Provide protocols for post mission health monitoring and care
• = Required for Mars
• • = Required for Moon and Mars
Deliverables to Life Sciences. Medical care requirements are dependent on
mission scenarios. For example, they may be minimized for Earth orbit and Moon
operations, where rescue times are short (Table 11-15).
Table 11-15
Medical Care Systems --Deliverables To Life Sciences
Mission scenarios including timelines and activities such as EVA and EHA.
• = Required for Mars
• • = Required for Moon and Mars
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Facilities Requirements. Medical Care Systems development will be conducted in
the Human Factors Simulators, Human Rated CELSS Testbed, and SSF Life
Sciences Testbed discussed in Section II-C, E and F. Medical Care System specific
instrumentation and hardware will be required (Table 11-5).
Initiatives or Major Enhancements. Extended durations and extremely long
distances will require an unprecedented level of inflight medical care capability.
Current resource levels cannot support development of those systems.
I. Acquisition of Knowledge
Planning for scientific investigations is an integral part of operations and systems
development planning for Moon and Mars missions. The university, commercial, and
private scientific community will participate in establishing specific Science Plans and
development of Science and Technical Requirements Documents that will be used to
design Moon base, Mars transit, and Mars base laboratories (Table 11-16). Figure 11-9
provides a notional schedule for life sciences deliverables and illustrates its
continuous significant involvement of the life sciences scientific community.
Table 11-16
Acquisition of Knowledge -- Deliverables From Life Sciences
Provide science and technology requirements necessary to design the laboratory for Moon
• baseProvide science and technology requirements necessary to design Mars transit vehicle
research facilities
• Provide science and technology requirements necessary to design laboratory for Mars
base
• • Provide research proposals for SSF, Moon, Mars transit vehicle, and Mars base
laboratories
• = Required for Mars
• • = Required for Moon and Mars
J= Utilization of Ground-Based Research, Spacelab, SSF, Moon Base,
and Free Flyers
Research and technology development for exploration missions will involve a wide
diversity of ground-based research and flight platforms. Requirements for the
constrained programs for EHLSS, CS, and MCS are summarized in Appendix H; and
for robust programs, in Volume II, Table 2. The notional schedule in Figure 11-9
identifies the flight resources available to support specific phases of the exploration
program. Existing Life Sciences Programs are appropriately balanced between
human exploration and basic science.
1. Ground-Based Research
Ground-based research provides the science and technology foundation for flight
research. In fact, it is used extensively to develop alternatives and screen options in
order to reduce the risk and need for costly space flight experiments. Accordingly,
30
95% of the critical questions require additional ground-based research (Volume II,
Table 3).
2. Spacelabs
A continued Spacelab mission series with extended duration is required to obtain
information for environmental life support and monitoring of critical health parameters,
countermeasure development and testing, and verification of medical care
procedures. If Spacelab resources were available, they could contribute to
addressing 66% of the critical questions (Volume II, Table 4). They would be
particularly useful for technology validation and testing for EHLSS, and for
characterizing the "normal" physiological and behavioral responses to space flight
essential for CS and MCS. They will continue to provide the experimental foundation
necessary to elucidate the mechanisms whereby gravity or its absence affect living
systems.
3. Space Station Freedom Utilization
Permanent presence in space on SSF is the first step in the Mission from Planet Earth
(MFPE). SSF will provide the U.S. and its international partners the ability to develop,
test, and validate prototype Moon and Mars EHLSS, CS and MCS. Beginning duringMTC:
(1) The BMAC Program will focus on developing and validating
countermeasures for progressively longer duration on-orbit crew times
(2) Research programs will focus on the physiological and behavioral
adaptations to flight in order to: (a) define the normal envelope for
parameters in the space flight environment; (b) understand the underlying
mechanisms; and (c) develop models and simulations
(3) Repeated EVA during the construction phase will allow accumulation of
data and experience which will facilitate advanced equipment and
procedures for exploration
(4) Gravitational biology studies will focus on microgravity and radiation
interactions and the impact of microgravity on plant structure and function.
Extended Man-Tended Capability (EMTC) may provide information on long duration
exposure. This gradual buildup of duration will provide early data for exploration and
will improve the productivity of SSF during early Permanently Manned Capability
(PMC).
During PMC, the Crew Health Care System (CHeCS) will provide operational medical
care experience. Subsystems include a Health Maintenance Facility (HMF),
Environmental Health System (EHS), and a supporting hyperbaric chamber.
During PMC, SSF provides unique space flight advantages m extended duration,
technically advanced facilities, inflight sample preservation and analysis, sufficient
sample size (replications), variable g m to address biological questions..While some
questions can be investigated on short-duration space flights provided by Spacelabs,
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recoverable satellites, and even sounding rockets, many questions require a long-
duration facility such as SSF. For example, many biological processes (e.g., organism
development, multigeneration cycles, and adaptation) simply require extended
periods of time to occur. Also, the answers to many biological questions can only be
provided through extended duration experiments where the results of on-orbit
observation and analysis can be used to modify experimental parameters of ongoing
or sequential follow-on experiments. Technically advanced facilities and on-orbit
analysis will, for the first time, allow investigations involving key unstable biological
components that require immediate analysis, and structures, products, and
phenomena that are modified during reentry and return. Advanced sample
preparation and preservation technology will greatly enhance the science return from
on-orbit experiments by increasing the preservation options and variety of samples
available for more sophisticated ground-based analysis.
Inherent biological variability requires that sufficient time and sample number be
provided for an effect to be unambiguously manifested. Our ability to clearly interpret
past U.S and international life sciences flight experiments and provide operational
remedies has often been limited because there are too few replications. SSF
capabilities promise to provide the time and number of samples for clear interpretation
of statistically valid results. Furthermore, a continuously operating laboratory in space
will allow replication of experiments and eliminate the current two-plus year delay
required to manifest follow-up experiments to take advantage of exciting discoveries.
SSF will allow scientists to take advantage of biological diversity by selecting from the
full spectrum of biological species to address questions. Most importantly, it will allow
them to match the question to the most appropriate biological model. The ability to use
well characterized specimens that have been used extensively for research on Earth
will: (1) enhance the interpretability of results and development of a consensus in the
scientific commur_ity because extensive knowledge bases already exist; (2) decrease
the need for NASA,sponsored preparatory ground-based experiments; and (3)
shorten the time course and reduce the cost of acquiring answers to critical life
sciences questions. Furthermore, access to species not previously available in space
flight will attract an expanded scientific community and enrich the program. The
Space Physiology Facility, Gravitational Biology Facility, Centrifuge Facility, CELSS
Test Facility, and BMAC equipment on SSF will greatly enhance our ability to conduct
the kinds of interspecies comparative studies that have always been a fundamental
tool of life sciences research.
Small centrifuges for lower organisms, cell cultures, and small plants and animals in
conjunction with the Centrifuge Facility for larger plants and animals will provide the
ability to manipulate gravitational levels from near zero to 2g for a broad diversity of
species. This capability will allow control of gravity as a variable in a manner
analogous to the way light intensity, temperature, nutrient levels, drug dosages, etc.,
have always been manipulated to elucidate the fundamental mechanisms and
processes involved in the structure and function of living systems. Furthermore, they
will allow us to explicitly evaluate the effect of Moon (0.16 g) and Mars (0.38 g) gravity
levels on candidate organisms fer bioregenerative life support systems for Moon and
Mars bases. In addition, experiments with animals as surrogates for humans will allow
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predictions of the effects of Moon, Mars, and transit vehicle gravity regimes on
humans.
When the Life Sciences SSF Testbed becomes operational it will be used for
validation of life support, medical care, and countermeasures under operational
conditions for transit vehicles.
Finally, SSF provides the real lessons learned from the experiences of building,
operating, living, working, and conducting research in a large, increasingly complex,
long-duration facility in space. The Advisory Committee on the Future of the U.S.
Space Program, 1990, and the Report of the Synthesis Group on America's Space
Exploration Initiative, 1991, recommendations on the importance of SSF are
substantiated by the fact that over 83% of the critical questions in life sciences need
SSF (Volume II, Table 5). The Centrifuge Facility will support over 36% of the critical
questions (Volume II, Table 6).
4. Moon Base Utilization
Moon base facilities will provide the opportunity to expand research that will reduce
the logistics burden for Moon operations and enhance human performance on Moon
and Mars surfaces. A research site outside the Earth's magnetosphere will facilitate
detailed study of GCR, and the base will be an operational test of radiation shielding.
Moon operations will accelerate the development, testing, and validation of CS and
MCS, and will provide extensive information on 0.16 g operations. Extensive
experience with life support systems will accelerate and refine EHLSS. A Moon base
testbed for bioregenerative components of an integrated PC-bioregenerative system
will accelerate CELSS development. Moon bases allow evolutionary development,
testing, and verification of EHLSS, CS and MCS systems for the Mars missions.
Research equipment for Moon missions will allow study of the effects of radiation and
hypogravity (microgravity and 0.16g) on suitable organisms; and the conduct of early
exobiology experiments. Even after consideration of the advantages of conducting
research in low Earth orbit, 65% of the critical questions would benefit from access to
Moon bases (Volume II, Table 7).
Exploration planning includes an Initial Operating Capability (IOC) on the Moon that
provides a single, integrated habitat that supports a crew of five for 14 days. External
shielding will provide radiation protection, and the habitat will include life support,
crew accommodations, health care equipment, science facilities, and utilities.
The life support system is expected to be an advanced SSF regenerative system, with
greater than 98% oxygen recovery, hygiene water processor, and nonexpendable
water polisher/bacteria barrier. The Next Operating Capability (NOC) will extend the
surface infrastructure to support crews for up to 90 days and could include prototype
Mars technology. The NOC2 habitat at a second site will utilize life support technology
planned for the Mars mission. This advanced system will incorporate waste
processing to reduce requirements for consumables. It will also include advanced
countermeasure and medical care systems.
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5. Free Flyers
The utilization of reusable, low cost, free-flying platforms should be considered to
address the research thrusts that cannot be accommodated with the previously
described facilities. Planning for free flyers should be tailored to the priorities and
schedules necessary to accelerate or increase the efficiency of efforts to develop
solutions for Moon and Mars missions. They would enable investigations of
microgravity and radiation effects on living organisms, including plants, rodents, cell
and tissue cultures, and other biological specimens. A recoverable should have the
capability for access to unique orbits (e.g., polar) for extended periods (e.g., 30 to 60
days). A recoverable would enable real-time active measurements of all components
of GCR and investigation of the interaction between microgravity and radiation. These
studies would validate ground-based predictions and models in the space
environment. Thirty percent of the critical questions would benefit from access to free
flyers (Volume II, Table 9).
36

III. PROVIDING ACCESS TO SPACE FOR
BASIC RESEARCH
LIFE SCIENCES
A= Basic Science Not Immediately Applicable to Moon and Mars
Missions
Throughout its evolution, life on Earth has been exposed to the constant force of
gravity. Therefore, it is axiomatic that gravity helped shape and continues to influence
the structure, function, and ongoing evolution of all living organisms. Because of its
pervasive influence, understanding the effects of gravity on life is a fundamental
question of substantial, inherent scientific value in our quest to understand life.
Knowledge of the effects of gravity on lower organisms, plants, humans, and other
animals, as well as elucidation of the basic mechanisms by which these effects occur,
will be of direct benefit to: (1) the quality of life on Earth through applications in
medicine, agriculture, industrial biotechnolgy, environmental management, and other
human activities dependent on understanding biological resources; (2) understanding
the impact of, and providing countermeasures for, long-term exposure of humans to
the microgravity of space flight and the partial gravity of Moon and planetary bases;
and (3) development of bioregenerative life support systems for use on human
exploration missions.
Space flight provides the only environment in which the force of gravity can be
removed or discrete levels of gravitational force between 0 and 1 g can be provided to
address critical scientific questions. Variable g hardware will allow control of gravity
as a variable analogous to the way in which light intensity and quality, temperature,
nutrient levels, drug dosages, etc., have always been manipulated to elucidate the
fundamental mechanisms and processes involved in the structure and function of
living systems. Also, space is the .only environment in which other fundamental
biological processes and mechanisms can be studied in the absence of coupled and
sometimes overwhelming effects of gravity.
The closed environment of spacecrafts provides a unique opportunity to conduct
controlled experiments to investigate the impacts of environmental factors such as
atmosphere, light, confined space, radiation, and their interaction with gravitational
force. Twenty-two percent (22%) of the critical questions in the Life Sciences
Discipline Science Plans (Volume II, Table 2) address research which is not
applicable to MFPE missions. The existing Life Sciences Program provides
appropriately balanced support for this research consistent with NASA goals.
Moon and Mars missions will provide both the opportunity to conduct research, foster
science and math education, and spark the imagination of scientists and the American
public, adding impetus for space, sciences research in general. The Life Sciences
Program must maintain its balanced approach.
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B= Inherent Scientific Merit of the Science and Technology Research
that Supports Moon and Mars Missions
Most of the science required for Moon and/or Mars missions has inherent scientific
value and is justifiable on its own merit. In many instances the experimental data
necessary to understand the structure and function of living systems is the same
fundamental data required for applications that would improve "quality of life on Earth,'+'
or which would allow design of spacecraft, space bases, and space suits that will
enable human exploration of our solar system. Both "science for the sake of science,"
(including understanding of the origin, evolution and distribution of life in the universe)
and "human health and well-being in space" and will undoubtedly benefit from the
understanding of physico-chemical processes, and biological perception and
transduction of gravity.
C. Science Enabled by Moon and Mars Missions
Moon and Mars missions will provide broad impetus for science and accelerate
acquisition of knowledge in gravitational biology across all disciplines. The following
discussion focuses only on those areas of science which will be specifically facilitated
or enhanced by Moon and Mars missions, immediately applicable to enabling those
missions.
1. Introduction
The Exobiology Program, the scientific study of Mars, and the enabled science that
can be accomplished on such a mission are among the primary justifications for
going to Mars. The Synthesis Group Report and NASA Office of Exploration planning
(Appendix G) emphasize that "planning for scientific investigations shall be an
integral part of operations and exploration missions." Mars and Moon missions
enable activities that offer promising and unique science opportunities. Of twelve Life
Sciences Division disciplines, seven have critical questions 1 enabled by these
missions.
!i_,
!:
..
Table II1-1
Life Sciences Disciplines Enabled by Mars and Moon Missions
Exobiology
Cell and Developmental Biology
Neuroscience
Regulatory Physiology
Cardiopulmonary
Musculoskeletal
Behavior, Performance and Human Factors
Footnote1. 12% of the criticalquestionsIdentifiedin LifeSciences Division DisciplineScience Plans
are enabledbyMarsand orMoonmissions.SeeVolumeII Table 2.
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2. Exobiology
The Exobiology Program seeks to understand the origin, evolution, and distribution of
life and life-related molecules in the universe. It is a highly interdisciplinary program
encompassing such. diverse research areas as chemical evolution (the history of
carbon and carbon-containing molecules in the universe), microbiology,
paleomicrobiology, organic geochemistry, geology, planetology, radio astronomy, and
the Search for Extraterrestria.I Intelligence (SETI), to name a few. The program
requires extensive ground-based research in all of the areas mentioned, as well as the
opportunity for long-term orbital research (e.g., on SSF) and studies of interstellar
molecules and extraterrestrial bodies, such as comets, asteroids, meteorites, and
planets. All evidence suggests that the origin and evolution of life is inextricably
woven into the history and evolution of planets. The Earth is an example of such a
planet -- teeming with life, so much so that terrestrial life has completely reworked and
devoured its own earlier history. It is clear that other planets have evolved differently
from Earth. We need to understand the differences and why they occur. Life on Earth
began between 3.5 to 4 billion years ago. During this time frame, while life on Earth
was originating, the environment on Mars was warmer and wetter than at present, and
it was probably more hospitable to living processes. Planets, such as Mars, may or
may not have produced the appropriate organic molecules leading to life, and that life,
if it arose, may or may not have survived and evolved as the planet evolved we do
not know! Only by exploration and research can we resolve the multitude of questions
associated with the very profound issues of life's origin(s), evolution, and distribution.
The Planetary Protection Program, discussed in Section IV, is essential to ensure that
the scientific value of Mars is protected from biological and chemical (organic)
contamination from the Earth until our key scientific objectives are met. That program
encompasses the development of technology to clean, and if necessary, sterilize
spacecraft searching for the record of life, in order to avoid masking or even
destruction of important evidence on Mars by introducing terrestrial life forms and
organic molecules. The constituents most sensitive to such contamination are (if they
exist):
• Indigenous life forms
• Fossil organisms
• Organic molecules.
Table 111-2
Sites Within Solar System Likely to Contain Evidence of the Origin of Life*
1. Mars 4. Titan
2. Comets 5. Cosmic Dust
3. Meteorites
'Approximate priority order
Approach. The search for evidence of life (extant or extinct), life related organic
molecules, and water are the principal NASA objectives of a series of missions to Mars
that began with the Viking missions in the mid 1970s. The search continues with a
series of unmanned robotic precursor probes designed to further characterize the
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chemistry of the Mars atmosphere and planetary surface, geology, seismology, and
climatology. The Viking mission searched for indigenous life forms and organic
molecules but found none in two small localized sites. It is important to study a far
larger portion of the planet (i.e., equator to poles), in sites more representative of the
variety of Mars geographies, and in sites with characteristics of particular interest from
an exobiological point of view. This work can be done with orbiters, landers, and
rovers which can be cleaned and sterilized so that the planet is not contaminated and
future study compromised. Such a program accomplishes two things:
We will learn much more about Mars, the solar system, and the universe so
that future experiments can be better designed and more desirable sites for
scientific investigation can be identified.
We will have more confidence in the selection of human landing sites with
concerns for safety and the scientific potential of the area for detailed human
exploration. Human exploration will inevitably contaminate the planet;
therefore, from a scientific point of view the key data concerning life should
be obtained before that time.
While the likelihood of extant life on Mars is very remote, it is not zero, and the
likelihood of ancient (fossil) life is much greater. Human exploration will eventually
greatly facilitate the search for and study of ancient life -- an undertaking which may
be impossible to accomplish robotically.
Unmanned precursor missions, Moon bases, and SSF offer important opportunities for
research, such as long-term cosmic dust collection for organic analysis or simulations
of gas-grain interactions, which are scientific objectives of exobiology. Furthermore,
Moon missions can also provide significant opportunity for exobiology science
experiments, particularly those dealing with the record of chemical evolution in the
early solar system.
3. Other Specifically Enabled Science
Although the Exobiology Program has been identified as uniquely enabled by Mars
missions, unmanned precursor missions, Moon bases, and SSF offer exciting
opportunities to conduct other life science experiments. Microgravity research will also
be enabled by accelerated plant research required for long-term bioregenerative life
support (CELSS) on SSF. Basic science studies of muscle physiology, cardiovascular
function, vestibular and other neuroscience, regulatory physiology, and behavioral
and performance studies will also be enhanced.
A Moon base that can serve as a waystation and research base for Mars missions will
offer unique opportunities to conduct cellular and developmental biology experiments
within the reduced gravity of the Moon. In particular, it will be of great value to assess
reproduction and development (i.e., egg to egg) in this 0.16g environment compared
to that in l g centrifuges on site. In order to evaluate the impact of hypogravity on
human, animal and plant systems, studies should include a variety of species over the
phylogenic range (including, but not limited to, the well understood systems of mice,
insects, and roundworms). Many basic science questions included in Section Ill-A,
f,
ii
i_.
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and Mars mission questions included in Sections IV, V, and Vl can be addressed in
Moon or Mars bases, and could provide beneficial crew activity and exciting scientific
results in a Mars transit vehicle.
Cell and Developmental Biology. Questions focusing on gravity sensing
responses of cellular systems and the affect of gravity on the development of
anatomical structures of animals would be uniquely enabled by Moon and Mars
missions.
Neuroscience. Uniquely enabled science focuses on understanding basic
mechanisms of gravity perception, effects of altered gravity on changes in biological
rhythms, definition of appropriate neuronal models for understanding central
processing in altered gravity, and understanding how signals from different receptors
are involved in orienting in altered states of gravity and motion.
Cardiopulmonary. Uniquely enabled questions focus on a basic understanding of
the cardiovascular function in the microgravity environment. For example, cellular
changes in the function of the heart, morphological changes involving the
cardiovascular system, and understanding of pulmonary aging and pathology caused
by space flight. Neuroscience studies in relation to autonomic control of
cardiovasuclar action may be of great significance, both for spaceflight and medical
treatment on Earth.
Regulatory Physiology. Further flight and ground-based investigations into the
changes in the major regulatory systems of the body (the nervous, endocrine and
immune systems) induced by exposure to the space environment will be required to
support Mission to Planet Earth (MTPE).
Human Factors. Studies of the effect of space flight on sleep architecture, quality
and quantity would be specifically enabled by long-duration Moon base studies.
Musculoskeletal. Long-duration studies facilitated by Moon and or Mars missions
would help determine the effects of weight-bearing on development.
D. Educational Opportunities
The reason for voyages of discovery are tied to humankind's insatiable desire to
investigate the unknown and learn. The natural fuel for learning is inquisitiveness,
motivation and desire of students to learn. The spark that ignites the process is
excitement. History is replete with examples of the positive benefits of exploration on
technology and scientific knowledge. The Apollo Program had a dramatic impact on
the development of microelectronics, materials, microminiaturization and the plethora
of other "terrestrial applications" that NASA refers to by the term "spinoff." Most
importantly, the Apollo Program captured the interest of a generation of Americans and
motivated unprecedented numbers of young minds to pursue careers in space science
and engineering.
The most critical factors in great endeavors such as MTPE and MFPE include visionary
planners, committed sponsors, capable managers, daring explorers and large
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numbers of dedicated, skilled, and experienced scientists and engineers. By far the
most important resources are trained minds. The availability of men and women with
these skills requires a nation-wide educational system that attracts and retains
capable disciplined minds to the "hard sciences" and engineering fields. The current
trend of fewer and fewer students, particularly ethnic minorities and women, choosing
careers in these fields is alarming, is not in the best interest of NASA or the United
States, and must be reversed.
NASA life sciences educational programs include the Space Life Sciences Training
Program at field centers, a SETI education initiative (co-sponsored by NSF) focusing
Life in the Universe as an Integrated Science Teaching Program, the Planetary
Biology Intern Program, the Space Biology Research Associate Program, the
Planetary Biology and Microbial Ecology Program, the Aerospace Medicine Residency
Program, NASA Specialized Centers of Research and Training, and Spacelab Life
Science Curriculum Supplements. These efforts should be strengthened and further
integrated with the educational programs in other OSSA divisions, throughout NASA,
and across federal agencies. Participation with private industry and the university
community must be enhanced.
The Moon and Mars missions are a unique opportunity to spark the interest of students
throughout the world. The plan to get there must include resources and people
dedicated to communicating both the knowledge and the excitement, thereby ushering
in a new era in education.
E. Robust Program
It is impossible to address a robust science program within the bounds of robust and
constrained as defined in this report. Robustness of the science program depends on
the availability of flight research equipment, crew time, power, volume, etc. It also
depends on a broadly based ground research program and the availability of research
funds for principal investigators. It requires a spirit of openness to a diversity of
hypotheses across the extraordinarily broad area called life sciences. AMAC
encourages the development and implementation of a very robust science program.
42
AI
IV. ENVIRONMENTAL HEALTH
Introduction
AND LIFE SUPPORT SYSTEMS
Optimal Environmental Health and Life Support Systems (EHLSS) will protect the
crew from inhospitable space and planetary environments and provide transit vehicle
and planetary surface cabin environments which emulate Earth-normal conditions for
those factors that directly affect crewmembers. These capabilities will alleviate the
space environment causes of detrimental effects on crewmembers, thereby allowing
mission performance approximately equivalent to human performance on Earth, and
normal postflight lives (health and longevity).
Table IV-1 summarizes the life sustaining cabin environmental factors which must be
provided by the three major support systems when humans are confined to the closed
systems required for transit vehicles, planetary bases, or extra-vehicular (EVA) and
extra, habitat (EHA)activities. Mission duration and maximum crew recovery time (in
case of aborts) dramatically impact requirements.
TABLE IV-1
CRITICAL HABITABILITY FACTORS
FACTORS
Food
Water
Atmosphere
Waste Management
Toxicology/
Microbiology
Human Factors
SYSTEMS PROVIDING CAPABILITY
ENVIRONMENTAL
HEALTH & LIFE
SUPPORT
X
X
X
X
X
X
COUNTERMEASURES
X
MEDICAL CARE
C
C
C
C
C
X m Implies the potential for a solution
C-- Contingency capability for limited and temporary intervention or treatment
This table is applicable to both Moon and Mars missions; however, the advantages of
shorter duration missions and the capability for rapid return from the Moon will allow
employment of less sophisticated systems for Moon missions.
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Sl Constrained Program m Early Missions Without Bioregenerative
Life Support
The constrained program 1 for early Mars missions addresses critical issues in the
following areas:
Life Support Systems
Environmental Health (barophysiology, microbiology, and toxicology)
Behavior, Performance, and Human Factors
Radiation Health
Planetary Protection.
1. Food, Water, Atmosphere, and Waste Management
EHLSS with sufficient redundancy and backups to provide dependable water, food
(including nutrient balance) and atmosphere (e.g., gas concentrations, temperature,
humidity) are absolutely essential because countermeasures do not exist. If failure
occurs, the ability of Medical Care Systems (MCS) to intervene or treat (where it is
even possible) is temporary and palliative. Five critical issues (Table IV-2) focus on
these life support systems.
Table IV-2
Food, Water, Atmosphere, and Waste
• • Determine requirements for human waste subsystems
• • Certify functioning and sufficiency of expendable supplies and physico-chemical
regenerative technologies
• • Certify life support systems capability for providing EVNEHA surface exploration
• • Identify food,storage, processing and preparation technologies
• - Determine storage and processing requirements for potable and hygiene water
• • -- Required for Moon and Mars
:13'
Research Requirements. Research is required to define the acceptable limits of
quality and quantity for water, food, and atmosphere, and eventually to provide the
science and technology necessary to develop sustainable regenerative (biological
and/or physico-chemical) life support systems.
2. Environmental Health
Maintaining humans in confined systems presents a unique challenge, which is
exacerbated by extended mission duration, for toxicological and microbiological
management issues. Adequate redundancy and backup must be included because
optimized MCS (e.g., treatment with antibiotics, drugs) are palliative and can only be
utilized for relatively short periods to assure crew mission performance and recovery.
Footnote 1. 17% of the critical questions identified in the discipline plans support a constrained EHLSS
program (see Volume II, Table 2).
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Critical issues (Table IV-3) focus on microbial contamination and materials (e.g.,
chemicals, biologicals, and particulates), atmospheric composition, and pressure
anomalies that might adversely affect crew health and performance. Environmental
standards need to be developed for chronic conditions involving the long-duration of a
Mars mission. Monitoring strategies and procedures must be developed for
determining which components of the spacecraft internal environment or planetary
habitat must be monitored to adequately assess environmental safety, particularly
what contaminants are likely to build-up over the long-duration in a closed
environment. Sample types, numbers, and sampling frequency, as well as data
analysis, must be identified.
Table IV-3
Environmental Health
• • Establish standards for number and kinds of organisms in water, air, food and on surfaces
• • Identify crew health, safety, and performance effects of chronic exposure to respirable and
nonrespirable particles
• • Identify effects of atmospheric components on crew physical and psychological well-being
• • Identify effects on crew physiological responses of interactions between microgravity and
off-baseline atmospheric composition, pressure, and temperature
• • Determine impact of flight-induced physiological responses on crewmember susceptibility
to toxic materials, microorganisms, and environmental contaminants
• • Develop reliable approaches for predicting acceptable exposure levels from limited data
• • Assess available technology for identifying microorganisms in crew and environmental
specimens and how antimicrobial procedures control microorganisms in space
• • Develop real-time systems for monitoring air quality
• • Predict (utilizing traditional time exposure and human toxicological data) acceptable
values for inhalation and ingestion exposures to chemicals in space flight
• • Determine effects of space flight on microbes
° ° = Required for Moon and Mars
Research Requirements. Ground-based research and space flight experience
have established a scientific basis for defining standards for air and waterborne
gaseous and particulate microorganisms, and atmospheric composition and pressure.
However, information regarding their long-term effects on crew performance and
health is insufficient. Enhanced capability (i.e., advanced sensors) for real-time
environmental monitoring systems is required to support a Mars mission. Additional
research is needed to develop technology for environmental control and monitoring
systems for gas composition, pressure, temperature, and humidity. This research and
development is required for the cabin environment of planetary bases, spacesuits and
transit vehicles.
Human exploration missions will require establishment of standards for the number
and kinds of microorganisms in air, water, food, and on surfaces within the spacecraft
cabin or planetary habitat. Assessments of the presently accepted or proposed
standards, such as the spacecraft maximum allowable concentration (SMAC) values
for toxicants, and the maximum allowable counts of microorganisms need to be
conducted. Validating the applicability in space of Environmental Protection Agency
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(EPA) potable water standards, and EPA and Food and Drug Administration (FDA)
standards for food is a necessary step in defining standards for exploration missions.
EVA will be part of any exploration mission scenario, either as a planned activity or in
an emergency during transit. Therefore, issues involving the prevention of
decompression sickness and acceptable risks for conducting EVA (e.g., venous gas
bubbles, bends, Central Nervous System (CNS) effects, and cardiovascular
symptoms) must be fully understood. Ground-based research must continue or be
accelerated, and flight validation during extended Spacelab missions, on SSF, and at
the Moon outpost, will be required before a Mars mission.
3. Behavior, Performance, and Human Factors
For the early Mars mission, critical EHLSS issues (Table IV-4) in habitability and
human factors focus on problems involving habitability requirements for transit
spacecraft and planetary habitats and human-machine interfaces. Research and
technology development for habitability requirements and human-machine interfaces
will provide designs that maximize productivity and minimize occupational injuries.
MCS, in a manner analogous to Earth operations, will be utilized to treat occupational
illness and injuries.
Table IV-4
Human Factors and Habitability Issues
• • Determine requirements for habitability (e.g., lighting, work/rest schedule) to maximize
performance
• • Determine optimum allocation of functions, including operator discretion, between humans
and machines to maximize maintainability and reliability
•- Determine behavioral correlates of space-induced physiological changes
• • = Required for Moon and Mars
The habitable volume and crew size limitations for transit vehicles and planetary
bases, only allow EHLSS that partially provide (e.g., by habitat design) near Earth-
normal conditions for factors that impact mental health. However, countermeasures
(e.g., crew selection, planned activities, work/rest cycles) may sustain mental health
which approaches Earth-normal, allowing acceptable mission performance and
postflight recovery. If countermeasures are insufficient and crew mental health and
morale degrades, MCS will play only a limited role.
Data on performance assessment and mental workload during missions are limited in
scope in areas of task analysis (e.g., experiment errors, lost data, and equipment
mishandling due to human-machine interface problems). Some inflight evaluations of
workstation design are being performed on Space Shuttle flights to identify the most
effective design for utilization in space. Procedures for allocating functions between
humans and machines must be developed before embarking on long-duration
missions.
Spacecraft habitability problems (e.g., high noise levels and unpleasant odors) have
been reported during short-duration space flight. Limited observational data from
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Space Shuttle missions (e.g., crews perceive the living space as confined, food as
restricted in quality and diversity, lack of privacy and personal hygiene facilities)
suggest that significantly improved habitability will be essential for maintaining crew
mental health and performance on long-duration missions.
Research Requirements. Ground-based research, aviation research and
operational experience, and data from isolated and confined settings have yielded
information regarding human performance and productivity. The applicability of this
extensive knowledge base for behavior, performance, and human factors designs for
operations in long-duration space flight must be thoroughly examined.
A recent report by the National Research Council Space Studies Board (1991)
emphasizes the importance of conducting ground-based studies in a variety of
research settings in order to understand group performance and functioning. It is their
recommendation that studies involve confined groups for three to four years. It is also
important to validate the results from analog settings involving laboratories and field
experiments (e.g., Antarctic analog) in operational environments (i.e., Spacelabs,
SSF, and Moon base).
4. Planetary Protection
Because Mars is potentially hospitable to life, missions to this planet provide an
exciting and unique opportunity to increase our knowledge of the origin, evolution, and
distribution of life in the universe. Contamination from Earth would obfuscate evidence
concerning chemical-biological evolution and the existence of hypothesized extinct
and extant species. A planetary protection program is required to protect Mars from
biological and chemical contamination as well as to protect Earth from importation of
biological materials from Mars.
Requirements and procedures to prevent forward contamination demonstrated on
Viking missions must be refined for Mars missions. Policies, procedures, equipment,
and facilities to protect against back contamination are less developed (Table IV-5).
Table IV-5
Planetary Protection
, Establish improved requirements to protect Mars from Earth contamination applicable to
robotic precursors and human missions (forward contamination)
° Establish requirements for robotic and human exploration to protect the Earth from
biological contamination from Mars (back contamination)
• = Required for Mars
Research Requirements. Technology development efforts required to support
planetary protection include development of: (1) alternative sterilization methods (e.g.,
alternatives to dry heat sterilization); (2) remote sealing, verification and monitoring
technologies; (3) aseptic transfer technologies; (4) developmental risk analysis
methods; and (5) containment technology and appropriate quarantine protocols for the
receiving labs on Earth. Robotic missions prior to manned exploration are mandatory.
In conjunction with early sample return, plans must be initiated for an Earth-based
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Mars sample quarantine (containment and analysis) facility in which samples will be
isolated and analyzed. There is a need to form an interagency committee for
jurisdiction over planetary protection concerns.
Cg Constrained Program - Human Operations in the Radiation
Environment of Space
Low level radiation poses a significant health hazard, that becomes more severe with
extended exposure duration. Duration of exposure and levels of radiation within
transit vehicle and planetary base habitats vary with mission scenario, thereby posing
unique mission dependent challenges for design of crew support systems (see Table
IV-S).
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TABLE IV-6
MISSION SCENARIO SENSITIVE
ENVIRONMENTAL FACTORS m
RADIATION
MISSION SCENARIOS
(1) Transit Vehicles
• Mars Missions
• Moon Missions
• EVA
(2) Planetary Surfaces
• Base
Mars
Moon
• EVA
Mars
Moon
SYSTEMS PROVIDING CAPABILITY
ENVIRONMENTAL
HEALTH & LIFE COUNTER-
SUPPORT
X
X*
X*
X
X
_
X*
MEASURES* *
MEDICAL CARE
C
C
C
C
C
C
C
* m Solar event prediction required
* * Protectants for radiation exposure
X Implies the potential for a solution
C Contingency capability for limited and temporary intervention or treatment
There are neither countermeasures nor totally effective medical treatments for humans
exposed to radiation, therefore EHLSS shields are the only means of protecting
humans for extended durations in transit or on planetary surfaces. The capability to
provide sufficient warning of large solar events should allow unshielded Moon transit;
Moon and Mars EVA; and Mars transit vehicles that incorporate shielded sanctuaries.
Similarly a solar event warning capability would enable EHA on planetary surfaces
and sanctuary architectures for bases. Shielding with regolith may provide acceptable
radiation levels throughout human habitats in planetary bases. Currently, information
i:
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necessary to quantify health hazards and design effective shielding from HZE is based
on empirical models.
The radiation environment of space external to Earth's atmosphere is so hostile to life
as we know it that there can be no compromises, and the issues (Table IV-7) must be
addressed in the constrained program.
Table IV-7
Radiation Health
• • Determine the interplanetary radiation environment for:
• • Galactic cosmic radiation (GCR) as a function of partial energy, linear energy transfer
(LET) and solar cycle for mission profiles
• • Maximum flux, integrated fluence, and the probability of large solar particle events
(SPE) during any mission
• • Determine the internal space radiation environment of space vehicles
• • Develop improved protection from GCR and SPE (proton radiation)
• Determine how a radiation field is transformed as a function of depth of different
materials
• Determine doses related to heavy ions and solar particle flux in deep space
• Determine the particle multiplicities of nuclear radiation products
• Quantify the biological effects of GCR and proton radiation from SPE
• Determine the interaction effects of radiation and hypogravity
• Validate ground-based research in space
• • = Required for Moon and Mars
Research Requirements. Required research includes:
• Characterization of radiation environments in transit vehicles
• Determination of the radiation effects of protons and heavy ions on biological
systems
• Determination of the risks of stochastic effects (i.e.,cancer and genetic) and
acute deterministic effects (e.g., damage to rapid cell renewal systems in bone
marrow, gut and skin), and late deterministic effects (e.g., cataracts and CNS
damage)
• Development of methods (e.g., pharmacological agents and bone marrow
preservation) for protecting against:
• Acute effects that might occur with a very large SPE
• Late effects (in particular cancer) from HZE and proton exposure.
It is critical for NASA to formalize agreements to utilize one or more of the federal
accelerator facilities, and to assure that those facilities remain in operation until
necessary ground-based research is completed.
In order to develop effective radiation protection, Moon orbitors and rovers must
include the capability to quantify GCR and SPE proton levels. They must also include
the means to evaluate potential radiation shielding and accommodate experiments to
determine biological effects from HZE and SPE exposure.
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The primary research thrust should be in prevention of exposure to the maximum
extent possible since countermeasures or treatments are not sufficiently developed
and might not yield solutions by the time exploration missions are initiated.
D. Constrained Program m Later Missions With Bioregenerative Life
Support
The volume and mass of stowage necessary to support crews increases with mission
duration and crew size; therefore, hybrid and/or bioregenerative systems will become
essential for later Mars missions. The primary difference between "early mission" and
"late mission" constrained programs is the exclusion of bioregenerative life support
systems from early mission scenarios. If ongoing research programs produce
technological breakthroughs in bioregenerative systems or physico-chemical systems
meet unforeseen difficulties, it might be feasible and beneficial to use the former in
earlier exploration missions.
The constrained program for later Mars missions (i.e., with bioregenerative life support
systems) addresses critical issues in the following life sciences areas:
Life Support Systems
Plant Biology
Cell and Developmental Biology
Radiation Biology.
1. Life Support Systems
Life support designs for Skylab, the Space Shuttle, SSF, and Mir (if one excludes
fresh vegetables grown periodically on Soviet missions) are based on stowage of
materials before launch and resupply. This has been adequate for short-term Earth
orbital and short-duration Moon missions.
Regenerative life support systems based solely on physico-chemical (PC)
technologies being developed for SSF and human exploration missions, cannot
regenerate food from waste. Eventually, the operational system must include
biologically based components utilizing green-plant photosynthesis capable of
generating food, oxygen, and potable water, removing carbon dioxide, and using
microbial degradation and mineralization of waste. SSF provides an opportunity to
develop, test, and gradually introduce regenerative technologies, particularly for water
and air, to reduce transportation burdens.
The fundamental strategy of the Controlled Ecological Life Support System (CEL.SS)
Program is to emulate the life-sustaining processes of Earth. However, because of
constraints on volume, mass, energy, and crew time, integrated bioregenerative m PC
systems will undoubtedly be the most practical for late missions.
Present understanding of the size, volume, and energy required for a total CELSS
suggests that for mission lengths of 600- to 1000- days, such systems would not
provide significant savings over PC life support systems. However, some fresh food
derived from plants may be desirable for nutritional and psychological reasons. For
,i
'i
i
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example, Soviet experiences with long duration Mir missions indicate that the
presence of living plants and the availability of fresh foods have enormous positive
impact on crew psychological well-being and work capacity.
Research Requirements. The major issues (Table IV-8) associated with PC air
regeneration include replacement of consumed oxygen, removal of carbon dioxide,
and reduction of the amounts of volatile organics and particulates. Major issues
associated with PC water regeneration include identification of particulates and
solutes in waste water streams that must be processed, establishment of realistic
requirements for the product (purified water), evaluation of potential methods of solute
removal, and maintenance of long-term water quality in a dynamic recycling system.
Issues associated with solid waste stabilization include reduction of volume,
containment and removal of off-gases; containment or neutralization of pathogenic
organisms; and storage.
Table IV-8
Life Support Systems
Physico-Chemical
• Determine best technologies for recycling potable and hygiene water
• Determine effects of the space environment on microbial interactions with space systems
(especially bioregenerative) and humans
• Evaluate and select strategies and techniques to control causes of life support system
instability
• Evaluate use of mathematical models in system design, simulation, and systems
operations
• Determine specific caloric, fluid, macronutrient, fiber, and micronutrient requirements
• Develop prioritized acceptability criteria for foods
Bioregenerative
• Assess CELSS instabilities due to limited volume and intense dynamics
• Determine CELSS produced foods to satisfy acceptability criteria
• Evaluate extent to which microorganisms in a physico-chemical waste processor may
degrade CELSS performance
• Establish CELSS system design and operation requirements considering redundancy,
subsystem failures, monitoring and control technologies, interaction between
bioregenerative and physico-chemical subsystems
• • Determine sensors required to automate CELSS
• • Determine available air treatment technologies, CELSS utilization, and development of
technologies for space application
• • Determine acceptable thresholds for revitalized air in an operational CELSS
• • Determine conditions required for optimizing food generation and water recycling of crop
plants
• • Determine whether extraterrestrially grown crop plants can produce sufficient edible
biomass to support humans
• • = Required for Moon and Mars
Human acceptance, nutritional standards, and processing and storage requirements
for food were assessed at the highest levels of criticality for research for a Mars
mission. It is highly likely that fresh foods derived from plants will be required for
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extended missions. Many of the high-priority research issues for CELSS development
(e.g., storage requirements for potable water and control of microbial films) are also
required for pure PC systems (Table IV-8). This life support research is also important
to developing technologies essential for environmental health of humans in space.
Investigations must include the possibility that fresh foods, particularly plant-derived
foods, will be required to enhance crew morale and mental health and prevent
nutritional deficiencies. Such deficiencies could be due to inadequacy of the diet,
flight-related changes in nutritional requirements, or crew appetites on long-duration
missions.
It is crucial that basic studies be conducted to determine whether safe and sufficient
supplies of water, air, and food can be provided by current or developing expendable
systems within presently understood constraints of spacecraft storage capacity, crew
size, and mission duration. Trade-off studies comparing expendable systems with
even partial recycling of water and air using biological systems have the highest
priority for research and development in the CELSS Program.
Research on photosynthetic productivity should be cooperatively developed with
National Science Foundation (NSF) and United States Department of Agriculture
(USDA). Research on waste recycling and food processing should be cooperatively
developed with Department of Energy (DOE), USDA, National Institutes of Health
(NIH), NSF, EPA, and FDA.
2. Plant Biology
A knowledge of plant gravitational biology (particularly in microgravity and at Moon
and Mars gravity levels) is integral to implementation and operation of a
bioregenerative life support system in space. Specifically, basic information about
plant gravity thresholds and the effects of gravity on nutrition, growth, differentiation,
reproduction, metabolism, and photosynthesis provides the fundamental basis for
such a system. Therefore, the criticality of these research issues (Table IV-9) in
support of exploration missions is directly related to decisions to incorporate a plant-
based bioregenerative life support system.
Research Requirements. The United States has had a moderately funded
ground-based plant biology program for the past 15 years, and the flight program has
been far from robust. As a result, many critical issues pertaining to plant gravitational
biology have not been answered, and many life support scientists in the CELSS
Program require answers to the same scientific questions as do scientists concerned
with more basic questions. For example, what is the gravitational threshold for normal
and productive plant growth and development? Can plants go from seed-to-seed-to-
seed in the space flight environment? How are crop frequency and size affected by
microgravity or other space-related environmental influences? As a result, there is
considerable overlap between CELSS and plant space biology.
Many of the plant biology issues assessed as criticality 2 may become criticality 1 if
ongoing space-based research reveals additional problems with plant development
il
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and physiology and if bioregenerative life support is required during early manned
missions.
Table IV-9
Plant Biology
• • Determine whether plants can reproduce through multiple generations in space or on the
Moon or Mars
• • Determine microgravity and other space-factor effects on single cell or higher plants
growth rates; differentiation; anabolic, catabolic and photosynthetic pathways or apparatus;
nutrient absorption pathways; support polymer synthesis; chromosomal integrity and
behavior during cell division; water transport; transpiration; embryogenesis and life cycle
stages in plants.
• • Determine the threshold levels for gravity effects
• • Identify perception and response to microgravity differences between species and
between tissues
Determine interaction effects between radiation, environmental factors and microgravity on
development of botanical systems
• • = Required for Moon and Mars
3. Cell and Developmental Biology
Space flight experiments to date have not demonstrated debilitating cellular effects
from exposure to the space flight environment. However, since inflight experiments
have been limited, there is insufficient evidence to draw definitive conclusions. The
primary issue (Table IV-10) in cell biology is the requirement to obtain such evidence
from a well-controlled flight science program.
Table IV-10
Cell and Developmental Biology
Determine microgravity effects on cells and the influence of magnetic fields and radiation
Determine low dose radiation and lowered gravity effects on male and female germ cells
-- What events in gametogenesis and early germ maturation are gravity sensitive and
how can these results relate to proliferation and differentiation of other individual cell
types?
-- Can altered gravities affect fertilization and do these results indicate more general
mechanisms of membrane alteration in individual cells?
-- Which responses are transmitted maternally and which are intrinsic to the developing
embryo?
-- How do altered gravity levels effect axis polarity and asymmetries of zygotes?
-- Are there gravity or other environmental effects that can cause change in gene
activation, transcription or translation?
• = Required for Mars
• • = Required for Moon and Mars
E. Robust Program
The robust program for EHLSS would include the following elements:
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An expanded basic research program
m Accelerated research by expanding the number of principal investigators
(PIs) and the diversity of approaches
An enriched radiation protection program
A series of dedicated retrievable biosatellites to collect HZE-based
radiation data, including multigenerational data on different species
m Characterization of solar cycle dependence of space radiation, trapped
radiation flux, and energy spectra of electrons
Determination of probabilities for GCR-related damage
Characterization of mechanisms involved in modulating damage,
including utilization of animal models to extrapolate human radiation
risks, such as probabilities for different radiobiological outcomes (e.g.,
cataracts, detrimental genetic development); and utilization of cellular
mechanisms to understand whole organism effects
An expanded life support program
Development of life support systems that provide food production for
transit vehicles and planetary bases
Development of highly automated systems designed with advanced
sensors (e.g., immobilized bioactive molecules) and controls that can
respond to toxicological and microbiological contamination events
m Accelerated development of processes to convert non-edible plant waste
to edible food ingredients
Development and application of genetic engineering
Accelerated programs to optimize cost-effective design solutions for
habitability and performance
Sophisticated models and simulators that have the highest fidelity that is
technically feasible to establish cost effective design solutions to human
factors issues, such as behaviorally and ergonomically-designed
systems for providing better habitation and human-machine interfaces
Refined anthropometric standards and automated systems for crew
communication and training
An enhanced space physiology program
Additional studies to understand physiological and other responses
under different atmospheric pressures and compositions, including
combustion/flammability, particle deposition and evolution
Expanded studies of space flight environmental conditions that influence
regulation of temperature, fluids and electrolytes
Studies to identify biomarkers for detection of human exposure to
contamination
An accelerated program to develop engineering requirements and
determine biological consequences for artificial gravity engineering (e.g.,
tethers, rotating spacecraft and short-armed or long-radius centrifuges)
i,
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Development of enhanced waste treatment and biological containment
systems to delay contamination of Mars and extend the window of
opportunity for exobiology studies of Mars.
F. Requirements for Moon Exploration Missions
Because of the relatively short Moon recovery times and mission durations, Moon
EHLSS facilities, equipment, and procedures can evolutionarily build in complexity
from SSF capabilities until they allow a full scale operational test of Mars mission
capabilities. As indicated in the boxed lists in the previous discussion, the only issues
for Mars missions that are not required for Moon missions are: (1) planetary protection;
and (2) effects of continuous long-duration radiation exposure.
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V. COUNTERMEASURE SYSTEMS
A. Introduction
Countermeasures Systems (CS) compensate for the detrimental effects of the space
environment on crewmembers. While EHLSS systems prevent the space environment
from degrading the crews' health status by providing or emulating Earth-normal cabin
conditions (e.g. normal temperature, pressure, gas concentration, shields to minimize
radiation from reaching the crew, and artificial lg transit vehicles), CS must
compensate for the fact that the crewmember is directly exposed to a hazardous
environment. There are three types of CS: (1) those that depend upon preflight
selection criteria; (2) those that prevent adaptive responses to microgravity and other
space flight environment factors and therefore are prescribed throughout the mission
(e.g., intermittant artificial gravity); and (3) those that restore or correct a deficit that only
becomes evident during transition to a new g field (e.g., landing on Mars or return to
Earth) and would be administered just before and/or after the transition. Ideally, CS
will prophylactically intervene to prevent illness, injury, and pathophysiology that
would result in behavioral and performance degradation. Countermeasure Systems
must provide acceptable mission performance and postflight recovery when: (1)
EHLSS cannot provide nominally Earth-normal environmental conditions for crews
because science or technology are not available, or where cost and schedule
limitations prohibit them; or (2) EHLSS fail, but only for short periods. Critical
questions 1 in life sciences that support a constrained research and development
program for CS are detailed in Volume I1.
B. Constrained Program -- Countermeasures for Crew Exposure to
Hypogravity
U.S. and Soviet flight experiments, ground-based research, and operational flight
experience have identified detrimental effects on human health and performance =n
microgravity on short-duration missions, even though currently available
countermeasures are used. Generally, undesirable effects become more severe with
extended exposure duration. Duration of exposure and levels of gravity within transit
vehicles and in planetary base habitats are directly related to specific mission
scenarios. Likewise, the impact on crew physiology, mission performance, and
postflight recovery are mission specific (Table V-l).
The requirements for countermeasures become more complex as NASA advances
from Spacelabs to SSF to Moon and Mars missions of increasingly extended duration
with multiple gravity levels (Table V-2).
Although improved capability is desirable, the Apollo Program demonstrated the ability
for crews to successfully perform short-duration Moon mission tasks during
microgravity transit EVA and surface (0.16g) EHA. Gravity thresholds for biological
processes have not been determined. Therefore, the impact of extended duration
exposure to 0.16g on the Moon surface is unknown. Consequently, the requirements
for countermeasures in long-duration Moon bases cannot be fully defined.
Footnote 1. 11.5% of the criticality 1 and 2 questions support a constrainedCS program(Volume II, Table
2).
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TABLE V-1
PROTECTION AGAINST HYPOGRAVITY EFFECTS
SYSTEMS PROVIDING CAPABILITY
MISSION SCENARIOS
(1) Transit Vehicles
• Mars Missions
• Moon Missions
• EVA
(2) Planetary Surfaces
• Base
Mars
Moon
• EHA
Mars
Moon
ENVIRONMENTAL
HEALTH & LIFE
SUPPORT
*
COUNTER-
MEASURES*
*
TBD
TBD
* -- May include artificial gravity
X -- Implies the potential for a solution
C
TBD
X
X
MEDICALCARE
C
C
C
C
C
C
C
-- Contingency capability for limited and temporary intervention or treatment
-- Indicates uncertainty about system requirements at 0.16g and 0.38g
Data from U.S. and Soviet space flights dictate a critical requirement for improved
countermeasures in microgravity transit vehicles. The known detrimental effects of
microgravity, and the absence of biological threshold data or specific data on
livingsystems under Mars (0.38g) gravitational conditions make it prudent to plan for
countermeasures at a Mars base even in the shortest (<30 day) scenarios. Human
centrifuges could be technologically and programmatically feasible as
countermeasures for decreased gravity within planetary bases or a Mars transit
vehicle. However, scientific evidence on the merit of intermittent gravity loading under
these conditions is needed.
The microgravity countermeasures research plan encompasses activities necessary to
establish the strategies for developing, testing, and validating the efficacy of
procedures, tools, models, and systems necessary to maintain health and
performance. This report addresses the most complex case (microgravity Mars transit
and effects of 0.16g and 0.38g are assumed to be as serious as microgravity) and
assumes that hypogravity countermeasures will be required during Mars transit and
Moon and Mars surface activities.
The constrained countermeasures program against hypogravity effects contains
critical issues from the following life sciences disciplines:
Musculoskeletal
Neuroscience
Cardiopulmonary
Regulatory Physiology
Cell and Developmental.
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Table V-2
Microgravity Countermeasure Requirements
Spacelabs
Current Capabilities <16 days _g
SSF
Orbiter*
Orbiter*
Orbiter*
Station
30 day _g
60 day _g
90 day _g
90 -? day p.g
Moon
Visit
Orbiter crew:
Surface crew:
< 20 days I_g
=14 days 0.16g
Plus several days I_g
Outpost
Orbiter crew:
Surface crew:
? days l_g
40-180 days 0.16g
Plus several days I_g
Settlement
Orbiter crew:
Surface crew:
? days #g
360-600 days 0.16g
Plus several days I_g
Mars Simulation
Moon orbiter: 120-460 days I_g
Mars (without artificial gravity)
Visit
Orbiter crew:
Surface crew:
Transit
Surface
Transit
600-1000 days l_g
? days #g
30-100 days 0.38g
? days p.g
Outpost
Orbiter crew: --1500 days p.g
Surface crew:
Transit ? days I_g
Surface =600 days 038g
Transit ? days I_g
* Options being studied
Countermeasure procedures are currently being developed, utilized, and evaluated in
both the U.S. and Russian space programs. The normal sequence of adaptive
physiological events, normal variability between individuals, and the interaction
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among individual countermeasures confound evaluation of their effectiveness.
Current countermeasures include"
Pharmacological (anti-motion sickness, anti-orthostatic intolerance and
anti-bone loss drugs)
Exercise (treadmill, cycle ergometer and resistance exercise; isometric,
isokinetic, isotonic and concentric protocols)
Dietary (fluid loading, mineral and/or metabolic supplements)
Environmental (lighting, oxygen pre-breathing)
Mechanical (lower body negative pressure, gravity suit)
Psychological (ground support, biofeedback)
Special training (preflight adaptation trainer, skill maintenance).
Crews in Mars transit vehicles with EHLSS systems that may incorporate artificial
gravity should experience near Earth-normal conditions. This may be helpful in transit
and on return to Earth. Chronic exposure to coriolis forces necessary to create arificial
gravity will have to be studied. The physiological response to transition between the
vehicle providing artificial gravity and the Mars surface (0.38g) during arrival and
departure are unknown. Extensive U.S and Soviet EVA experience suggests that
microgravity effects for EVA or transition to Mars gravity from transit vehicles (with lg
artificial) will not require EHLSS or CS. But the deconditioning resulting from stopping
the rotation (for lg artificial) of the transit vehicle may affect performance during and
after Mars landing. The physiological and behavioral consequences of repeated,
planned or emergency EVAs from a lg transit vehicle are also unknown.
1. Musculoskeletal
The extensive list of issues (Table V-3) related to musculoskeletal systems reflects: (1)
extensive evidence of detrimental effects from U.S. and Soviet space flight; (2) the
results of relatively robust flight and ground-based musculoskeletal research
programs; and (3) evidence that, without countermeasures, crews are likely to suffer
mission limiting (or terminating) injury or illness and/or irreversible damage from a
long duration Mars mission.
Table V-3
Musculoskeletal
i Determine regulation of muscle metabolism during normal activity and exercise, afteracute and chronic unloaded states, and during recovery from unloading
• Determine the endocrine and nutritional requirements to maintain bone, muscle, and
connective tissue, the interaction with mechanical loading and the effects induced by
space flight
• ° Determine whether bone loss is reversible in terms of mass, ultra- and microstructural
organization
-- Extent to which irreversible adaptations in bone architecture affect structural
integrity
• Identify bone and connective tissue markers or metabolism
• = Required for Mars
• • = Required for Moon and Mars
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In muscle the primary effect of adaptations to space flight appears to be a loss of
contractile protein in the muscle fibers. This translates to a loss in the cross-sectional
area of muscle fibers which is proportional to the loss of force potential. The extent of
loss remains undefined. The loss in cross-sectional area reflects a general loss of
muscle mass. Although there are subsequent and even simultaneous adaptations in
the type of contractile protein (e.g., types of myosin) expressed by some fibers, the
principal adaptation of physiological significance seems to be the loss of contractile
protein.
Connective tissue (bone and soft tissue) function is also affected by space flight.
However, the precise effect and time course of changes in connective tissue is not as
clearly defined as those in skeletal muscle. It is known that bone growth is inhibited in
growing rats during space flight. In older rats bone length is unaffected by short flights
(i.e., up to 2 weeks) but some structural remodeling may occur. The effects of space
flight on other connective tissue, such as those which contribute to the extra fiber
space in skeletal muscle and the tendonous component of muscle and ligaments of a
joint remains undefined. Although much less is known about soft connective tissues,
initial indications are that they are highly affected by unloading during rat tail
suspension, human bedrest studies, and space flight.
The functional significance of these changes lies in the high probability that muscle
atrophied because of space flight, if suddenly required to be active, may be particularly
susceptible to injury at one or more attachment interfaces between the contractile
elements of muscle and the connective tissue that transmits forces to the bones. To
develop countermeasures for muscle atrophy, understanding of the mechanisms by
which the space flight environment induces muscle atrophy must be significantly
improved.
There is clear evidence that forces transmitted by or to musculoskeletal tissues play a
modulatory role in the adaptation of bone to space flight and the effectiveness of
countermeasures. It is equally clear that some hormones can influence both the kind
of proteins expressed (e.g., slow or fast myosin) and the amount of protein. Further, it
is becoming increasingly obvious that musculoskeletal tissues may be affected by
growth factors. In establishing countermeasure strategies to maintain musculoskeletal
homeostasis, it is important to consider that previous research has not been successful
in fully preventing atrophy of this system using conditioning paradigms predicated on
low force, high frequency activities (i.e., aerobic treadmill and cycling).
Research Requirements. Based on current information, one key goal is to develop
countermeasures to the known adaptative changes in space flight that lead to
impaired function. Specifically, efforts must be made to define the force patterns of
specific types of muscles and bones during routine activities over the microgravity to
lg range to determine the role these forces play in maintaining structure and function
of muscle, connective tissue, and bone.
Research efforts to define the role of growth factors in modulating musculoskeletal
proteins during growth and development, and during adaptations to the space
environment, are equally important. The primary goal for programmatic development
of efficacious countermeasures for musculoskeletal function in prolonged spaceflight
is to identify factors that influence musculoskeletal protein synthesis and degradation,
and its assembly and disassembly as organized intercellular and extracellular and
60
transmembrane functional units (e.g., sarcomeres). A fundamental scientific
understanding, which includes the sequence of physiological and molecular events
that lead to protein modulation, will provide the basis for selecting effective
countermeasures for a variety of functionally unique musculoskeletal units (e.g.,
flexors vs. extensors, or arms vs. legs).
Since heavy resistance exercise (i.e., high force, low frequency) has been shown to
induce muscle hypertrophy in both human and animal subjects, it is reasonable to
more extensively explore high force, low frequency countermeasures. It is important to
examine: 1) different activity paradigms in combination; 2) the combination of activity
and pharmacological and hormonal interventions; and 3) the interaction of activity and
intermittent exposure to gravitational loads.
Development of effective measures to prevent, limit, or counter bone loss will require
research to: (1) identify the sites, time course, and magnitude of bone loss in
microgravity, 0.16g and 0.38g; (2) understand the interactions with other body systems
(e.g. endocrine), other space flight factors (e.g., nutrition and circulation rhythms), and
countermeasures for other adaptations (e.g., mechanical loading and exercise
countermeasure for hypogravity; (3) characterize bone recovery on planetary surfaces
(0.16g, 0.38g and lg); (4) quantify the risk of fractures; and (5) develop
countermeasures. It is essential to understand the effects of space flight on the
mechanisms which control changes in bones (e.g., balance of osteoblastic and
osteoclastic activity, perfusion dynamics, changes in serum calcium balance) in both
males and females. The impact of the space flight environment on bone fracture
healing in unknown.
2. Cardiopulmonary
The potential for cardiovascular problems is well known from U.S. and Soviet space
flights. Cardiovascular difficulties include orthostatic intolerance, headward shift of
body fluids, reduction in aerobic capacity and musculoskeletal weakening associated
with fluid and electrolyte changes (Table V-3). Various countermeasures for these
problems have been implemented both in the United States and Russia, but none has
been fully successful. Weakness and orthostatic intolerance pose potential
operational hazards during transition to Moon, Mars, or Earth gravity fields, or
emergencies during flight.
Table V-4
Cardiovascular
Determine relationship (and threshold) between electrical and mechanical (cardiac
output and reserve) cardiovascular responses and exposure to various gravity levels
(force, frequency and time interval)
Determine most effective countermeasures to avert adverse cardiovascular effects for
both long- and short-duration missions and how they should be applied
• = Required for Mars
• ° = Required for Moon and Mars
Less is known about the stability of electrical activity of the heart. There is evidence of
electrical instability (e.g., arrhythmias) during EVA and during Moon exploration. It is
not known whether arrhythmia is part of the orthostatic intolerance syndrome, or more
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importantly, whether the stress of prolonged weightlessness, increases the occurrence
of arrhythmias and reduces mechanical efficiency of the heart. The cardiovascular
and pulmonary (e.g., ventilation and respiration) effects of crew exposure to toxins and
radiation pose a completely unexplored threat.
Research Requirements. Integrated physiology research programs involving each
body system function must address beneficial and detrimental adaptations. Careful
study of neurovascular and cardiac responses must continue, and include histological
and morphometric (e.g., electron microscopic) studies of small vessels and neural
structures. Comprehensive investigations, on Earth and in microgravity, of intracellular
and intercellular processes, including elucidation of myocardial cellular and molecular
biology, is a promising approach to develop optimal countermeasures. Many of these
issues could be clarified by low Earth orbit (e.g., Space Shuttle, SSF) experiments on
animals.
3o Regulatory Physiology
Regulatory physiology is central to research programs involving any individual body
system and must be incorporated into all investigations aimed at understanding
adaptation processes and countermeasures.
The physiology of humans is composed of a totally integrated set of complex
subsystems that: (1) adapt to changes in their internal and external environments; and
(2) maintain critical physiological parameters (e.g., temperature, fluid and electrolyte
levels) at relatively stable levels (i.e., homeostasis). Operational observations
andspace flight experiments have demonstrated changes in a wide diversity of these
physiological parameters and processes. We do not know which of these changes are
simply adjustments to a new homeostatic equilibrium (analogous to changes that
occur when humans change diets, altitudes, climates, etc., on Earth) appropriate for
the hypogravity environment (i.e., what is "normal" in hypogravity) and therefore do not
require countermeasures (in fact countermeasures during space flight could be
detrimental). Nor do we know which are life or performance threatening changes that
must be ameliorated. It is clear that hypogravity countermeasures must consist of
integrated approaches that encompass the complete set of human subsystems, and
they must be evaluated for beneficial and detrimental effects (Table V-4).
a. Endocrinology
The transmission of information in the body and its integration across subsystems
depends on integrated central nervous system (CNS) and endocrine (neurohumoral,
neuroendocrine) communication systems. Recent endocrinology studies of diffuse
and extensive control mechanisms outside the CNS (e.g., kidney, gut) have
demonstrated widespread regulatory effects. Endocrine and neuroendocrine
secretions play an extensive modulatory role, and are the basis for developing and
sustaining regulatory changes throughout the body.
Measurement of changes in hormonal synthesis, release, and target cell or organ
response during space flight is essential to understanding adaptation to this new
environment. Understanding the effect of space flight-induced changes in hormones
on the brain is key to homeostatic regulation of physiological processes (e.g., body
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Table V-5
Regulatory Physiology
• Determine effects of space flight on sleep cycles and regulation of circadian rhythms and
their impact on physiological adaptation, response to stress and performance and
develop countermeasure systems accordingly
• Determine how adaptive responses to space flight effect absorption, potency, toxicity and
side effects of hormones and medications
• Determine effects of extended missions on kidney functions, especially filtration,
reabsorption, secretion and excretion (e.g., fluid and electrolyte losses, kidney stones)
• Determine effects of prolonged space flight, EVA, and countermeasures on thirst,
sweating, appetite and body temperature regulation
• Determine nature, time course, and severity of immune function changes in space flight
and which factors are responsible
• Determine how space flight factors affect nutritional requirements and gastrointestinal
function (e.g., absorption, motility, secretion)
• = Required for Mars !,
temperature, fluid balance, biological rhythms) and is central to understanding the role
of gravity in: (1) the evolution and regulation of living systems, and (2) physiological
and behavioral (e.g., emotional state, performance) changes that occur in humans
during space flight.
Although data regarding the detailed responses of the neuroendocrine system to
extended space flight are limited, it is clear that countermeasures to stabilize
endocrine levels are required. Furthermore, pharmacological and behavioral
manipulation of the endocrine system is an attractive avenue for introducing
countermeasures for other space flight adaptations.
Research Requirements. The changes in hormone levels, receptor activity, and
hormone action during space flight and re-exposure to a gravitational and other space
flight environment must be understood and countermeasures for detrimental
adaptations must be developed. Research to understand the effects of space flight
induced endocrine system changes on the function of other homeostatic systems (e.g.,
cardiovascular, immune, musculoskeletal, and central nervous system) is key to
understanding adaptations to space flight, and developing countermeasures for those
systems.
b. Fluid and Electrolyte Balance
Mechanisms leading to the acute loss of fluid and electrolytes observed during the
initial phase of adaptation to microgravity during U.S. and Soviet space flights are not
fully understood. Mechanisms operative in regulation and maintenance of fluid and
electrolyte balance during chronic exposure to microgravity are even less defined.
Regulation of body fluid and electrolyte balance is a fundamental homeostatic
function. Severe dehydration or loss of electrolytes (especially sodium and
potassium) can alter cardiac performance, skeletal muscle function, temperature
regulation and cellular electrochemical gradients, potentially resulting in circulatory
collapse. The regulation of fluid and electrolytes is essential to the ability to respond to
physical and emotional r stress. It is important to understand, as completely as
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possible, the fluid and electrolyte changes that occur during exposure to microgravity,
as well as changes in hormones and other factors regulating those balances. A more
complete analysis of renal function, including changes in blood urea nitrogen and
occurence of kidney stones is required.
Research Requirements. Mechanical, dietary, behavioral, and chemical
countermeasures will be evaluated for long-duration missions. Studies should include
the magnitude, time course, and steady state levels of changes in key electrolytes
within different body fluid compartments, throughout the process of adaptation to
microgravity. The functional relationship between changes in fluid and electrolyte
regulatory mechanisms and cardiovascular system deconditioning in microgravity
should be studied. Ground models, such as antiorthostatic bedrest as a method of
simulating microgravity for studying long-duration space flight induced alterations in
fluid and electrolyte metabolism, and computer models, should be validated with
humans in space. This is essential to enable screening of countermeasure systems
for long-duration missions.
c. Hematology
Loss of red blood cell mass is a significant and consistant response to space flight.
Further, it may represent a model of the effects of space flight on proliferative tissues.
Despite substantial investigation in the United States and Soviet Union, the etiology,
biological mechanisms, and potential operational significance of the loss of red blood
cell mass have not been adequately defined. The loss undoubtably contributes to
orthostatic intolerance and decreased postflight exercise capacity. While the primary
cause appears to be the influence of microgravity itself, the etiology is probably
multifactorial, including influences such as hypokinesis and hypodynamia, bone
demineralization and remodeling, muscle atrophy, altered hemodynamics, modified
oxygen demand or oxygen carrying capacity, and nutritional and metabolic
disturbances which in turn may be due to microgravity. The influence of other
environmental factors such as hyperoxia, hypobaria, ionizing radiation, toxic
contaminants, and accelerative stresses of space flight remains to be established.
Research Requirements. Available information does not permit extrapolation of
the course of red blood cell dynamics during space missions lasting a year or longer.
Nor can the possibility be ruled out that the loss red blood cell mass could compromise
the safety and effectiveness of crews in flights complicated by illness, injury, or life
support equipment malfunction. Lack of information on mechanisms of red blood cell
formation and release during space flight emphasizes the need to acquire more data.
Moreover, uncertainties exist as to probable responses of the hematopoietic system
during space missions lasting a year or longer. Therefore, reduction in red blood cell
mass represents a contingent operational medical problem. Until the cause and
mechanisms of these changes are understood, appropriate countermeasures cannot
be developed and validated. However, infusion of red blood cells or erythropoistin are
potential solutions.
d. Immunology
Pre- and postflight measurements have demonstrated that space flight causes a
suppression of the cell mediated immune system, which returns to preflight levels
within approximately 30 days after return to Earth. Due to limited inflight data, we do
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not know: (1) inflight functional levels, or (2) the time course and magnitude of
suppression. Therefore, we cannot predict whether functional levels could stabilize at
a new depressed space flight homeostatic level or continue to decline. We cannot
predict whether recovery will occur after extended duration missions. Furthermore, we
do not know which space flight environmental factor causes the suppression, and we
do not know the medical significance.
The immune system of higher animals protects the body from exogenous (e.g.,
infectious bacteria, fungi, and viruses) or endogenous (e.g., neoplastic) threats to
survival. Surveillance and destruction of neoplastic or otherwise antigenically
transformed cells before they can form a tumor and metastasize and spread cancer
throughout the body will be particularly important in space because the relatively high
radiation environment and potential for exposure to toxicants in closed cabins could
increase the rate of mutation or tumorigenesis.
Research Requirements. The question of the time course, magnitude, and
potential clinical significance of changes in immune competency must be addressed
with a program of clinical and scientific investigations involving carefully designed and
integrated ground-based and flight experiments. Space flight-related decrement(s) in
immune function that would affect the identification and elimination of infectious
organisms or surveillance of the internal environment for transformed cells must be
identified. Their impact on crew health and safety must be assessed, and, if required,
appropriate prophylactic or therapeutic measures developed. This is a particularly
vulnerable area since state-of-the-art remedial procedures lag. It will be important to
evaluate effects of space flight deconditioning and countermeasure procedures for
beneficial as well as adverse effects on the immune system.
4. Neuroscience
Adaptation to space has a major impact on the motor system and on motor
coordination because of the absence or reduction of gravity. Major neurological
issues are shown in Table V-5. Antigravity muscles are unloaded continuously and
antigravity reflexes, utilized in maintaining posture and locomotion on Earth, are
inactive or modified. As a result, there is a loss of extensor reflexes in space. This
may lead to the fetal posturing of legs that has been observed in space flight. Sensory
information about limb position is not interpreted correctly in the absence of vision, and
voluntary pointing accuracy and perception of static limb position are impaired. Upon
return to Earth, there is postural imbalance and locomotor incoordination, including
difficulty in walking and standing with eyes closed, and in executing quick turns.
These symptoms occur even after relatively short missions where changes in muscle
strength are minor. This indicates that such changes are largely due to lasting effects
of adaptation of both central motor programs and the proprioceptive system.
Anecdotal evidence from the Soviet space program of physical incoordination even
several months after a mission, suggests that motor patterns may take a long time to
readapt. The time required to fully readapt to preflight levels after very long periods of
exposure to microgravity is unknown. A prolonged period of postural inactivation and
impairment of locomotion would not be acceptable in the event of an emergency
during the landing on Mars that demanded quick egress from the space vehicle.
Moreover, it could also seriously impair the ability of astronauts to accomplish mission
c.
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tasks, or even care for themselves, in the Mars gravitational environment. There are
no known countermeasures other than readaptation during exercise in a l g
environment.
Table V-6
Neurosclence
Determine sensory inputs and coordination of muscular function for generation of
posture and locomotion before, during, and after flight
If an onboard centrifuge is used as a countermeasure, will repeated transition from 1-g to
microgravity cause maladaption
Determine optimal countermeasures for motor readaption to partial gravity or 1-g after
adaptation to microgravity
Determine whether the decrease in afferent input to the vestibular, proprioceptive, and
somatosensory systems that are associated with long-duration space flight result in
permanent reflex deficits
• = Required for Mars
• • = Required for Moon and Mars
Research Requirements. Disabling motion sickness on return to a gravitational
environment must be understood and alleviated. Studies of the motor system to
understand and devise countermeasures to postural readaptation in space are
required before a mission to Mars is possible. Important questions related to this
objective include: (1) How are the sensory inputs and coordination of motor function
organized for generation of posture and locomotion before, during, and after flight? (2)
What adaptive processes modify motor control systems, including the occulomotor
system? (3) What is the dynamic range of adaptation of motor responses in altered
states of gravity? (4) What processes explain the altered perceptions of joint and body
position in microgravity? (5) Will the decrease in afferent input to the vestibular,
proprioceptive, and somato-sensory systems and the adaptation associated with long-
duration flight result in permanent reflex deficits? (6) Are there morphological or
structural changes in CNS and neuromuscular functions that form the basis for these
deficits? and (7) If an onboard short-radius centrifuge is adopted as a physiological
countermeasure, will humans be able to maintain a dual state of adaptation, and will
they suffer from motion sickness when transitioning from microgravity to hypergravity?
5. Cell and Developmental
Cell and developmental studies provide the fundamental scientific knowledge and
understanding of mechanisms necessary for development of effective
countermeasures. Understanding the effect of the space environment on cellular and
developmental processes (i.e., the generation, maintenance, differentiation, and
turnover of tissue-specific cells) in adult humans is essential (Table V-6). These
include erythropoietic stem cells (that produce red blood cells), osteogenic cells (that
remodel bone), epithelial cells (that continually differentiate, function, and turnover)
and the dynamic morphogenesis and differentiation of microvasculature. Cellular
systems that have exhibited potentially serious alterations in space include: immune
cell activation, muscle contractile activity and atrophy; mineralization-demineralization
dynamics of bone and cartilage; secretory function of exocrine and endocrine
epithelia; and cardiac myocyte electrical coordination. Changes in gene expression
and altered mitotic activity (e.g., tumor formation) also fall into this category.
66
Table V-7
Cell and Developmental
• • Determine microgravity adaptation and other space flight effects on
musculoskeletal system responses including:
-- Biomechanical unloading
-- Fluid distribution, composition and pressure
-- Impacts on fluid homeostasis
• • Determine interactive effects of radiation and microgravity
• • How do neoplasms common to chronological aging relate to limitation of cell
lifespan and susceptibility to abnormal growth regulation under altered
gravitational fields?
• = Required for Mars
° ° = Required for Moon and Mars
Research Requirements. The key issues that need to be addressed are: What are
the effects of reduced gravity or other space flight environmental factors on gene
expression, cell division, cell differentiation, cell and tissue interactions, signal
generation and reception, signal transduction and target response, endocytosis and
secretory activity? It is essential that a variety of cell types (in vivo and in vitro) be
analyzed for microgravitational effects to elucidate mechanisms and develop
countermeasures that inhibit or reverse deleterious effects.
6. Artificial Gravity
It is highly probable that imposing some level and pattern of artificial gravitational force
on humans over a period of months and years would be an effective countermeasure.
However, there is little information available on the physiological effects of intermittent
g loading or the effects of different levels; of g loading. It would seem prudent to
identify how variable levels of gravity can be used to normalize physiological
processes. This program should identify the gravity levels that are necessary to
maintain affected tissue and physiological systems, determine how these loads should
be applied (e.g., continuous vs. intermittent), and provide protocols to minimize or
eliminate undesirable side effects. Artificial gravity countermeasures should be
integrated with other countermeasures such as exercise, hydration, and sensory-motor
training. Additionally, these studies will contribute to our fundamental understanding
of the effects of gravitational and coriolis forces on physiological systems.Artificial
gravity may be necessary if other countermeasures are not sufficient for long-duration
Mars missions. It is possible that artificial gravity countermeasures could reduce the
cost and logistics burden while enhancing crew performance on Mars missions. The
payoff for artificial gravity countermeasures or a continuous l g environment on the
transit vehicle will be larger if physiological adaptation to Mars gravity (0.38g) is
significantly less than that experienced in microgravity, thereby allowing simpler
countermeasures throughout the mission.
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C. Constrained Program m Countermeasures for Crew Exposure to
Space Flight Factors
Living systems have an exquisitely refined capability to integrate sensory input (e.g.,
visual, thermal, light, nutrient levels, gravity), coordinate global subsystem responses
(e.g., circulatory, musculoskeletal), and produce a unified whole body response (e.g.,
redirect blood flow to body surfaces, sweat and increase water intake to adjust
temperature). Furthermore, responses to inflight environmental factors could
exacerbate the effects of microgravity (e.g., sleep disturbances and orthostatic
intolerance). Therefore, it is artificial to separate the inflight effects of hypogravity from
other space flight effects. However, the separation is pragmatically necessary, both for
this plan and to design interpretable experiments. Countermeasure systems for these
should be readily identifiable. The following life sciences disciplines address critical
issues that primarily respond to space environmental factors (Table V-7), but include
some aspects of hypogravity response:
Behavior and Performance
Environmental Health
Regulatory Physiology.
Table V-8
Spacecraft Cabin Environmental Factors
Pressure
Temperature
Gas composition
Microbiology and Toxicology (quality/quantity)
Lighting (intensity, quality, duration)
Food (quality, diversity, quantity)
Restricted habitability and personnel hygiene standards
Confinement and isolation
Potentially sustained stressful situations
1. Behavior, Performance and Human Factors
Most of the research in this area is required for a Mars mission, of even the shortest
possible duration. The overall issue is effective functioning of a crew enclosed in a
confined environment in microgravity and subjected to continuous operational and
environmental stress (Table V-8). Problems of morale, hostility, and breakdowns of
communication have been documented with increasing frequency as the duration of
the interaction increased, even in ground-based operations. Problems are
compounded by the stresses of space, for example: (1) deconditioning in
microgravity; (2) closed environmental life support systems; (3) unpredictable risk of
radiation exposure beyond the magnetosphere; and (4) limited (low Earth orbit and
Moon) or extremely long- duration (Mars) escape or abort capability.
Although data are limited, both the U.S. and Soviet space programs have
documented behavioral problems, including fatigue, irritability, depression, anxiety,
mood fluctuations, boredom, tension, social withdrawal, and motivational changes.
Instances of hostility between flight crewmembers, and space and ground crews have
been reported. Data from short-duration (10-day) space flights demonstrate
68
Table V-9
Behavior, Performance, and Human Factors
• • Determine criteria for evaluating individual and crew performance/productivity
• • Determine effects of prolonged space flight on behavior and group dynamics (including
differences such as age, sex, culture)
• Determine critical characteristics of leader influence on productivity and stability among
crewmembers
-- Define optimal crew command structure for Moon and Mars missions
• Establish protocols for training effective ground and space crews in such areas as
enhanced communication, crew coordination, interpersonal dynamics, and problem
solving
• Determine requirements for optimal integration failtomated systems with human
capability to maximize productivity and reliability.
• = Required for Mars
• • = Required for Moon and Mars
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Although data are limited, both the U.S. and Soviet space programs have
documented behavioral problems, including fatigue, irritability, depression, anxiety,
mood fluctuations, boredom, tension, social withdrawal, and motivational changes.
Instances of hostility between flight crewmembers, and space and ground crews have
been reported. Data from short-duration (10-day) space flights demonstrate
deleterious effects on physical performance, particularly disturbances in sensory-
motor systems, visual function (e.g., illusions) and proprioception. Some reflexes are
slightly impaired early in flight but recover after adaptation. Postflight data show
similar visual function impairments, including illusions and mass discrimination
deficiencies. Explanations of these phenomena include changes due to learning of
new perceptual and motor skills and/or effects of spatial disorientation and space
motion sickness. The evidence from short-duration space missions indicates that
behavioral capabilities can be maintained during space flight despite small decreases
in work capacity early in flight. There is no database for long-duration missions.
Investigations of sleep patterns and performance have been conducted on several
short-duration missions. Poor sleep quality and fatigue have been reported and
approximately 30% of U.S. Shuttle astronauts have requested sleep medication in
flight, though none had a history of usage on Earth.
The psychosocial dynamics of small groups of humans living in confined and isolated
environments for prolonged periods are not well understood, even for ground
operations. Critical issues focus on interactive crew behavior and performance.
Selection criteria for crew composition and structure, and training protocols are key
areas. They must consider the individual in the context of the group including
suitability of skill mix and interpersonal attributes. Selection criteria that address
leadership, and its impact on order, morale and group cohesion are critical.
Research Requirements. The most critical research elements include: how the
individual will perform; how the group will continue to function effectively; monitoring
and compensation strategies for environmental stresses; optimal integration of
automation and human capabilities; and crew selection criteria. Behavior and
performance countermeasures include: performance evaluation criteria; monitoring
i.
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and control strategies for performance-related stress effects; mission stage-specific
assessments of physical and cognitive performance capabilities; crew selection
criteria related to group productivity and stability; protocols for enhanced
communications; and development of special EVA performance requirements.
Research elements related to performance and group functioning include:
microgravity and other space environment factors effects on fundamental behavioral
processes such as perception, sensation, learning, and motor skills; physiological
changes and reliable correlates of performance; circadian rhythms, sleep patterns and
work/rest schedules; and individual and team motivation and coping strategies for
environmental stressors. Supporting research includes workloads, schedules,
interactions with ground support teams, nonintrusive performance data collection, and
modeling of complex performance.
A carefully integrated sequence of events, programmed to facilitate crew selection,
should remain sufficiently resilient and elastic to incorporate modifications as the state-
of-the-science advances. The process should include: (1) psychological testing to
"select out" and "select in" candidates on the basis of personal and group interviews
and psychological tests followed by group situations to determine compatibility; (2)
simulation training of candidate crews in a high fidelity Mars transfer vehicle mock-up
(a confinement period of three to four months will be required to gain experience and
data on crew compatibility and performance); and (3) SSF testing for a three to four
month exposure to test crew compatibility and performance in microgravity and to
provide information for designing the Mars transit vehicle and base.
2. Environmental Health
The major environmental health issue for countermeasures involves adaptative
responses of the body to altered pressure, varying concentrations of gases and
contaminants (Table V-9). Problems associated with reduced pressure include
decompression sickness and physiological problems associated with environmental
gas concentrations, including hyperoxia and hypercapnia. Physiolgical monitoring
equipment is required to study the effects of alterations in the environment on
cardiovascular, regulatory, neurosensory, musculoskeletal, behavioral (performance),
and other systems. Countermeasure systems will include surveillance, detection,
warning, and remediation.
Table V-10
Environmental Health
• • Determine effects of prolonged exposure to microgravity and other space flight
environmental factors
• • = Required for Moon and Mars
Research Requirements. Ground-based research should include studies on
decompression sickness, mechanisms leading to countermeasures that facilitate safe
EVA, optimal suit pressures, and gas compositions. Ground-based research and flight
investigations should address the interaction of hyperoxia, hypercapnia, hypoxia,
hypobaria, decompression sickness, ambient pressure, and microgravity. Ground-
based research also includes the development of protocols for training to cope with
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decompression sickness and other adverse physiological responses. Research to
develop models to predict physiological response to varying environmental conditions
is also needed.
3. Regulatory Physiology
a. Circadian Rhythms/Sleep
Circadian rhythms (i.e., characteristics of living systems that cycle with a relatively fixed
and predictable period of about 24 hours) are a fundamental property of most
organisms. Circadian rhythmic variations are observed in almost all biochemical,
cellular, physiological, and behavioral systems. These rhythms are generated by
internal (i.e., endogenous) biological clocks that are normally entrained or
synchronized to 24-hour changes in the physical environment by external signals
(e.g., light-dark cycle). Extensive biochemical, molecular and cellular studies are
ongoing to elucidate the biological mechanisms by which circadian rhythms are
generated and entrained.
Biological rhythms are a common feature of regulatory systems, and the proper timing
of circadian rhythms is vital for optimal health of organisms. Recent studies of humans
focus on the importance of circadian rhythms and sleep for normal mental and
physical health, and on methods to influence them for optimizing performance in a
variety of work environments. Understanding and managing circadian rhythms in the
absence of the normal 24-hour cycle of Earth signals is critical for crew health and
performance.
Research Requirements. Countermeasures would include the design of lighting
systems, imposed work/rest schedules, time-of-day scheduling of activities such as
EVA and exercise, and use of pharmacological agents.
b. Metabolism/Nutrition
Metabolic status and nutritional requirements of humans are affected by changes in
physiological state. Responses to weightlessness, limited food choices, and exposure
to radiation during space flight could affect human metabolism and nutritional
requirements, which in turn affect physiological systems. Thus, metabolic regulation
and nutritional balance are integral parts of maintaining health and performance in
space. In addition, long-duration effects of space flight on gastrointestinal (including
liver) and kidney function and absorption of nutrients are unknown.
The therapeutic effect of drugs depends on the rate at which they are absorbed,
metabolized, and eliminated; and on their distribution within the body. Changes in
gastrointestinal, hepatic, or renal function or in circulatory dynamics may modify drug
pharmacodynamics.
Long-term exposure to microgravity may change metabolic and energy requirements.
Therefore, metabolic efficiency and steady state energy expenditure in space during
nominal activities, exercise, and EVA should be determined. If there are changes,
physiological factors must be elucidated and countermeasures must be developed.
71
Research Requirements. Countermeasures, discussed in other parts of this report,
are being considered for bone demineralization, cardiopulmanary function, muscle
atrophy, fluid shifts, electrolyte imbalances, etc. All of these are affected by metabolic
and nutritional status. Therefore, nutritional countermeasures are an integral
component of other countermeasure systems. For example, exercise is a primary
countermeasure against muscle atrophy, and may be useful in minimizing bone
demineralization, and provision of special amino acid combinations could aid in
preventing muscle atrophy.
c. Temperature Regulation
Temperature regulation is an example of a highly complex, integrated regulatory
system that maintains homeostasis in the face of wide variations in environmental
conditions. In humans, except for an occasional episode of fever or exercise-induced
hyperthermia, body temperature rarely varies more than two degrees centigrade from
baseline throughout an individual's lifetime. A normally functioning thermoregulatory
system is vital for the health of the individual. For example, thermoregulation is
drastically impaired by body fluid alterations during dehydration. Sustained high fever
can cause severe damage and even death. Even transient exposure to high or low
temperature leads to discomfort and radically impairs sleep and performance.
Alteration of core body temperature observed on COSMOS and Spacelab flights led to
numerous thermoregulation studies which document the effect of space flight.
Anecdotal data from U.S. and Soviet space studies suggest that there may also be a
shift in the thermal comfort zone. Current evidence suggests changes in the capability
to homeostatically respond to altered thermal environments (i.e., ambient temperature)
or loads (i.e., exercise or EVA). Other components of the space flight environment
(e.g., light, pressure, and gas composition) may also alter this system.
Determination of whether a countermeasure system is necessary and establishment of
design requirements await further understanding of the effects of space flight on
thermoregulation. However, cooling garments have already been used for EVA, and
environmental health and hydration strategies may provide simple countermeasures
for extended duration missions.
D. Robust Program
The robust program for CS would include development of artificial gravity
countermeasures capability as a parallel program with other microgravity
countermeasures. The engineering requirements to deliver artificial gravity (e.g.,
tethers, rotating space craft, short-armed or long-radius centrifuges) would be
developed in conjunction with EHLSS applications.
Artificial gravity is the only alternative for a Mars mission, if countermeasures currently
being investigated in low Earth orbit are not sufficient for long duration missions. An
artificial gravity countermeasure program would begin with investigation of the effects
of intermittent g at various g-loads, rotation rates, and frequencies with and without
activity as a universal or partial CS. It would include intensive, highly focused studies
on the effects of 0.16g and 0.38g. Some studies of intermittent g and the effects of
continuously rotating environments can be conducted on the ground using simulators
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and models. Most of this research will require small variable g centrifuges for a variety
of diminutive model organisms and the Centrifuge Facility on SSF. Facilities on the
Moon will enhance this research.
Slow rotating rooms will be used to examine the chronic physiological effects of
continuous rotation on humans in lg. The robust program would include a human
variable gravity research facility in space to support basic investigations of the efficacy
of fractional gravity in attenuating the effects of prolonged exposure to microgravity
conditions. This facility would investigate human performance in a prolonged
microgravity condition, habitability-related problems of working and living in a partial or
intermittent gravity environment, effects of variable-rotation rate, level of artificial gravity
required, and effect of duration, performance and productivity. It would evolve to
become a full scale prototype used to simulate different scenarios and phases of Moon
and Mars exploration missions.
A robust program will include advanced computer models and simulators for all
components of the constrained countermeasures program. It will accelerate inclusion
of artificial intelligence capabilities and will include enhancements in the basic science
studies focusing on the mechanisms which underpin countermeasures development.
The robust program will investigate the extensive knowledge base resulting from
experiments on estivation and hibernation in animals both to: 1) understand how
modifications in body systems compensate for inactivity, which may provide totally new
insights for countermeasures, and (2) to understand how changes in the environment
and internal control systems initiate and control reduced metabolic activity, which may
provide an initial pathway toward the benefits which would derive from a suspended
animation-like capability for long-duration space missions.
E. Requirements for Moon Exploration Missions
Because of the relatively short Moon recovery time and mission duration,
Countermeasure Systems can evolutionarily build in complexity from SSF capabilities
until they incorporate a full scale operational test of Mars mission capabilities. The
boxed lists in the previous discussion identify issues that are not required for Moon
missions. The identified differences in life sciences research and technology programs
for Moon and Mars missions are due to differences in mission durations and rescue
times. Development of countermeasures for Mars missions will require extensive data
on long-term effects of hypogravity and other space flight environmental factors, and
better understanding of the underlying mechanisms in the musculoskeletal,
cardiovascular, regulatory physiology, neuroscience, cell and developmental, and
behavior, performance and human factors areas.
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Vl. MEDICAL CARE SYSTEMS
A. Introduction
An appropriate level of inflight medical care is a critical element in overall mission
success. The capability to treat a broad range of medical and surgical conditions is
justifiable both for humanitarian reasons and to ensure that the crew is healthy enough
to perform their assigned duties. As a general principle, increasing isolation and
mission hazard should be countered by an increasingly capable and autonomous
health care system, although it is axiomatic to note that not all clinical conditions will
be treatable in space. The overarching objective is to provide treatment capabilities
for most feasible conditions without imposing an unacceptable burden on the
constrained resources available within spacecraft and planetary habitats. Thus, the
overarching MCS requirement is research and development needed to determine
potential risks and to identify the mission resources required. Studies must include
trade-offs between onboard medical capability and rescue capability (e.g., Assured
Crew Return Vehicle for SSF).
Countermeasures and medical care systems form a continuum in terms of overall crew
health. Countermeasures represent a preventive medicine approach to limit the
deleterious medical effects of unopposed space flight deconditioning, where the
medical care systems provide clinical treatment for overt illness or injury. Medical care
system requirements result from endogenous medical risk (i.e., that which any
individual has as a result of hereditary, lifestyle, and prior illness), unopposed
physiological deconditioning in microgravity, environmental factors (radiation
exposure, atmospheric contamination, or rapid pressure changes) and psychological
stress associated with living and working in an isolated, hazardous and confined
environment. The body's tremendous ability to acclimate, both: (1) allows humans to
exist in a microgravity environment which was not experienced during the evolutionary
process; and (2) confounds medical treatment in space. Many physiological
parameters change in the flight environment. It is not known whether the degree to
which these changes occur are simply appropriate adjustments to a new "normal"
homeostatic level suitable to that environment. Consequently, it is not known when or
if intervention to adjust parameters toward "Earth normal" is beneficial; and diagnosis
and treatment of illness without a clear definition of "normal" is difficult at best.
Exposure to the space environment is known to cause changes in drug kinetics,
absorption, and action, increases in size of internal organs (e.g., the spleen), changes
in the shape and function of the heart and vessels, and multiple alterations in
regulatory physiology. The clinical significance of these alterations is not yet clear due
to limited experience with medical observation and care inflight. Furthermore, the
broad issue of clinical response of the space-adapted crewmember to pathological
conditions (e.g., hemorrhage, fracture or lacerations) has not been addressed. It is
possible that modified disease processes will require a different approach for
providing medical care.
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Table VI-1 identifies the Life Sciences Division disciplines 1 that support solutions in
clinical medicine and therapeutic response, and summarizes other requirements for
MCS.
TABLE Vl-1
PROVISIONS FOR MEDICAL CARE SYSTEMS
ILLNESS AND INJURY
EVENTS
Occupational Health:
Endogenous medical risk
factors
EHLSS failure or
degradation
CS failure or inadequacy
Surgical and medical
regimes:
Cardiopulmonary
Musculoskeletal
Metabolic Disorders**
Radiation Health
Cell and Developmental
Function
SYSTEMS PROVIDING CAPABILITY
ENVIRONMENTAL
HEALTH & LIFE
SUPPORT
COUNTER-
MEASURES**
MEDICALCARE
X
X
X
X*
X
X
C
C
C
C
C
C
C
X -- Implies the potential for a solution
C -- Contingency capability for limited and temporary intervention or treatment
* -- If synergism between microgravity and radiation exists
** -- Pathological regulatory physiology
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B. Constrained Program m Surgical and Medical Regimes
1. Cardiopulmonary System
Medical care systems for exploration missions will require the ability to diagnose and
treat major cardiopulmonary emergencies, including but not limited to"
• Decompression sickness (not exclusively a cardiopulmonary problem)
• Myocardial infarction (heart attack)
• Pulmonary embolus
• Cardiac arrhythmias/anginaJcongestive heart failure
• Cardiopulmonary arrest.
Footnote 1. Less than one percent of the critical questions in Life Sciences Division Discipline
Science Plans support a constrained program in Medical Care Systems. See Volume II,
Table 2 for details.
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Table VI-2
Cardiopulmonary
oo
Determine beneficial and harmful delayed or persistent consequences of long-term
space flight and identify appropriate short-term (i.e., hours to days) and long-term (i.e.,
months to years) postflight rehabilitative measures
Identify risks for bubble formation and decompression sickness associated with pre-EVA
denitrogenation/decompression schedules and exercises
Determine cardiovascular electrical and mechanical responses to EVA at different levels
of gravity (e.g., transit and surfaces of Moon and Mars)
--Determine what factors influence the occurrence, magnitude, and sequence of these
responses
Establish pulmonary life support procedures for protection or resuscitation in the event of
loss of EVA suit or cabin pressure, and for cardiopulmonary resuscitation and general
anesthesia
Determine whether space flight increases cardiac arrhythmias and identify mechanisms
Determine whether the extent of adaptation to space flight affects postflight orthostatic
intolerance
Determine space flight alterations in blood pressure and flows and functional
consequences in tissues and organ systems during long-duration flight or after return to
Earth
• = Required for Mars
• • = Required for Moon and Mars
Research Requirements. Additional study of decompression sickness (bends) and
design of improved space suits is required. Ground EVA simulations suggest that
bubbles frequently occur in the pulmonary artery, but that clinical bends occurs much
less frequently. While bubbles may be of little consequence in a normal subject, they
could be catastrophic in a subject with an undetected arterivenous shunt. Risks of
bubble formation and clinical decompression sickness associated with pre-EVA
denitrogenation/decompression schedules and exercises must be identified.
Standards for crew health and performance, including periodic monitoring of health
status, must be developed. The impact of expanded EVA (e.g., constructing SSF) and
EHA (base construction and Moon or Mars exploration) on the risk of decompression
sickness and suit design must be determined.
Certain types of arrhythmia will incapacitate a crewmember and endanger a mission.
Therefore, it is important to know whether the prevalence of cardiac arrhythmias is in
fact higher during space flight, and if so, what mechanisms, prevention, and therapy
are required. It is important to determine whether space alters pharmacokinetics and
dose response curves for beneficial and deleterious effects of anti-arrhythmic and
other cardioactive and vasoactive drugs. An understanding of the mechanisms and
treatment of orthostatic intolerance that could compromise landing and productivity on
the Moon or Mars, and on return to Earth is required. What is the threshold for
prevention of intolerance (e.g., will 0.16 or 0.38 Earth gravity prevent its occurrence?),
and are there more effective and/or less intrusive methods of therapy than those
currently employed (e.g., fluid loading, lower body negative pressure---LBNP)?
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2. Musculoskeletal
Major issues (Table VI-3) involve the prevention of excessive deconditioning and the
provisions for treatment of acute injuries. There is substantial risk of a crush injury of
muscle and bone when moving large masses in space; and muscle and tendon
sprains, bruises, and bone fracture with work or exercise. Prevention of excessive
deconditioning is necessary because:
1) Excessively deconditioned crewmembers may not be able to respond to inflight
or postflight situations requiring physical strength and stamina.
2) Routine EVA activities, which will characterize planetary surface exploration
programs, will require normal physical strength and stamina.
3) Crewmembers with excessive deconditioning will be prone to bone fractures,
tendon injuries, or muscle tears while doing physical work and/or exercising.
Table VI-3
Musculoskeletal
• Define the risk for bone loss on development of bone fractures, hypercalcemia, metastic
calcifications, and renal stone formation
• Determine whether atrophy from unloading makes muscle, tendon and the
myotendonous functions more susceptible to injury or damage on resuming normal
weight-bearing status
• Determine how well injured muscles repair in microgravity
• = Required for Mars
While prevention will be the primary MCS thrust, diagnosis and treatment must be
available for fractures, repair of ruptured tendons and ligaments, and prevention or
treatment for complications of fractures (e.g., pulmonary embolus). Diagnosis and
treatment must be provided for the secondary effects of muscle and bone tissue
wasting which may lead to mineral and electrolyte derangements. These include
hypercalcemia (which could cause metastatic calcification), muscle weakness,
changes in mental status, hypercalciuria (which leads to kidney stemes and
dehydration), and hyperkalemia (which could cause cardiac arrhythmia).
Research Requirements. Studies are needed to elucidate the biomechanics of
work/exercise in microgravity and partial gravity, both for activity within the vehicle and
EVA environments. The nature and mechanism of bone, skin, and muscle healing in
microgravity must be determined.
3. Metabolic Disorders (Pathological Regulatory Physiology)
The critical research elements for exploration missions include the effects of
microgravity on renal function, endocrine changes that effect the functioning of other
homeostatic systems, drug effectiveness, and the combined effects of microgravity and
EVA on thermoregulation and heat exchange (Table VI-4). The specific effects of the
demonstrated immunological and metabolic alterations of microgravity on the host
defense response to severe infection should be investigated. The role of
countermeasures in the control of septic processes in microgravity also must be
defined and their interactions quantified. Critical care, diagnosis, and treatment
should be available for renal failure and common clinical endocrine problems.
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Table Vl-4
Regulatory Physiology
Determine effects of space-induced endocrine changes on the function of other
homeostatic systems (e.g., cardiovascular, CNS, immune function, thermoregulation,
reproductive system, gastrointestinal system, and energy metabolism, sleep, behavior
and performance
Determine effects of microgravity on renal function. Are effects progressive or
reversible? Are there differences in filtration, reabsorption, secretion, and excretion?
Determine the nature of space flight induced effects of vasoactive, pharmacokinetic and
other drugs
Determine effects of space flight and EVA on thermoregulation and heat exchange
• = Required for Mars
• • = Required for Moon and Mars
Research Requirements. A key challenge within the area of regulatory physiology
involves the identification of "normal" parameters for the space-adapted individual.
These clinical norms are essential to the practice of medicine in the space
environment because clinical decisions are often made on the basis of deviations from
a baseline value. Both animal and human studies have shown marked variations of
endocrine function, examples of which include a tendency towards glucose
intolerance (diabetes) and marked decreases of certain regulatory hormones (such as
testosterone) in flight. The medical and operational impacts of these changes must be
assessed.
4. Radiation Health
The radiation environment for space exploration is not yet sufficiently understood, but
on the basis of what is known about exposure to ionizing radiation, it is likely to have
serious health implications. The primary research elements for radiation health were
presented in Section I (EHLSS). The important research elements from an MCS
perspective are discussed below.
Solar particle events (SPEs), commonly referred to as solar flares, pose a life
threatening radiation health risk for crewmembers outside the spacecraft and on
planetary surfaces. Therefore, the provision of a sanctuary to limit radiation dose is a
medical requirement. Determining the degree to which radiation impacts on bone
marrow and lymphoid tissue responses will impair the containment of invasive sepsis,
thereby preventing generalized septic response, is an important medical question.
Table VI-5
Radiation Health
Develop protocols to manage medical risks associated with acute and chronic exposure
to space radiation
• • = Required for Moon and Mars
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Determining the long-term medical consequences of exposure to high Z element
(HZE) particles present as a component of galactic cosmic radiation (GCR) is critical.
The biological hazards associated with HZE particles, i.e, the "late effects," are not
adequately known and may pose unacceptable long-term cancer risks. Exposure can
result in life-threatening and life-shortening effects, such as cancer, and other
detrimental consequences including cataract formation, mutagenesis, and other tissue
damage. Neurological and behavioral effects and their consequences on crew
performance must also be understood.
Research Requirements. In order to accomplish a realistic risk assessment for
radiation exposure during exploration missions, the fluency of GCR, and its biological
effects, must be determined prior to establishing medical standards for radiation
exposure in space. Other related issues include crew selection standards, personal
radiation protection, and medical protocols for treatment of radiation sickness.
5. Environmental Health
The critical issues focus on the treatment of medical problems related to adverse
temperature and gaseous environment conditions, procedures to prevent and
minimize the risk of decompression sickness, and assessment of EVA risks (Table Vl-
6). Also included are microgravity effects on the immune system and the degradation
or failure of the life support system.
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Table VI-6
Environmental Health
Determine treatment of medical problems related to spacecraft inner temperature and
adverse effects of the gaseous environment
Determine procedures and approaches to prevent decompression sickness or minimize
crew risks
Determine risks and risk relationships among detectable gas emboli, mild limb bend
symptoms that impair performance, and both CNS and cardiovascular systems that are
life threatening under EVA conditions
Determine effects of long-duration space flight on the human immune system
Required for Mars
Required for Moon and Mars
Research Requirements. There are several medical concerns related to
environmental health which generate research requirements. A key concern relates to
the medical consequences of continuous exposure to low level atmospheric
contaminants. An obvious difference between Earth-based occupations and extended
space missions is that individuals • essentially live in the workplace, without the
exposure relief that a terrestrial worker gets when leaving the job. Applicable
exposure standards, treatment protocols and risk assessment protocols which take
into account the changes in the immunological system will have to be developed. The
physiological effects of long-term exposure to hypobaric, normoxic environments
(should a reduced pressure spacecraft be selected) is an area of great uncertainty in
aerospace medicine. The longest hypobaric U.S. mission to date was the 84-day
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Skylab 4 mission. A related concern is the medical effects of extended habitation in a
spacecraft with a degraded life support system.
6. Cell and Developmental Function
Critical issues in this area focus on providing the scientific knowledge necessary for
development of procedures for risk management of pregnancy, osteoporosis, and
hemorrhage; determination of whether microgravity effects can be reversed;
characterization of the influence of radiation and microgravity effects on development
of germ cells; and determination of the effects of gravity on compensatory endocrine,
organ, circulatory, regenerative mechanisms, interaction with growth stages, and
wound healing (Table Vl-7).
Table VI-7
Cell and Development
Establish management procedures for premenopausal female crewmembers to minimize
risk of pregnancy, osteoporosis, and hemorrhage
-- What is the role of gravity in developmental biology?
Determine effects of gravity on compensatory mechanisms (e.g., (endocrine, organ,
circulatory, regenerative), interaction with growth stages, and wound healing
Determine whether gravity-related effects exist and if they can be reversed
-- What is the result of gravity-induced desynchronization during development?
• = Required for Mars
° ° = Required for Moon and Mars
Estrogen enhances retention of bone minerals and reduces development of heart
disease. It is therefore essential to maintain normal estrogen levels in female
crewmembers. However, except in postmenopausal females, normal estrogen
production is coupled to ovarian cycles and ovulation and thus there is the possibility
of ruptured follicles or pregnancy. Both of these conditions entail significant risk and
could become life-threatening .in space, but could be prevented by oral birth control
methods. However, experience on Earth indicates that those methods are not
completely reliable. Recently available progesterone-derivative implants (i.e.,
"Norplant"), or gonadotrophic release hormone agonists coupled with low-dose
triphasic steroid replacement, might be improvements. However, these hormone
protocols may have changing dose requirements over time in the space environment,
and therefore would require monitoring to allow for periodic adjustment of doses.
Also, interactions between estrogen levels and microgravity effects may be synergistic
in bone.
Research Requirements. Studies done in Soviet biosatellites suggest that
embryogenesis is disrupted or altered by microgravity. This concern and the obvious
problems of dealing with childbirth and childcare in the space environment make
pregnancy contraindicated during space missions. Research concerns, therefore, are
focused on the potential medical consequences of contraception in microgravity, i.e.,
formation of blood clots, osteoporosis, and behavioral effects. Another high level
research concern relates tothe function of individual cells in microgravity. Most
studies have focused upon physiological systems, rather than cellular function. This is
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an important concern across a broad range of issues, including immune function;
wound healing in various tissues (examples being corneal abrasions, skin lacerations,
or bone fractures); drug transport across cellular membranes, inflammatory and
allergic reactions; blood coagulation (visa vis the role of cellular elements); and repair
of damage from radiation. This is not a comprehensive list, but is a sample of potential
concerns. In many cases, the demonstration of competence of cellular function in a
given area (such as wound healing) will meet the research requirements. In other
areas, such as osteogenesis, it may be necessary to understand the mechanics of
cellular function in order to design effective countermeasures.
C. Advanced Medical Care Systems
U.S. and Soviet space programs have shown that medical contingencies do occur in
flight. Most U.S. space flight medical care experience has been limited to minor
ailments such as abrasions, contusions, colds, and space motion sickness. The
medical care systems aboard Mercury, Gemini, and Apollo were essentially enhanced
first aid kits equipped with bandages, ointments, drugs to treat a limited set of medical
conditions, and instruments for medical exams. Skylab, an early second generation
MCS, included provisions for minor surgery and dental procedures. The medical care
facility planned for SSF, the Crew Health Care System (CHeCS), contains three
subsystems: clinical care; exercise countermeasures; and environmental monitoring.
Mature requirements for surgical facilities in space have not yet been established.
This system is an advanced second generation of inflight medical care and requires
significant technology development in the following areas (not an all-inclusive listing):
• Compact digital radiography
• Compact clinical chemistry analyzers
• Environmental monitoring technology (based on mass spectrometry)
• Medical data collection, storage, and transmission.
Exploration missions will require an unprecedented level of inflight medical care
capability. Because of the extended duration, extreme distance from medical care
facilities, hazards associated with operational tasks (EVA, EHA), and the delayed
communications because of interplanetary distances. These systems will evolve from
and build upon the clinical care systems used on SSF. These "third generation"
medical systems will require significant technology development in key areas such as:
• Compact bone density imaging system
• Advanced telemedicine and telemetry capability for medical imaging (x-
rays, scans), medical data, and text
• Computer-aided medical diagnostic, monitoring, and therapeutic systems
• Compact soft tissue imaging systems (presumably derivations of existing
ultrasound imaging)
• Capacity to conduct major surgical procedures.
Advanced Biotechnology Development. While key elements of advanced
hardware can be derived from existing terrestrial medical devices, some applications
are unique to extended space flight and will require technology development efforts.
For example:
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• Extended shelf life (up to three years) pharmaceuticals
• Extended shelf life blood substitutes or blood (e.g., a lyophylized product)
• Research and development of liquid/gas separation devices. (Suction
capability is needed for medical, surgical, and dental procedures)
• The ability to bank lymphocytes or derive biological products
(lymphokineses). An advanced cell culture device (i.e., bioreactor) will
be required. These cells will be required to bolster immune function in
space, particularly after infection or radiation exposure
• Development of implanted ion selective electrodes and other sensors
that allow continuous monitoring of key physiological parameters.
D. Robust Program
In addition to the constrained program as outlined, a robust program would include the
following elements. These elements would limit the risk associated with long duration
exploration missions to a greater degree than would the constrained program.
• Renal dialysis
• Skin grafting
• Enhanced major surgical capability (would include more invasive and
complex procedures such as pinning bones). The exact menu of
procedures included in constrained or robust programs would be
determined in a trade study
• Advanced imaging and diagnostic capabilities, such as magnetic
resonance imaging (MRI) or computerized tomography (CT) scans would
be possible elements of a robust program. This also would be
determined by trade studies
• Crew medical personnel would be different across the two programs.
While even the constrained program would contain a physician (probably
a surgeon), the robust program may be characterized by a second health
care specialist, such as a psychologist or psychiatrist
• A robust program would be characterized by the ability to maintain
crewmembers as inpatients for longer periods of time (up to Six months)
and would include the capability for extended parenteral (venous)
feedings.
E. Requirements for Moon Exploration Missions
The medical care program for Moon missions would be similar to extended deep
space missions, with the exception that provisions for certain types of injuries, more
likely in the Moon environment, would be baselined. These might include treatment
for crush injuries, electrical burns, or other types of occupational injuries that are more
likely given the broad range of planetary surface activities planned for a Moon outpost.
The exact set of capabilities would be determined by a detailed trade study and should
be matched to the scope of surface activities. Because of the relatively short Moon
recovery time ( < 4 days), Moon medical care facilities, equipment, procedures, and
protocols can build in an evolutionary fashion from SSF capabilities until they
incorporate a full scale operational test of Mars mission capabilities.
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APPENDIX A
DESCRIPTION OF PROCESS
DISCIPLINE WORKING GROUPS 1
Over the past two years, the Discipline Working Groups developed Discipline Science Plans for each
NASA Life Sciences Division science disciplines. The plans describe the research required to support
NASA life sciences goals and responsibilities.
NASA Life Sciences Goals
GoaID Ensuring the health, safety, and
productivity of humans in space
Goal D Acquiring fundamental scientific
knowledge in space life sciences
The discipline plans, which include lists of critical questions that are prioritized within subdisciplinary
categories, are:
.
2.
3.
4.
5.
6.
7.
8.
9.
0.
1.
2.
Behavior, Performance and Human Factors
Regulatory Physiology
Cardiopulmonary
Environmental Health
Musculoskeletal
Neuroscience
Radiation Health
Cell and Developmental Biology
Plant Biology
Life Support, including CELSS
Planetary Protection
Exobiology
EXECUTIVE STEERING COMMITTEE 2
GOALS
. Define a robust research program and identify priorities required for exploration class missions
based on current knowledge and the projected and realistic resources within the next 5 to 15
years. Include ground-based research, availability of facilities, flight opportunities, and
international cooperation. Identify the risks associated with the proposed program.
, In the event that a robust program is not possible, due to constraints such as availability of
projected resources or schedule limitations, is there an alternative option for an adequate
program? Identify the risksassociated with such a program.
. What are the most important (from a life sciences standpoint) robotic precursor missions and
planetary protection research to be undertaken prior to human exploration?
Footnote 1. DisciplineWorkingGroups-- Extramuraland centeradvisorygroups(membershipinAppendixF) that
inconjunctionwiththe LifeSciencesDivisionDisciplineScientists,developedSciencePlans (includinga totalof 500
criticalquestions)for each of the 12 NASA LifeSciences,sciencedisciplines:Behavior,Performanceand Human
Factors;RegulatoryPhysiology;Cardiopulmonary;EnvironmentalHealth;Musculoskeletal;Neuroscience;Radiation
Health;Cell and DevelopmentalBiology;PlantBiology;Life Support,includingCELSS; PlanetaryProtection;
Exobiology.
Footnote 2. ExecutiveSteeringCommitteem DisciplineWorkingGroupChairpersons(see Footnote1) or
alternates,plusHeadquartersand Center programmanagersand scientists(includingprogramoffice
representativesfromSpace Shuttle,Space StationFreedom,AeronauticsExplorationand Technology)who
evaluated,revisedand prioritizedcriticalquestionsfrom Life SciencesDisciplineSciencePlans anddevelopeda
summaryWhitePaper. See AppendixD for detailsof membership.
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APPENDIX A
DESCRIPTION OF PROCESS
.
Unrelated to applications, define the most promising and unique science activities that would be
enabled by exploration mission(s).
STEP 1 Identify What Needs To Be Known.
Discipline Plans• The science discipline plans constitute the unconstrained Space Life Sciences
program. The critical questions contained in the plans form the basis for determining recommendations.
For each discipline, identify and categorize all critical questions within each subdiscipline according to the
following five categories: Each question may apply to more than one category. However, indicate the
primary category of application by noting so with an asterisk ("*"). The committee was partitioned into
discipline groups for completion of step 1 through step 5.
Cate0ories
1.
•
•
•
•
for Research Proaram Critical Questions:
Envlr0nmental Health and Life SUDDOrt Systems: Focuses on the activities required
for sustaining a safe, livable, and habitable environment (artificial gravity can be considered during
deliberations).
Countermeasure Systems: Assumes microgravity transfer vehicle. This includes activities
required for developing, testing and validating countermeasures to ensure crew health and
performance, and to minimize health risks throughout the mission(s).
Medical Care Systems: Focuses on activities required for acquiring the knowledge,
procedures, and technology necessary for ensuring crew health.
Enabled Science: Activities that include the most promising and unique science enabled by
exploration mission(s).
_J_,__CJ._.C.gJ Activities that are not necessarily related to exploration missions, but offer
scientifically promising and unique opportunites to pursue fundamental knowledge.
STEP 2: Assumption for Assessing Criticafity
If the Agency commits to going to Mars (i.e., a 2014 - 2018 time frame) with a crew of five or six, identify
within your discipline the critical questions for such a mission. Assess the criticality of each according to
the scale below, and record your response in the appropriate column on the data sheet.
Criticality Scale
Level 1
Level 2
Level 3
Level 4
Consensus That Answer Is Required For Mars Missions (Known Effect And Known
Problem For Mission)
Answers Might Be Required, But The Science Basis To Evaluate Risk Is Not Adequate
Required For Practical Optimization of Resources (Or Counter measure Effectiveness)
And Minimalization Of Risk
Important Science That Is Relevant To Exploration Mission(s).
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Assess Science Readiness Status for Research and Missions (For each criticalquestion
identified in Step 2)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Level 7
STEP 4"
Science Readiness Levels
Only Folklore of Practitioners And Anecdotal Data Available
Basic Scientific Concept Formulated
Ground Models Developed, Flight Validation Required
Flight Validation Performed
Countermeasures Identified
Countermeasures Tested
Operational Requirements Established
Assess the Readiness of Technology Necessary for Research or Missions (For each
critical question identified in Step 2)
Level
Level
Level
Level
Level
Level
Level
Level
1
2
3
4
5
6
7
8
Technoloa v Readiness Levels
Technology Need Identified
Technology And Conceptual Solution Available
Component And/Or Breadboard Validation In Laboratory Environment Exists
Component And/Or Breadboard Validation In Relevant Ground Or Space Environment
Completed
System/Subsystem Prototype Demonstration In A Relevant Ground Or Space
Environment Completed
System Prototype Demonstration In A Space Environment
Actual System Completed And "Flight Qualified" Through Test And Demonstration
Actual System "Flight Proven" Through Successful Mission Operations
STEP 5: Determine Schedule Requirements Necessary for Critical Questions (For each critical
question identified in Step 2)
•
,
3.
.
Schedule Questionnaire
When is the information required? (Near-Term (i.e., Less than 5 years) =1, Mid-Term (i.e., 6 to 10
years) = 2, Far-Term (i.e., More than 10 years) = 3)
What is the research time and effort required? (Substantial =1, Moderate =2, Low = 3)
Is there a clearly defined sequential path of scientific investigations? (Yes =1, No = 2, Do Not
Know at This Time = 3)
Are parallel or alternative pathways appropriate? (Yes =1, No =2, Do Not Know at This Time = 3)
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STEP 6: Prioritization of Disciplinary Critical Questions
All critical questions, from Step 2, have now been partitioned into five categories (i.e., Environmental
Health and Life Support Systems, Countermeasure Systems, Medical Care Systems, Enabled Science
and Basic Science). In addition, each question has been assigned one of four levels of criticality. Step 6
is a discussion and review of these findings to determine if specific items need to be recategorized or
repfioritized.
Include additional critical questions from the DisciplinaryPlans or as ad hoc inputs from the
Executive Steering Committee resulting from these discussions, as necessary.
STEP 7:
(a)
(b)
(c)
Implementation Strategies For Life Sciences - Matching Resources to Programmatic
Options
Include discussion of national and international cooperative activities including specific
flight platforms, as necessary.
Complete for each critical question identified in Step 2 and record responses on data
sheet.
Discussion and Validation of Schedule and Requirements -
1. Discuss and validate the discipline groups inputs on the data sheets provided. The
critical questions have been ordered with reference to time criticality (based on
assessments in Steps 3, 4, and 5) within each criticality level (i.e., 1 through 4) for three of
the five categories (i.e., Environmental Health and Life Support Systems,
Countermeasure Systems, and Medical Care Systems).
Platform Requirements-
1. What facilities are pecessary to complete the activity (i.e., ground, Shuttle/Spacelab,
SSF, robotic precursor missions, unmanned free-flyer, Moon outposts)? (Record
response by marking "X" in the appropriate column; provide comments if "other" columns
or robotic precursors are selected.)
2. Are flight validation studies required and in what sequence? (Yes =1, No = 2; if yes,
provide written comments.)
Resource Requirements - People and Facility Needs
1. Are current ground facilities (NASA Centers, Universities and private Industry)
sufficient to support the activity? (Yes = 1, No = 2; ff no, provide written comment on other
facilities necessary to complete thisactivity
2. Is there a sufficient life sciences community of outstanding scientists committed or able
to be recruited to support the activity? (Yes = 1, No = 2)
3. Will the activity serve as a vehicle for attracting new scientists into the NASA
community? (Yes = 1, No = 2)
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Discipline Consolidation -
Can this critical activity be grouped with any others from different disciplines?
1
2
3
4
5
6
7
8
9
10
11
12
13
14
No - Can Not Be Grouped
Do Not Know At This Time
If Yes, Specify Discipline(s) and Provide Comments
Behavior, Performance and Human Factors
Regulatory Physiology
Cardiopulmonary
Environmental Health
Musculoskeletal
Neurosciences
Radiation Health
Cell and Developmental Biology
Plant Biology
Life Support, including CELSS
Planetary Protection
Exobiology
Committee Products and Recommendations. The Committee is repartitioned
into groups representing the categories (i.e., Environmental Health and Life Support
Systems, Countermeasure Systems, Medical Care Systems, Enabled and Basic
Science).
o Develop a White Paper for each category and include recommendations and
priorities for constrained and robust life sciences programs:
C
GOAL -
PRODUCT-
STEP1
AEROSPACE MEDICINE ADVISORY COMMITTEF3
To recommend an integrated Life Sciences research strategy for human exploration
missions.
Organize critical research or technology development questions into explainable,
defendable, executable areas of focus and include consideration of optimum sequence.
For each critical question determine whether the SSF centrifuge can be used to resolve
the issue. If the centrifuge is required, indicate by placing an "X" in the appropriate column
on the data sheet.
STEP2 Review data and develop draft report for Life Sciences strategic considerations for human
exploration missions.
Footnote 3. AerosoaceMedicine AdvisoryCommittee(AMAC)m A NASA Advisory Councilcommittee that
reviewed, and in some cases, revised and reprioritized critical questions to generate this report. See Appendices A
& B for details of membership and process.
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AMAC CHARTER FOR THIS REPORT
The Aerospace Medicine Advisory. Committee (AMAC) is charged to
develop an implementation strategy in support of human Mars exploration
missions. This plan will identify specific projects and areas of research,
both basic and applied, within NASA and in collaboration with other
government agencies and countries which will contribute to these
objectives.
In view of the tight fiscal constraints facin_ NASA and OSSA in the out-
years, the plan should prioritize the researcn needs on spacelabs and SSF
in order to support advanced human space flight missions. This process
should include a review and priorit_zation of the projects, research
hardware and other laboratory facilities which will be necessary to carry out
this research in a phased and timely manner.
In developing the plan the Space Life Science Division 1991 Strategic Plan
should be reviewed. Inputs from other advisory committees should also be
obtained. Specifically include participation of the Life Sciences Advisory
Subcommittee of the Space Science and Applications Advisory Committee
as well as the National Academy of Science Committee on Space Biology
and Medicine and other advisory committees as appropriate. Participation
from a wide ranging group representing experts from other government
agencies and countries is encouraged.
On a final note, the plan should recommend a strategy which is consistent
with the budgets and schedules for implementing the manned space flight
goals mentioned above.
The plan should be available by mid January 1992 to serve as a basis for
establishing the 1993 to 2005 mission planning and resources baseline.
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Quest# Critical Question 1 2 3 4 5 6 7
lcl
ld2
lel
2a3
2fl 2
2g3
4al
_>
4a2
...¢
4a5
4a6
4a7
4bl
4b2
4b4
4cl
4c5
5c12
7al
What are the requirements for adequate quality of life as they relate to food, clothing, hygiene, vibroacoustics, lighting, and other X X
_ersonal needs (privacy, recreation) in spacecraft and habitats?
What factors should be considered (e.g. maintainability, reliability, operator discretion) when allocating functions between humans and X X
machines?
What are the behavioral correlates of physiological changes induced by the space environment? X
What are the optimal environmental conditions for ensuring synchronization of circadian rhythms in space, and what are the most X X
appropriate work-rest schedules for ensuring optimal health and performance?
What are the effects of pressure and gas composition in space flight and during EVA on changes on fluid and electrolyte regulation? X X
What environmental conditions of space flight influence temperature regulation? X
What impact do space flight-induced biological, physiological, and immunological changes have on the susceptibility of crewmembers to X
toxic materials alone or in combination? The concern is for both in- flight performance and residual health. (See Regulatory Physiology
Discipline Science Plan 1991 for further discussion of immunological issues)
How can traditional limited-time exposure and human toxicological data be used to predict acceptable values for inhalation and ingestion X X X
exposures to single chemicals and/or to mixtures including biological toxins and particles under flight conditions?
!What are the potential biomarkers for assessing either exposure or response to chemicals? X X
What are the effects of chronic exposure to ultrafine and larger (respirable and nonrespirable) particles on crew health, safety, and X X X
)erformance?
What approaches may be used when insufficient data are available to allow prediction of acceptable exposure levels? X
What are the acceptable numbers and kinds of microorganisms in air, water, food, and surfaces? X X X
What is the effect of space flight on all microorganisms? X X X
What technology is available to identify microorganisms in crew and environmental (air, water, surfaces) specimens. How are X X X
microorganisms controlled by anti-microbial procedures?
What, if any, are the interactions between the effects of microgravity on crewmembers and the effects of off-baseline levels of X X
atmospheric parameters, including gas composition, pressure, and temperature?
What are the effects of all potential atmospheric components, including contaminants and factors on physical and psychological X X X
well-being and crew performance?
What are the appropriate light wave length cycles to maximize vitamin D production? X X X
For a given mission, what are the fluxes of GCR in interplanetary space as a function of particle energy, LET, and solar cycle?
X
X
X
X
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7c3
7c4
i7c5
7dl
7d2
7d3
7d4
7e3
7e4
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What is the solar cycle dependence of space radiation?
What is the trapped radiation flux as a function of time, magnetic field coordinates and geographical coordinates?
What are the maximum flux, the integrated fluence, and the probability of large Solar Particle Events (SPE) during any mission? X
What are the doses related to heavy ions in deep space?
What are the factors that determine radiation flux of solar flares?
What will the radiation environment be within the space vehicle and what factors influence the flux, energy, and linear energy transfer X
Ispectra of the radiation?
How can protection against the effects of galactic cosmic rays and the proton radiation of solar events be improved? X X
What are the cross sections and yields for nuclear interactions of HZE particles in tissue and shielding materials? X
What are the angular distributions of nuclear interaction products? X
What are the particle multiplicities of nuclear interaction products? X
How is a radiation field transformed as a function of depth in different materials? X
What are the optimal ways of calculating the transport of radiation through materials? X
What is the precise energy deposition of heavy ions? X
What are the yields and energy spectra of electrons? X
How can the wealth of knowledge existing for energy deposition in gaseous media be extended to the liquid phase applicable to most living X
cells?
How do diffusion, recombination and other interactions of chemical intermediaries alter the chemical events at the DNA level? X
How is physical energy deposition related to biological effect? X
What are the probabilities of GCR to produce radiation damage at specific sites on DNA? X
How are processes like oncogene activation and oncogene suppressor inactivation involved in the carcinogenic effects of GCR radiation? X
What mechanisms are involved in modulating radiation damage at the molecular level (repair, errors in repair, gene amplification, etc.)? X
How can molecular mechanisms of radiation damage be used to understand effects in whole cells? X
What is the probability Of initiating neoplastic cell transformation or other steps leading to a cancerous cell? X
-low do cellular repair mechanisms modulate damage produced by energetic charged particles? X
How can the radiation effects on cells in culture be related to radiation effects in "normal" cells and tissues? X
X X X X
X X X X
X
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How can cellular mechanisms of radiation damage be used to understand effects in whole organisms? X
How can animal models be used to extrapolate probabilities of radiation risk to humans in space? X X
What is the relative biological effectiveness of different types of radiation for the relevant endpoints such as cancer; cataracts? X
What is the age dependence of relevant radiation effects in animals (cancer, cataractogenesis, life shortening, etc.)?
What should be the radiation dose limits for manned deep space missions? X
What is the probability of cancer as a function of dose, dose rate, radiation quality, gender, age at exposure, and time after exposure? X
What is the effect of GCR at different stages of the carcinogenesis process?
What is the probability of cataract formation as a function of the same quantities? X
What is the probability for genetic and developmental detriment incurred as a consequence of radiation exposure in space? X X X
What are the thresholds required for gravity to have an effect? X X X X
What are the differences, if any, between species and their tissues in their perception and responses to gravity? X X X X
Can plants successfully reproduce through more than one generation in space? X X X X
Is chromosomal integrity and behavior during cell division affected in microgravity? X X X IX X
Is cell, tissue, or organ differentiation affected in microgravity? X X X X
What effect does microgravity have on embryogenesis and the ensuing stages of the life cycle of plants from maturity to flowering and X X IX X
senescence?
Are micrcgravity-grown tissues and organs competent? X X X X X
Are the growth rates of higher plants or single cells affected by microgravity? X X X IX
Are there unique interactions between space radiation (or other environmental factors) and microgravity that affect the development of X X X X X X X
Ibiological systems in space?
Are anabolic and catabolic pathways and the photosynthetic apparatus and pathway altered in microgravity? X X X X
What effect does microgravity have on the synthesis of storage and support polymers? X X X X
Are pathways for plant nutrient absorption altered in microgravity? X X X X
What are the effects of the space environment on long distance transport of water and on transpiration? X X X IX
How is the effect of gravity (and microgravity) on cells influenced by magnetic fields and radiation? X X X X X X X
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What is the role of gravity in the regulation of circadian rhythms?
What are the effects of the absence of gravity on the generation, expression (period, phase, amplitude and/or waveform) and
entrainment of circadian rhythms?
Is it at the synchronizing agent (zeitgeber)?
If not, is it necessary for the action of other synchronizing agents (light, exercise)?
-- What .is the role of gravity in the ontogeny of circadian rhythms?
p Is there a difference in the role of gravity across the phylogenetic scale? Single cells to complex organisms?
What is the-gravity threshold for it actions in the regulation of circadian rhythms? Does this gravity threshold vary with the
complexity of the organism? ' .
Can crop plants produce sufficient edible biomass extra-terrestrially to support human crews? The following constraints should be
considered in studying this question:
Closed environments
_ Recycling
Limited space
-- Gravity effects
Phytogenic volatile compounds and other trace contaminants
Radiation
-- Adventitious biota (microbial and other)
What conditions are required to optimize the food generating and water recycling capacity of crop plants? The following factors
represent the minimum that should be considered in studying this question:
-- Ught quantity, quality, periodicity, gas composition and density
Root environment: substrate, nutrients, volume, temperature, etc.
Aerial environment: gas composition and pressure, temperature, planting density, etc.
Nhat are the effects of adventitious biota (microbial and other) over long periods in a CELSS?
What robotic and automated procedures should be developed for planting, growing, and harvesting of crop plants?
How can molecular genetic technology, including germplasm screening, be used to develop crop cultivars better fit for CELSS use in
space? (for example)
-- Improve nutrient quality and bioavailability
Reduce natural toxicants
-- Optimize plant architecture
X X X X
X X X X X X
X B3(X X X
X B3(X X
X ED(X X
X 133(X X
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9a7
9b8
9b9
What is the potential for using the following alternative food sources in a CELSS?
m Animals (aquatic and terrestrial vertebrate and invertebrate)
m Algae
-- Fungi
n Bacteria
Nontraditional higher plants
-- Tissuecultured cells
-- Synthetics
What are the specific nutritional requirements for humans in space? This question should consider at least the following:
-- Caloric requirements
Will the nutritional requirements of the crew change and require modified diets over time of flight
-- Fluid requirements
-- Distribution of the macro nutrients (protein, carbohydrate, lipid)
Fiber and micronutrient requirements
What are the acceptability criteria for foods and in what priority order should they be evaluated? Some criteria include:
-- Safety and freedom from toxic substances and infectious agents
_ How will the crew respond to diet on a Mars mission
-- Nutrient and attribute balance
Familiarity/cultural experience
-- Tasteltexturelcolorlshape =
n Flexibility in preparation methods
-- Cooking (time, complexity, etc.)
m Seasoning (diversity of options)
-- Compatibility with other menu items
Variety
What food groups fulfill these requirements?
-- How can the biomass candidates be used or modified toachieve the desired requirements?
1 2 3
X E£tX
X X X
X X X
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Quest# Critical Question
9bll
9b12
9b13
9b14
9b165
9c168
9c17
9c18
9c19
9c21
9c22
9c23
How stable in storage are foods considered for Mars mission and how can storage stability in space be increased?
D What are the safety and quality considerations of storage?
What processes are feasible to use in a CELSS?
-- Are additives needed? If so, which ones?
-- What are the storage/inventory requirements?
For what types of foods will storage be unnecessary?
Is there a need for packaging? If so, which products will require it?.
What food processing and storage technologies will need to be developed for space application? X
How will existing and new processing and storage techniques perform in the constraints of a CELSS environment?
-- What differences are there in product development for space compared to land-based activities?
-- What are the influences of processing, cooking, and serving on -- nutrient and attribute stability?
How can processing and cooking techniques be used to modify and improve the acceptability of foods offered the crew?
Can edible foods and/or ingredients be derived from non-edible plant wastes? X
What are the crop plant-specific limits of this capability?
How will non-recyclable materials be minimized in a CELSS program? X
How do the above nutritional questions apply to CELSS produced foods, used either as a nearly complete diet or as a supplement to stored X
food?
What are the processing requirements necessary to handle human wastes? what are the health and safety requirements for the waste
treatment subsystem?
What are the processing requirements necessary to convert metabolic wastes into nutrients suitable for plant growth?
What will be the limits of the composition of the processed waste streams with regard to the following parameters:
m Organic an inorganic materials
-- Potentially toxic materials
Water content?
What currently available waste treatment/nutrient regeneration technologies can be adapted to a CELSS use, and what technologies will
need to be developed for space application? (Note question 16.8)
To what extent will micro-organisms used in a physico-chemical waste processor present an issue of performance degradation?
What are the production rates and chemical compositions of the different waste streams that are to be processed in a CELSS?
What can be done about food packaging, crop selection, etc., to minimize the amount of material that ends up in the waste streams?
1 2
X
X
X
X
X
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9c24
9c245
;9c25
9c26
9c27
9c28
9c29
9c30
9d31
Critical Question 1 2 3 4 5 6 7
Can plant transpiration water qualify as potable and hygiene water? If not, what currently available water treatment technologies can X X X
be adapted to polish transpiration water in a CELSS, and what technologies will need to be developed for space application?
What are the best technologies for recycling the water required for a Mars mission to acceptable potable and hygiene levels? X X X X
If the crop plants in a CELSS can be used to meet the production rate demands for potable and hygiene water, then what types and X X X X
numbers of plants will be required, and what environmental conditions will these plants require?
What currently available water treatment technologies can be adapted to recycling the various grades of water (hygiene, wash, etc.) in X X X X
a CELSS and what technologies will need to be developed for space application?
What are the storage requirements for potable and hygiene water in a CELSS? Consider: X E_ X X
-- Safety/redundancy
-- Control of microbial film on surfaces
-- Volume
What will be the acceptability thresholds for revitalized air in an operational CELSS? X X X
What currently available air treatment technologies can be adapted to a CELSS use, and what technologies will need to be developed for X X X X
space application?
What types and surface area of plants will be required to meet the production rate demands for revitalized air and what environmental X X X X X
conditions do these plants require?
What strategies or techniques exist for monitodng and control of the known or suspected possible causes of life support system X X X X
instability? Consider:
-- Pests or pathogens (disease)
SMACS
-- Toxicants produced by humans, by processing procedures, or by the plants themselves
-- Atmosphere leakage
Perturbations in environmental controls
-- Radiation
-- Microgravity
-- Unanticipated ecological interactions
-- Scheduled or unscheduled system or mission events
Failure of microbial cultures in algal fermentation systems
-- Food variety
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)d33
)d34
)d35
;)d36
_d37
9d38
9e39
9e40
9e41
9e425
9e43
9e44
Critical Question
What are the requirements for CELSS system design and operation to achieve safe and reliable operation? Address the following:
Subsystem redundancy
- Interaction with Chemical - Physical regeneration
System modeling and behavior
Alternative strategies for system monitoring and control
-- Failure of a subsystem
Is a CELSS, because it operates within a limited volume and intense dynamics, subject to unknown or poorly characterized instabilities,
such as chaotic behavior?
What are the thresholds of system size (minimal) and system safety and reliability (maximal), and can these be extended in an
integrated, controlled system?
How can mathematical models be utilized to aid in system design, system simulation, and system operations?
What are the power requirements and launch mass and volume for an operational CELSS ?
What robotic and automated procedures should be developed for control, monitoring, and operations?
What sensors are required for automation of a CELSS?
What is the productivity, transpiration, and dry matter partitioning of plants at less than lxg (micro-, 15%, and 38% gravity)?
What is the morphology and reproductive capability of plants at less than lxg (micro-, 15% and 38% gravity)? Will this modify crop
selection criteria for space bases?
What countermeasures can be utilized if productivity or reproduction is significantly decreased?
Can the physico-chemical regenerative technologies and processes required for a Mars mission life support system function in the space
environment? Consider:
Maintenance of liquid-gas interfaces (e.g., for nutrient delivery)
Transfers and separations of liquids, solids, and gases
Combustion
What is the composition of air, water, and spacecraft systems and how is it monitored to assure crew health safety and performance?
What are the effects of the space environment on microbial interactions with space systems and humans?
Can proposed food processing techniques be modified to work effectively at reduced gravity?
Can safe and sufficient supplies of water and air be provided for the trip/stay to/at Mars? Do current expendable systems exist to
provide safe and sufficient supplies of water and air for the Mars mission?
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9flc
9f3a
9f4c
9f5a
9f5f
9f6a
9f6b
101
102
Critical Question
Can safe and sufficient supplies of food be provided for the trip/stay to/at Mars? Do current expendable systems exist to provide safe
and sufficient supplies of food for the Mars mission?
Can wastes be successfully disposed of on a Mars mission without impacting planetary protection? X X
Do regenerative systems exist to provide safe and sufficient supplies of food for the Mars mission? X X
Do automated real-time systems exist to monitor air quality/toxicology for Mars mission? X X X
Do automated systems exist to monitor food safety/quality for Mars mission? X X
Do systems exist to provide EVA/EHA capabilities required for Mars transit? iX X X
Do systems exist to provide EVA/EHA capabilities required for Mars surface exploration? X
What requirements should be placed on robotic and human missions (orbiters and landers) to protect Mars with respect to biological X X
contamination imported from Earth (forward contamination)?
What provisions must be taken during the course of robotic and human exploration to protect the Earth from harm caused by the X X
Importation of biological materials from Mars (back contamination)?
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What are the major human factors principles that govern optimal assignment of responsibilities between space crews and ground teams
_and among crew and team members? What ground-based organizations are required for effective support of flight crew performance on
a Mars mission?
What are the critical elements and processes involved in decision- making by ground teams and space crews operating autonomously or X X X X
in combination?
What are the critical characteristics of leaders that effect reciprocity and productivity of crews? What are the optimal crew command X X ;X
structures for a Mars mission?
What are the optimal communication procedures for coordination among crew members and between ground and space crews? X X X X
How does prolonged space flight affect behavior and group dynamics (including species, sex, and age differences)? X X X X X
What psychological and behavioral characteristics are exclusary? What behavioral and psychometric criteria should be used for X X X
selecting candidates for a Mars mission?
What are the protocols for training effective ground teams and space crews in problem solving, enhanced communication, crew X X X X
coordination, and interpersonal dynamics?
What are the optimal designs for living/working areas in spacecraft/habitats to maximize morale and performance? X X X
What are the factors involved in integrating automated systems with human capabilities to promote productivity and reliability? What X X X X X
are the significant issues of control and intervention by human operators, and countermeasures for particular missions?
What are the requirements for formatting, distributing, managing, accessing, updating, and presentation of information for optimal X X
ndividual and crew performance? What are the requirements for crew input to the data management system?
What are the human factors issues in teleoperation? X X X X X
What are the physical and cognisant performance capabilities and requirements of humans in different stages of space flight as a function X X X X
of mission parameters, e.g. duration, gravity field, physical environment?
What are the anthropometric requirements for work stations to accommodate individual team members to maximize performance? X X X X
How can artificial intelligence systems be used to support human decision-making in long-duration space flight? X X X
What are the mission specific design and protocol requirements for telecommunications to optimize crew performance? X X X X
What are the effects of living in the space flight environment on cognitive functions (including attention, memory, information X X X
processing and decision-making) and on work capacity?
How do the fundamental behavioral processes of perception and sensation, learning and cognition, and motor skills change in space? X X X
What is the time course of adaptation?
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lfl
lf2
lf3
lf6
lf7
lf10
lfll
_1f13
lf15
lgl
lg2
lg3
lg5
2al
2a2
2a6
1 2 3 4 5 6 7
What procedures are needed for analyzing missions for their demands on human performance (e.g. task analytical techniques and X X X X
models)?
What are the most effective schedules for work, rest and recreation, exercise and sleep for enhancing human performance and X X X X
adaptation during long-duration exposure to space?
What are the special performance requirements and capabilities and equipment requirements for extravehicular activity (EVA)? X X X X
How is workload optimized for various space explorations? X X IX X
What are the criteria for evaluating individual and crew performance and productivity during space missions of various durations? X X X
What minimally intrusive hardware and software capabilities are best suited for obtaining performance data in flight? X X X X
How do circadian rhythm cycles and sleep influence performance and interact with the space environment to affect ability to accomplish X X X X X
mission goals? What countermeasures (e.g., pharmacology, lighting, etc.) can be developed to improve performance and productivity?
What models can developed to describe the effects of fundamental behavioral stressers on mission performance? IX X X
What are the best psychophysiological correlates of effective performance variation in the space environment? In what way do X X X X X
physiological changes incurred in space affect task performance?
What are the effects of stress on crew and ground team performance and what method of detection and intervention strategies (e.g. X X X
selection, training, crew support) would prove effective?
What methods characterize the process of individual and team adaptation to stressors (e.g. isolation, confinement, and risk) inherent in X X X
space flight?
What are the factors that shape individual and team motivation and the ability to cope effectively with environmental stress? X X X
What are effective protocols for sustaining crews in case of loss of a crew member inflight, or loss of a family member or friend on X X X
earth ?
What are the effects of the space environment on sleep, sleep cycles, or the generation, expression (period, phase, amplitude and/or X X X X X
waveform), and entrainment of metabolic, endocrine, reproductive, and/or behavioral circadian rhythms? Of these effects, which
result from altered gravity and which result from other environmental factors?
iWhat are the effects of intermittent and variable gravity fields on circadian rhythms, and how does this affect the use of artificial X X X X IX X
gravity as a countermeasure to microgravity?
What are the effects of exercise on circadian rhythms and sleep? What pharmacological and nonpharmacological (e.g. light, exercise) X X X X X
agents can be used to reset the human biological clock? What are the effects of routine administration of pharmacological agents in
space on circadian rhythms and sleep?
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1 2 3 4 5 6 7
;What are the appropriate ground-based analogs for studying the effects of extreme environments on human circadian rhythms? X X X
What are appropriate research models for simulating the effects of the space environment? iX
What are the effects of non-gravity-related physical-chemical and psychological space-flight-induced stressors on circadian rhythms X X iX iX X
and sleep?
What roles do age and gender play? Is there a response of the circadian system to the space environment? X X X X
What are the effects of cephalad fluid shifts on circadian rhythms? X X X X X
Does the well documented decrease in red blood cell mass termed "anemia of space flight" represent a normal microgravity-associated X X X X X
adaptive process (self-limiting) or a transient response (self- correcting) to changes brought about by various space-flight-related
stimuli (stressors)?
What is the most effective way to restore red cell mass during simulated and actual microgravity? Should red cell mass be restored X X X X
during space flight? Are these acute or chronic changes and are they of sufficient magnitude or duration to pose an unacceptable medical
risk and warrant the development of countermeasures (prophylactic or therapeutic)? Formulate mathematical and computer models of
tissue adaptation and cellular transient response to altered load histories?
What are the relationships between the stressors associated with space flight; the source, duration and magnitude of the stressor; and X X X X
decreased immune function?
Are there effective operational procedures or countermeasures to counteract the stressors or their effects?
Are there terrestrial (1 g) human, animal and/or computer models that simulate or reproduce the effects of space flight/microgravity X X
with regard to the immune system in space?
Is the basal metabolic rate and metabolic efficiency altered during extended space flight? Are there changes in energy metabolism and X X X X
storage in space, especially in substrate utilization?
What are the effect of changes in cell and nutrient turnover during space flight on nutritional requirements? X X X X
What are the optimal noninvasive microanalytical methods and techniques for use during space flight to monitor nutritional status? X X
What are the mechanisms underlying the negative nitrogen balance and changes in lean body mass incurred during space flight? What are X X " X X X
the possible interventions, including dietary alterations in proteins and amino acids?
Do the effects of space flight require added supplements of vitamins, minerals, or other nutrients? What is the safe range of exogenous X X X X X
vitamin intake for long-term space flight? Are nutritional requirements modified by transient digestive disturbances, such as the I
anorexia, nausea, and vomiting associated with space sickness?
What is the time course and nature of body composition change due to space flight? Do changes in body composition (age and gender) X X X X X
have an effect on crew health and performance?
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Critical Question 1 2 3 4 5 6 7
What are the fluid and electrolyte regulating mechanisms underlying the cardiovascular responses to microgravity? X X X X X
What are the mechanisms for the chronic adaptive shifts in fluid and electrolytes during space flight? HOW does the new steady state X X X X X
affect the body's ability to respond to heat stress, electrolyte loading, EVA, and countermeasures?
What are the best methods to accurately measure fluid loss, fluid intake, plasma volume, extracellular fluid, total body water, and X X X X
interstitial volume in space flight?
What are the effects of circadian rhythm changes in space flight on the responsiveness of the fluid and electrolytesystem? X X X X X
What are the roles of renal blood supply and renal electrolyte handling in extracellular fluid volume control during simulated and actual X X X X X
microgravity?
What are the effects of prescribed countermeasures on thermoregulation? X X X X X
JOf the various countermeasures available to combat adverse cardiovascular effects on long- and short-duration missions, which are X X X X X X
most effective, when and how should they be applied, and in what sequence? These include but are not limited to LBNP, fluid anti-g
irehydration, centrifugation, and exercise.
What are the specific mechanisms underlying the orthostatic hypotension observed after flight? What are the effective X X X X X X
countermeasures for this?
What is the relationship between the cardiovascular adjustments to space flight and those occurring in Earth-based models such as X X X X X X
bedrest, immersion, and head-down tilt?
Are the baroreflexes modified by space flight and how do these affect orthostatic tolerance? Are chemoreflexes and osmoreflexes X X X X X
modified by space flight and how do these affect orthostatic tolerance?
How are countermeasures to adverse cardiovascular effects of long- duration space flight affected by changes in fluid distribution? X X X X X X
Are there appropriate animal and/or computer models for studying each functional element of cardiovascular adjustments to X X X X X
microgravity?
What is the relationship between cardiovascular response and exposure to varying gravity levels (force, internal frequency, and time !X X X X
interval )? Is there a threshold?
Are there changes in cardiac performance and contractile efficiency during long term exposure to microgravity? IX X X X X
Is pulmonary function altered in long-duration space flight at rest, exercise, or in a disease state? X X X X X
Are there appropriate animal and/or computer models for studying each functional element of pulmonary adjustments to microgravity? X X X X X X
What is the relationship, if any, between the pulmonary adjustments to space flight and those occurring in Earth-based models such as
bedrest, immersion, and head-down tilt?
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Quest#
4c8
5al
i5a2
5a4
5bl
5b2
_, 5b3
¢
._= 5b4
I_0
5b5
5b6
5b7
5cl
5c2
5c3
5c5
Critical Question 1 2 3 4 5 6 7
What are the adaptations and deteriorations associated with prolonged exposure to unusual atmospheric environments, including the X X X X X
impact of microgravity, and how can countermeasures be utilized against these deteriorations?
What is the time course and extent of muscle atrophy during either prolonged spaceflight or unloading? X X X X X
How is muscle metabolism regulated during normal activity and exercise, after acute and chronic unloaded states, and during recovery X X X X X
from unloading?
iWhat are the physiological similarities and differences of ground- based models of muscle atrophy and fiber transformation and X X X X X
weightlessness-induced muscle atrophy and fiber transformation? Howvalid are ground-based models for studying the characteristics
of space-flight-induced muscle changes?
What are the molecular signals and mechanisms that are responsible for the control of muscle hypertrophy and atrophy, and what are X × X X X
the specific stimuli that are generated by exercise or disuse to signal increased or decreased protein accumulation in muscle cells?
What is the molecular interrelationship between catabolic and synthetic rates of protein metabolism in unloaded muscles? X X X X X
What are the effects of altered levels of hormones and their receptors in regulating the physiology of unloaded muscle? X X X X iX
What is the link between mechanical activity (stress) and hormonal state in regulating protein turnover and gene expression and X X X X X
structure and function of muscle, as investigated by both ground-based and flight experiments? How can this information be used to
integrate neuromuscluar and musculoskeletal models of mechanics and adaptation to develop countermeasure protocols?
What is the role of specific hormones, pharmacologic agents, and growth factors in regulating protein and gene expression in response to X X X X X X
unloading?
What are the effects of unloading on the muscular intracellular and extracellular matrix? X X X X X
What is the molecular basis for the effects of unloading on the susceptibility of muscle to injury or damage upon resuming normal X X X X X
weight-bearing states?
What are the rate, extent, and time course of bone and connective tissue loss for different areas of the body during exposure to X X X X X
microgravity or simulated microgravity? How is the time course of regional tissue loss correlated with changes in the tissue stress
and strain histories at the same site? To changes in regional microcirculation? To other regional and systemic factors?
Which endocrine and nutritional processes are required for maintenance of bone and connective tissue? How do these processes interact X X iX iX X
with mechanical loading? Are these processes affected by space-flight?
What are specific countermeasures that impact effectively upon bone and connective tissue structure and function? X X X X X
What are the similarities and differences of ground-based models and spaceflight-induced bone and connective tissue loss with respect to X X X X X
biomechanical, histomorphometric, biochemical, and hormonal changes?
10
Ct.
X
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5c6
5c7
5c8
5c9
5c10
5cl I
5dl
_>
!
.._ 5d3
ro
oo
5d4
5d5
5d6
5d7
5d8
5d9
5d10
5dl 1
5dl 2
5d13
6al
Is bone loss reversible in terms of mass, ultra- and micro-structural organization, and microstructure? To what extent do irreversible X X X X
architectural adaptations affect structural integrity?
What are histomorphological and architectural changes that occur in bone and connective tissue because of space-flight? X X X: X
How does mechanical stress and changes in stress contribute to bone and connective tissue formation? Are stress and/or changes in X X X X
stress required for continued structural integrity?
What are the critical characteristics or components of normal daily tissue stress and strain histories that regulate bone and connective X X X X
tissue development, maintenance, and adaptation? How are these characteristics affected by microgravity?
How are regional changes in bone and connective tissue related to regional changes in muscle tissue? X X X X
How are neuromuscular activation patterns and musculoskeletal mechanics altered during activity (including exercise) in microgravity X X X X
compared to l-g?
What are the patterns of in-vivo mechanical loading (e.g., tissue strain, stress, strain rate, stress rate)in normal and Iow-g X X X X
environments?
What are the bone and connective tissue markers of metabolism (protein synthesis, secretion, and degradation)? How can bone marker X X X X
data be used to investigate and predict regional changes in bone metabolism?
Which endocrine-receptor perturbations modulate tissue responsiveness to mechanical stresses? IX X X X
Which specific models predict bone and connective tissue structural transients during altered load environments? X X X X
What key elements of bone and connective tissue structural assembly impact the biomechanical properties? X X X X
Are there specific load histories that affect the macromolecular assembly of connective tissues? X X X X
What are specific signal transduction processes relevant to the modulation of structural molecules during altered load histories? X X X
How do changes in mechanical forces and tissue stress (e.g., shear, stress) and/or electrical forces (piezoelectric and tissue streaming X iX iX
potentials) result in mechanisms that are associated with translational alterations in connective tissue structural proteins? X
Is cytokine production and response to cytokine by osteoblasts and osteoclasts affected by exposure to microgravity? X X X
Are precursor cells of osteoblasts and osteoclasts affected by microgravity? X X X X
Do precursor bone cells respond to maturation stimuli in a microgravity environment as they do on earth? X X IX X
Do osteoblast require gravity to function normally? If developed in microgravity will they function normally? X X b_X X
Are there changes in the processing of signals from the semicircular canals or otolith organs that occur with adaptation? Do these X X X X
changes take place within the vestibular nuclei, cerebellar structures or other related brainstem and cortical structures? What is the
time course of such changes and do they correlate with space motion sickness?
X
X
X X
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X X
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6a3
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6bla
6bl b
6b2
_ 6b3
..= 6b4
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6b5
6b7
6c2a
6c3
6c4
6c5
6el
6e2
7g7
1 2 3 4 5 6 7
What are the circuitry and signals in the vestibular nuclei and brainstem that generate a gravito-inertial frame of reference? What are X X X X X X
the roles of the different regions of the cerebellum?
What are the neural (morphophysiological) and neuroendocrine bases for motion sickness? What changes in neurotransmitters, X X X X X X
neuroendocrine, or neurohumoral release can be correlated with space motion sickness?
What is the distribution of receptors for anti-motion sickness drugs in central vestibular pathways? X X X X X X
How does gaze stabilization change in altered gravitational states? What are the characteristics of gaze and eye-head coordination with X X X X X
varying visual, vestibular, and somatosensory inputs?
What is the most appropriate three-dimensional model of the angular and linear VOR and of central vestibular processing that will X X X X X
account for alterations in eye movements in microgravity?
What are sensory inputs and coordination of muscular outcomes organized for generation of posture and locomotion before, during, and X X X X X X
after flight?
What are the optimal countermeasures for motor readaptation to partial-g or 1-g after adaptation to microgravity? X X X X X X
What are the pharmacology, physiotogy, and output pathways that control the autonomic and endocrine outputs characteristic of motion X X X X X X
sickness?
What adaptive processes modify motor control systems? What is the dynamic range of adaptation of motor responses in altered states X X X X X
of gravity?
What models of sensory-motor transformation can be used to predict motor behavior best in altered gravitational states? X X X X X X
What psychophysical correlates can best be used to describe spatial orientation? X X X X X
Does a change in vestibular input lead to changes in visual and auditory localization and multisensory spatial orientation? X X X X X
What ground-based paradigms and models are most effective in evaluating interactions of angular and linear acceleration, X X X X iX X
proprioception, somatosensory and visual inputs in determining orientation in a three-dimensional environment? How do these
interactions change in altered gravity?
What processes explain the altered perceptions of joint and body position in microgravity? X X X X X
Will the decrease in afferent input to the vestibular, proprioceptive and somato-sensory systems associated with long-duration flights X X X X X X
result in permanent reflex deficits?
If an on-board centrifuge is used as a countermeasure (physiological system maintenance), will going from 1-g to microgravity cause X X X X
repeated maladaptions?
What pharmacological agents should be developed and tested as prophylactic agents for low LET? × X X X
7>
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811113
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8Vbl
8Vb2
8Vb4
8Vb5
8Vb7
8VblO
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Critical Question 1 2 3
X X X
4
XHow are-the following cell functions influenced by gravity and/or affected by microgravity: the expression and regulation of genetic
information; cell division; cell differentiation; signal transduction, including signal-membrane interactions, membrane-effector
interactions, and signal-effector linkage; membrane dynamics; intracellular transport; secretion; alternate pathway regulation; and
cell-to-cell communication? The importance of selecting cells and cell lines that can provide interpretable results bearing on precise
questions cannot be overemphasized.
How will altered gravitational fields and vectors change the information content of the three-dimensional microenvironment of the cells X X X X
stroma and matrix connections)? How does microgravity affect these signals under both homeostasis and challenge? Representative
challenges would be wounding of dermal fibroblasts and keratinocytes (or epidermal/dermal wounding in vivo), differentiation of
microvessel endothelial cells in vitro (or growth of the microvasculature in vivo, particularly following wounding or tumor
implantation), and application of stress to active osteoblasts (or bones in vivo).
How long can single cells cope with changes in gravitational force without adverse results? Do these effects persist after return to unit iX X X X
gravity?
What structural and morphometric alterations will occur in the extracellular matrix, the connective tissue, and the musculoskeletal X X X X
jsystems in long term spaceflight?
I-- How will this result in altered differentiation of cells, and in changed tissue composition?
What are the joint effects of radiation and microgravity? X IX X X
-- How do neoplasms common to chronological aging relate to limitation of cell lifespan and susceptibility to abnormal growth regulation
under altered gravitational fields?
What are the subcellular mechanisms whereby hair cells transduce acceleratory information, amplify it and bring about signal X X X X
transmission? Is there a fundamental mechanism that is true across the animal kingdom?
How does gravity affect the regulation of metabolism,? Basal metabolic rate? Energy, metabolism, storage and substrate utilization? X X X X
Body composition (fat and protein metabolism)?
What is the role of gravity in the regulation of the distribution, composition, and pressure of water/fluids in living systems from cells X X X X
to complex organisms? How do these changes influence other homeostatic and regulatory mechanisms?
How does microgravity affect the function including feeding behaviors of gastrointestinal function? X X X X
What is the role of gravity on sensory thresholds (audition, visual, taste, pain)? How do endocrine, neurohumoral, and metabolic X X X X
mechanisms influence this effect?
What role do endocrine and neural systems play in controlling/modifying adaptation to gravity? X X X X
How does gravity interact with other environmental factors to control regulatory physiology and behavior? X X X X
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8VI1 Is musculoskeletal growth, development, and function compromised during spaceflight and can they readapt upon return to Earth? The X X X X X X
structure and functional systems that should be examined carefully are: (1) the postural muscles, (2) muscle spindles, (3)
weight/load-bearing bones and joints, (4) intervertebral discs, (5) the architecture of the connective tissues of the body and (6)
musculoskeletal innervation.
8VI2 What are the systemic, local, cellular, and subcellular mechanisms involved in adaptation to altered gravity especially bioenergetics and X X X X X X
associated processes and cell-to-cell interactions?
8VI4 What is the role of fluid redistribution in the response of the musculoskeletal system to altered gravity and how does gravity impact the X X X X X IX
homeostasis of fluid compartments within tissues?
8VI6 What are the biochemical pathways responsible for synthesis, secretion, assembly, distribution, and degradation of structural and X X X X X
functional proteins in muscle in response to altered gravity?
8VI7 What are the transduction mechanisms that couple mechanical stress to musculoskeletal mass and strength? What are the activation and X X X X X
force development processes of muscle and bone cells?
8Vl9 What signals the musculoskeletal adaptation to spaceflight? Are the signals the same as those found in biomechanical unloading on Earth? X X X X X
8VI10 What local changes occur in the musculoskeletal system in response to changes in stresses, strains, and strain rates? X X X X X X
8V!15 Do various risk factors(e.g., age, gender, species, strain (race), nutrition) modulate the musculoskeletal response to altered gravity? X X X X X X
12 1 Do we need artificial gravity countermeasures to protect from physiological deconditioning of a mission to Mars? X X X X X X
12 2 How should artificial gravity be applied in terms of g-load, rotation rate, and intermittent versus continuous exposure? X X X X X X
Q.
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2d4
2d9
2e4
2ell
2e14
2e15
2fl
2f4
2f6
2gl
3a3
3a6
3a9
3a!2
3a13
Critical Question 1 2 3 4 5 6 7
What are the effects of space-induced endocrine changes on the function of other homeostatic systems (e.g. cardiovascular, central ,X X X X X X
nervous system, immune function, thermoregulation, reproductive system, gastrointestinal system, and energy metabolism)?
Are there in-vitro tests that reliably predict decreases in immune function in space flight? X X X X
What are the long-term effects of prolonged space flight after return to 1 g? X
How long do neutrophilia, lymphocytopenia, monocytopenia, eosinopenia, and reduced blastogenic responses persist after flight? X X iX
What are the pharmacokinetics (absorption, distribution, metabolism, and elimination) of drugs likely to be used in space? Which X X X iX X
methods of administering drugs are the most effective in providing a predictable response during space flight?
Does space flight alter gastrointestinal function, including the absorption of essential nutrients and the functioning of gut flora? What X X X X X
are the effects of space flight on liver function? Are the effects progressive? Are they reversible?
What is the nature of space flight-induced changes in effect of vasoactive drugs? X X X X X
What is the nature of space flight-induced effect of pharmocokinetics of drugs? X X X X _X
What are the time course and magnitude of fluid shifts and changes in fluid compartment volumes during acclimatization to hypogravity X X X X X
and during return to 1 g after flight?
What are the effects of microgravity on renal function, e.g. stone risk? Are the effects progressive? Are they reversible? Are there X X X X X X
differences in filtration, reabsorption, secretion, and excretion?
What are the time course and magnitude of the diuresis, natriuresis, and kaliuresis resulting from exposure to hypogravity? X X X X X
What are the effects of space flight and/or EVA on thermoregulation processes and heat exchange? X X X X
What are the cardiovascular responses to extravehicular activity (EVA) at various levels of gravity (e.g., microgravity, planetary X X X X X
surface exploration)? What factors influence the occurrence, magnitude, and sequence of these responses?
There is an increase in cardiac arrhythmias associated with space flight and, if so, what are the specific mechanisms responsible for X X X X
them?
Does the extent of adaptation affect postflight orthostatic tolerance? X X X X X
Following long-term space flight, are there delayed or persistent consequences, either beneficial or harmful? As a corollary, are there X X X X
appropriate rehabilitative measures that should be applied both in the near-term (hours to days) and long-term (months to years) after
flight?
Since microgravity alters blood pressures and flows to some tissues, what are the structural and functional consequences in these X X X X X
various tissues and organ systems with long-duration flights?
::3
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3b3
4b3
4c2
4c3
4c9
5a9
>
' 5a10
5c4
7g6
81111
In the environment of microgravity, does the absence of sedimentation cause deeper penetration by aerosol particles in the lung? In the X X X X
spacecraft environment, what are the aerosol concentrations, particle size profiles, and bacterial contaminations? Do these factors
iconstitute a health hazard?
lWhich pulmonary life support procedures should be used for effective protection or resuscitation of crewmembers in the event of loss of X X X
)ressure in the EVA suit or cabin, and for cardiopulmonary resuscitation and general anesthesia?
What is the effect of long-duration space flights on the human immune system? (Reg. Physiol see p. 6) X X X
What procedures and approaches prevent decompression sickness or minimize crew risk? iX X
Treatment of medical problems of spacecraft inner temperature, and adverse effects of the gaseous environment? X X X
What are the risks for bubble formation and clinical decompression sickness associated with various pre-EVA X X X
denitrogenation/decompression schedules and exercise?
Does the atrophy from unloading make muscle, tendon, and the myotendinous junction more susceptible to injury or damage on resuming X X X IX
normal weight-bearing states?
How completely and how well does injured muscle repair in microgravity? X X X X
What potential risks does bone loss present to the development of bone fractures, hypercalcemia, metastatic calcification, and renal X X X X
stone formation?
How are risks associated with acute exposure to space radiation to be managed medically? X X
How will the reproductive status of premenopausal female crewmembers be managed to minimize the risk of pregnancy, osteoporosis, X X X
and hemorrhage from ruptured follicles during ovulation? What is the role of gravity in developmental biology?
m Does the developmental ontogeny of animals raised through more than one life cycle under a changed gravity field differ from the 1-g
classical pattern? Does this altered pattern reside in the genome, or is it relayed from hormonal and stromal interactions?
-- Are there critical windows of susceptibility for developmental processes, or is development affected in a gradient?
-- If gravity-related effects exist, can they be reversed in the short- or long-term?
-- What will be the result of gravity-induced dys-synchrony (temporal or hormonal) during development?
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Quest#
81114
8Vb3
8Vb9
Critical Question
What are the effects on the male and female germ cells of protracted, chronic, low dose exposure to space radiation outside the Van
Allen belts? What events in gametogenesis and early germ cell maturation are gravity sensitive, and how can these results relate to the
oroliferation and differentiation of other individual cell types?
-- Can altered gravities affect fertilization, and do these results indicate more general mechanisms of membrane alteration in individual
cells?
-- Which responses are transmitted maternally, and which are intrinsic to the developing embryo?
-- What are the results of altered gravity fields on the axis polarity and symmetries of the zygote?
-- Are there gravity effects that can terminate in changes of gene activation?
What is the role of gravity on thirst and feeding behaviors (appetite, taste preference, and thresholds)?
How does gravity affect compensatory mechanisms (e.g. endocrine, organ, circulatory, regenerative processes)? What is the
interaction with growth stages? What is gravity's effect on wound healing?
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Adapt
ADV
AFT
AMAC
AMWG
ARC
BMAC
CELSS
CFR
CHeCS
CHROMEX
CNES
CNS
CS
CSA
CT
CV
DARA
DEF
DELIV
Demo
DEV
DMES
DOD
DOE
D.V.M
DWG
ECF
EDOMP
e.g.,
EHA
EHLSS
EHS
EMTC
EPA
ESA
etc.
EVA
FAC
FDA
FY
g
GCR
HDQ
HDT
HEI
HMF
Hyp
HZE
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ACRONYM LISTING
Adaptation
Advanced
Autogenic Feedback Training
Aerospace Medicine Advisory Committee
Aerospace Medicine Working Group
Ames Research Center
Biomedical Monitoring and Countermeasures
Controlled Ecological Life Support Systems
Code of Federal Regulations
Crew Health Care System
Chromosome Experiment
Centre National of Etudes Spatiales
Central Nervous System
Countermeasures Systems
Canadian Space Agency
Computerized Tomography
Cardiovascular
Deutsche Agentur Fur Raumfahrt Angelegenheiten
Definition
Deliverables
Demonstration
Development
Dimethylethoxysilane
Department of Defense
Department of Energy
Doctor of Veterinary Medicine
Discipline Working Group
Exercise Countermeasure Facility
Extended Duration Orbiter Medical Program
For Example
Extra-Habitat Activities
Environmental Health and Life Support Systems
Environmental Health System
Extended Man-Tended Capability
Environmental Protection Agency
European Space Agency
Et Cetera
Extra-Vehicular Activities
Facility
Food and Drug Administration
Fiscal Year
Gravity
Galactic Cosmic Radiation
Headquarters
Head Down Tilt
Human Exploration Initiative
Health Maintenance Facility
Hypergravity
Heavy Charged Particle
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i,e°_
IML
IOC
IPA
JEM
JSC
K
KSC
LABS
LBNP
LDM
LET
LMEPO
M.D.
M.P.H.
M.S.
MCS
Mech
MFPE
MRI
MS
MSRO
MSVR
MTC
MTPE
NASA
NASDA
Neurolab
Neuroscience
NIH
NMR
NOAA
NOC
NRC
NS
NSCORT
NSF
NSTS
02
OAST
OPS
OSSA
P
PC
Perf
Ph.D.
Physiol
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ACRONYM LISTING
High Atomic Number, Z, and Energy, E, Particles
For Example
International Microgravity Laboratory
Initial Operating Capability
Initial Operational Capability
Initial Payload Analysis
Japanese Experiment Module
Johnson Space Center
Thousands
Kennedy Space Center
Laboratories
Lower Body Negative Pressure
Long Duration Missions
Linear Energy Transfer
Lunar, Mars Exploration Planning Office
Medical Doctor
Master of Public Health
Master of Science
Medical Care Systems
Mechanics
Mission From Planet Earth
Magnetic Resonance Imaging
Musculoskeletal
Mars Site Reconnaissance Orbiters
Mars Surface Rovers
Man-Tended Capability
Mission To Planet Earth
National Aeronautics and Space Administration
National Space Development Agency of Japan
Neurological Laboratory
Neurological Science
National Institutes of Health
Nuclear Magnetic Resonance
National Oceanographic and Atmospheric Administration
Next Operating Capability
National Research Council
Neurosensory
NASA Specialized Center of Research and Training
National Science Foundation
National Space Transportation System
Oxygen
Office of Aeronautics and Space Technology
Operations
Office of Space Science and Applications
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Physico-Chemical
Performance
Doctor of Philosophy
Physiology
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PIs
PMC
Psych
Reg
REPT
REQ
REQTS
RES
Resp
Ret
RTOP
SBI
SCI
Secr
SEI
SETI
Sim
Skylab
SL-J
SLS
SMAC
Spacelabs
SPE
SSF
TBD
Tech
TECH
U.S.
U.S.S.R.
Univ.
US
USAF
USDA
VS
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ACRONYM LISTING
Principal Investigators
Permanently Man-tended Capability
Psychological
Regulatory
Report
Requirements
Requirements
Research
Response
Retired
Research and Technology Operating Plan
Space Biology Initiative
Science
Sciences
Secretion
Space Exploration Initiative
Search for Extraterrestrial Intelligence
Simulated
Sky Laboratory
Space Laboratory-Japan
Space Life Sciences
Spacecraft Maximum Allowable Concentration
Space Laboratories
Solar Particular Events
Space Station Freedom
To Be Determined
Technical
Technology
United States
United Soviet Socialist Republics
University
United States
United States Air Force
United States Department of Agriculture
Versus
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Microgravity
Less Than
Greater Than
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